<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page1-div" style="position:relative;width:918px;height:1188px;">
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft20{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft21{font-size:11px;font-family:Times;color:#211f21;}
	.ft22{font-size:10px;font-family:Times;color:#ffffff;}
	.ft23{font-size:13px;font-family:Times;color:#ffffff;}
	.ft24{font-size:19px;font-family:Times;color:#ac2b30;}
	.ft25{font-size:14px;font-family:Times;color:#211f21;}
	.ft26{font-size:7px;font-family:Times;color:#ad393e;}
	.ft27{font-size:8px;font-family:Times;color:#ad393e;}
	.ft28{font-size:10px;font-family:Times;color:#211f1f;}
	.ft29{font-size:9px;font-family:Times;color:#211f21;}
	.ft210{font-size:9px;font-family:Times;color:#211f21;}
	.ft211{font-size:9px;font-family:Times;color:#211f21;}
	.ft212{font-size:7px;font-family:Times;color:#231f20;}
	.ft213{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft214{font-size:11px;font-family:Times;color:#211f21;}
	.ft215{font-size:11px;font-family:Times;color:#211f21;}
	.ft216{font-size:13px;font-family:Times;color:#211f21;}
	.ft217{font-size:19px;line-height:42px;font-family:Times;color:#ac2b30;}
	.ft218{font-size:10px;line-height:21px;font-family:Times;color:#211f1f;}
	.ft219{font-size:9px;line-height:19px;font-family:Times;color:#211f21;}
	.ft220{font-size:9px;line-height:19px;font-family:Times;color:#211f21;}
	.ft221{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page2-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft20">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft21">3287</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft20">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:67px;left:77px;white-space:nowrap" class="ft22"><b>www.impactjournals.com/oncotarget/&#160;</b></p>
<p style="position:absolute;top:65px;left:625px;white-space:nowrap" class="ft23"><b>Oncotarget, Vol. 5, No. 10</b></p>
<p style="position:absolute;top:122px;left:87px;white-space:nowrap" class="ft24"><b>Transmembrane voltage potential of somatic cells controls&#160;</b></p>
<p style="position:absolute;top:147px;left:87px;white-space:nowrap" class="ft217"><b>oncogene-mediated tumorigenesis at long-range&#160;<br/>Brook T. Chernet1&#160;and Michael Levin1</b></p>
<p style="position:absolute;top:212px;left:87px;white-space:nowrap" class="ft27"><b>1&#160;</b>Center&#160;for&#160;Regenerative&#160;and&#160;Developmental&#160;Biology&#160;and&#160;Department&#160;of&#160;Biology&#160;Tufts&#160;University&#160;200&#160;Boston&#160;Avenue,Suite&#160;</p>
<p style="position:absolute;top:231px;left:87px;white-space:nowrap" class="ft219">4600 Medford, MA 02155 U.S.A.&#160;<br/><i><b>Correspondence to</b>: Michael Levin,&#160;<b>email</b>: michael.levin@tufts.edu<br/><b>Keywords</b></i>:&#160;cancer,&#160;tumors,&#160;ion channels, bioelectricity,&#160;resting potential,&#160;V</p>
<p style="position:absolute;top:281px;left:516px;white-space:nowrap" class="ft212">mem,&#160;transmembrane&#160;potential,&#160;HDAC,&#160;butyrate,&#160;micro-</p>
<p style="position:absolute;top:292px;left:87px;white-space:nowrap" class="ft220">environment, bacteria<br/><i><b>Received</b>: April 14, 2014&#160;</i></p>
<p style="position:absolute;top:311px;left:291px;white-space:nowrap" class="ft29"><i><b>Accepted</b>: April 30, 2014&#160;</i></p>
<p style="position:absolute;top:311px;left:507px;white-space:nowrap" class="ft29"><i><b>Published</b>: May 1, 2014</i></p>
<p style="position:absolute;top:337px;left:87px;white-space:nowrap" class="ft211">This is an open-access article distributed under the terms of the Creative Commons&#160;Attribution License, which permits unrestricted use,&#160;</p>
<p style="position:absolute;top:351px;left:87px;white-space:nowrap" class="ft220">distribution, and reproduction in any medium, provided the original author and source are credited.&#160;<br/><b>ABSTRACT:</b></p>
<p style="position:absolute;top:403px;left:177px;white-space:nowrap" class="ft214"><b>The microenvironment is increasingly recognized as a crucial aspect&#160;of cancer. In&#160;</b></p>
<p style="position:absolute;top:422px;left:141px;white-space:nowrap" class="ft221"><b>contrast&#160;and&#160;complement&#160;to&#160;the&#160;field’s&#160;focus&#160;on&#160;biochemical&#160;factors&#160;and&#160;extracellular&#160;<br/>matrix,&#160;&#160;we&#160;&#160;characterize&#160;&#160;a&#160;&#160;novel&#160;&#160;aspect&#160;&#160;of&#160;&#160;host:tumor&#160;&#160;interaction&#160;&#160;–&#160;&#160;endogenous&#160;<br/>bioelectric&#160;signals&#160;among&#160;non-excitable&#160;somatic&#160;cells.&#160;Extending&#160;prior&#160;work&#160;focused&#160;<br/>on&#160;the&#160;bioelectric&#160;state&#160;of&#160;cancer&#160;cells&#160;themselves,&#160;we&#160;show&#160;for&#160;the&#160;first&#160;time&#160;that&#160;the&#160;<br/>resting&#160;potentials&#160;of&#160;distant&#160;cells&#160;are&#160;critical&#160;for&#160;oncogene-dependent&#160;tumorigenesis.&#160;<br/>In the&#160;<i>Xenopus laevis</i></b><b>&#160;tadpole model, we used human oncogenes such as mutant&#160;KRAS&#160;<br/>to&#160;drive&#160;formation&#160;of&#160;tumor-like&#160;structures&#160;that&#160;exhibited&#160;overproliferation,&#160;increased&#160;<br/>nuclear&#160;size,&#160;hypoxia,&#160;acidity,&#160;and&#160;leukocyte&#160;attraction.&#160;Remarkably,&#160;misexpression&#160;<br/>of&#160;&#160;hyperpolarizing&#160;&#160;ion&#160;&#160;channels&#160;&#160;at&#160;&#160;distant&#160;&#160;sites&#160;&#160;within&#160;&#160;the&#160;&#160;tadpole&#160;&#160;significantly&#160;<br/>reduced&#160;the incidence&#160;of these tumors. The suppression&#160;of tumorigenesis could also&#160;<br/>be&#160;achieved by&#160;hyperpolarization&#160;using native&#160;CLIC1&#160;chloride&#160;channels,&#160;suggesting&#160;a&#160;<br/>treatment modality not requiring gene therapy. Using a dominant&#160;negative approach,&#160;<br/>we implicate HDAC1 as the mechanism by which resting potential changes affect&#160;<br/>downstream cell behaviors. Based on published data on the voltage-mediated changes&#160;<br/>of&#160;butyrate&#160;flux&#160;through&#160;the&#160;SLC5A8&#160;transporter,&#160;we&#160;present&#160;a&#160;model&#160;linking&#160;resting&#160;<br/>potentials of host&#160;cells to&#160;the ability of oncogenes to&#160;initiate tumorigenesis. Antibiotic&#160;<br/>data&#160;suggest that&#160;the relevant butyrate is generated by a native bacterial species,&#160;<br/>identifying a novel link between the microbiome and cancer that&#160;is mediated by&#160;<br/>alterations in bioelectric signaling.&#160;</b></p>
<p style="position:absolute;top:808px;left:87px;white-space:nowrap" class="ft213"><b>INTRODUCTION</b></p>
<p style="position:absolute;top:848px;left:123px;white-space:nowrap" class="ft216">Normal embryonic development, as well as&#160;</p>
<p style="position:absolute;top:866px;left:87px;white-space:nowrap" class="ft216">repair and dynamic maintenance of complex structures&#160;</p>
<p style="position:absolute;top:884px;left:87px;white-space:nowrap" class="ft216">throughout the lifespan, both depends upon a set of signals&#160;</p>
<p style="position:absolute;top:902px;left:87px;white-space:nowrap" class="ft216">that&#160;keeps individual cell activities orchestrated toward the&#160;</p>
<p style="position:absolute;top:920px;left:87px;white-space:nowrap" class="ft216">large-scale&#160;anatomical&#160;goals&#160;of&#160;the&#160;host.&#160;Morphogenesis&#160;</p>
<p style="position:absolute;top:938px;left:87px;white-space:nowrap" class="ft216">and remodeling can be challenged by cancer, which can&#160;</p>
<p style="position:absolute;top:956px;left:87px;white-space:nowrap" class="ft216">be viewed as a process in which cells escape or become&#160;</p>
<p style="position:absolute;top:974px;left:87px;white-space:nowrap" class="ft216">isolated from the normally tight morphogenetic control&#160;</p>
<p style="position:absolute;top:992px;left:87px;white-space:nowrap" class="ft216">of the organism [1-6].&#160;To achieve robust development,&#160;</p>
<p style="position:absolute;top:1010px;left:87px;white-space:nowrap" class="ft216">signaling pathways need to affect their target cells with&#160;</p>
<p style="position:absolute;top:1028px;left:87px;white-space:nowrap" class="ft216">sufficient&#160;&#160;spatiotemporal&#160;&#160;resolution&#160;&#160;to&#160;&#160;integrate&#160;&#160;organ&#160;</p>
<p style="position:absolute;top:1046px;left:87px;white-space:nowrap" class="ft216">sculpting,&#160;anatomical&#160;polarity,&#160;tissue&#160;identity,&#160;and&#160;growth&#160;</p>
<p style="position:absolute;top:1064px;left:87px;white-space:nowrap" class="ft216">rates&#160;appropriate&#160;to the large-scale&#160;order&#160;maintenance&#160;</p>
<p style="position:absolute;top:810px;left:487px;white-space:nowrap" class="ft216">within&#160;the&#160;body.&#160;In&#160;the&#160;context&#160;of&#160;cancer,&#160;it&#160;has&#160;been&#160;well&#160;</p>
<p style="position:absolute;top:828px;left:487px;white-space:nowrap" class="ft216">documented that healthy neighboring cells help to stabilize&#160;</p>
<p style="position:absolute;top:846px;left:487px;white-space:nowrap" class="ft216">aberrant cell behavior [7-9] to control tumorigenesis&#160;</p>
<p style="position:absolute;top:864px;left:487px;white-space:nowrap" class="ft216">by tissue-level organization that adheres to the proper&#160;</p>
<p style="position:absolute;top:882px;left:487px;white-space:nowrap" class="ft216">patterning&#160;needs&#160;of&#160;the&#160;host&#160;[10-14].&#160;Indeed,&#160;fascinating&#160;</p>
<p style="position:absolute;top:900px;left:487px;white-space:nowrap" class="ft216">classical and recent data show that actively patterning&#160;</p>
<p style="position:absolute;top:918px;left:487px;white-space:nowrap" class="ft216">environments, such as embryos and regenerating&#160;</p>
<p style="position:absolute;top:936px;left:487px;white-space:nowrap" class="ft216">amphibian limbs, can normalize and reprogram tumors&#160;</p>
<p style="position:absolute;top:954px;left:487px;white-space:nowrap" class="ft216">[15-31].&#160;Thus, in addition to any cell-autonomous&#160;</p>
<p style="position:absolute;top:972px;left:487px;white-space:nowrap" class="ft216">properties that may have gone awry in cancer cells, it is&#160;</p>
<p style="position:absolute;top:990px;left:487px;white-space:nowrap" class="ft216">crucial&#160;to&#160;understand&#160;the&#160;non-cell-autonomous&#160;patterning&#160;</p>
<p style="position:absolute;top:1008px;left:487px;white-space:nowrap" class="ft216">signals that may be exploited to prevent and treat cancer.&#160;</p>
<p style="position:absolute;top:1026px;left:523px;white-space:nowrap" class="ft216">Endogenous bioelectric signaling among all&#160;</p>
<p style="position:absolute;top:1044px;left:487px;white-space:nowrap" class="ft216">(not just excitable) cell types is one component of&#160;</p>
<p style="position:absolute;top:1062px;left:487px;white-space:nowrap" class="ft216">the microenvironment, and is now known to mediate&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft30{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft31{font-size:11px;font-family:Times;color:#211f21;}
	.ft32{font-size:13px;font-family:Times;color:#211f21;}
	.ft33{font-size:6px;font-family:Times;color:#211f21;}
	.ft34{font-size:13px;font-family:Times;color:#211f21;}
	.ft35{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft36{font-size:14px;font-family:Times;color:#211f21;}
	.ft37{font-size:6px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page3-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft30">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft31">3288</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft30">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft32">instructive information&#160;for&#160;large-scale pattern&#160;formation&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft32">[32, 33]. Bioelectrical processes, such as extracellular&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft32">electric&#160;&#160;fields&#160;&#160;and&#160;&#160;transmembrane&#160;&#160;resting&#160;&#160;potentials&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft32">produced&#160;by ion&#160;channel&#160;and&#160;pump&#160;proteins,&#160;regulate&#160;cell&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft32">activity [34-36]. In particular, proliferation, differentiation,&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft32">migration, and apoptosis are all important cell behaviors&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft32">relevant to cancer that are guided partly by bioelectric&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft32">signals, such as resting voltage potential (V</p>
<p style="position:absolute;top:208px;left:360px;white-space:nowrap" class="ft33">mem) in non-</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft32">excitable cells [37-39]. It was recognized long ago that&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft32">the&#160;electrical&#160;properties&#160;of&#160;mature&#160;tumors&#160;differ&#160;from&#160;that&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft32">of healthy tissue [40-42], and we recently showed that&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft32">monitoring of a distinctly depolarized resting potential&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft32">allows early detection of tumors&#160;<i>in vivo</i>. Moreover, forced&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft32">hyperpolarization via&#160;a number&#160;of different&#160;channels&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft32">prevents those cells from forming tumors [43], revealing&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft32">resting potential as an instructive cue and not merely&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft32">a marker [39]. Indeed, a number of ion channels are&#160;</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft32">now known to be&#160;<i>bona&#160;fide</i>&#160;oncogenes [44-54], and ion&#160;</p>
<p style="position:absolute;top:394px;left:87px;white-space:nowrap" class="ft32">channel blockers are an important area for cancer drug&#160;</p>
<p style="position:absolute;top:412px;left:87px;white-space:nowrap" class="ft32">development [55-58].&#160;</p>
<p style="position:absolute;top:430px;left:123px;white-space:nowrap" class="ft32">However,&#160;it&#160;is&#160;important&#160;to&#160;note&#160;that&#160;ion&#160;channels&#160;</p>
<p style="position:absolute;top:448px;left:87px;white-space:nowrap" class="ft32">are&#160;not&#160;simply molecular markers&#160;or&#160;targets&#160;within&#160;the&#160;</p>
<p style="position:absolute;top:466px;left:87px;white-space:nowrap" class="ft32">cancer&#160;cells&#160;themselves.&#160;Gradients&#160;of&#160;resting&#160;potential&#160;are&#160;</p>
<p style="position:absolute;top:484px;left:87px;white-space:nowrap" class="ft32">a long-range, global system for exerting patterning control,&#160;</p>
<p style="position:absolute;top:502px;left:87px;white-space:nowrap" class="ft32">and thus a tractable candidate for manipulation of the&#160;</p>
<p style="position:absolute;top:520px;left:87px;white-space:nowrap" class="ft32">crosstalk&#160;by&#160;which&#160;microenvironment&#160;suppresses&#160;aberrant&#160;</p>
<p style="position:absolute;top:538px;left:87px;white-space:nowrap" class="ft32">cell behavior [59]. For example, selective depolarization&#160;</p>
<p style="position:absolute;top:556px;left:87px;white-space:nowrap" class="ft32">of glycine-gated chloride channel-expressing cells in&#160;</p>
<p style="position:absolute;top:574px;left:87px;white-space:nowrap" class="ft32">the&#160;<i>Xenopus</i>&#160;model results in a metastatic conversion of&#160;</p>
<p style="position:absolute;top:592px;left:87px;white-space:nowrap" class="ft32">melanocytes,&#160;which&#160;over-proliferate,&#160;acquire&#160;an&#160;arborized&#160;</p>
<p style="position:absolute;top:610px;left:87px;white-space:nowrap" class="ft32">shape, and invade blood vessels and soft tissues in an&#160;</p>
<p style="position:absolute;top:628px;left:87px;white-space:nowrap" class="ft32">MMP-dependent manner [46, 60, 61].&#160;This effect occurs&#160;</p>
<p style="position:absolute;top:646px;left:87px;white-space:nowrap" class="ft32">at considerable distance, via a serotonergic pathway, and&#160;</p>
<p style="position:absolute;top:664px;left:87px;white-space:nowrap" class="ft32">demonstrates&#160;how&#160;disruption&#160;of&#160;long-range&#160;endogenous&#160;</p>
<p style="position:absolute;top:682px;left:87px;white-space:nowrap" class="ft32">physiological signaling can activate a cancer phenotype in&#160;</p>
<p style="position:absolute;top:700px;left:87px;white-space:nowrap" class="ft32">the absence of carcinogen exposure or DNA&#160;damage.&#160;The&#160;</p>
<p style="position:absolute;top:718px;left:87px;white-space:nowrap" class="ft32">data suggest that bioelectric gradients are&#160;a fascinating&#160;</p>
<p style="position:absolute;top:736px;left:87px;white-space:nowrap" class="ft32">new aspect of cancer:host interaction, and that the notion&#160;</p>
<p style="position:absolute;top:754px;left:87px;white-space:nowrap" class="ft32">of microenvironment may need to be expanded to account&#160;</p>
<p style="position:absolute;top:772px;left:87px;white-space:nowrap" class="ft32">for long-range interactions mediated by&#160;V</p>
<p style="position:absolute;top:784px;left:359px;white-space:nowrap" class="ft33">mem&#160;changes&#160;</p>
<p style="position:absolute;top:790px;left:87px;white-space:nowrap" class="ft32">throughout tissues.</p>
<p style="position:absolute;top:808px;left:123px;white-space:nowrap" class="ft32">The existing literature&#160;on roles of ionic signaling in&#160;</p>
<p style="position:absolute;top:826px;left:87px;white-space:nowrap" class="ft32">cancer leaves open a number of fundamental questions.&#160;</p>
<p style="position:absolute;top:844px;left:87px;white-space:nowrap" class="ft32">What role might remote&#160;V</p>
<p style="position:absolute;top:856px;left:275px;white-space:nowrap" class="ft33">mem&#160;modulation play in&#160;</p>
<p style="position:absolute;top:862px;left:87px;white-space:nowrap" class="ft32">oncogene-induced&#160;carcinogenesis?&#160;While&#160;distant&#160;changes&#160;</p>
<p style="position:absolute;top:880px;left:87px;white-space:nowrap" class="ft32">of resting potential can trigger a metastatic conversion [60,&#160;</p>
<p style="position:absolute;top:898px;left:87px;white-space:nowrap" class="ft32">61], it is not known whether or how such signaling plays&#160;</p>
<p style="position:absolute;top:916px;left:87px;white-space:nowrap" class="ft32">a&#160;role&#160;when&#160;canonical&#160;oncogenes&#160;initiate&#160;tumorigenesis.&#160;A&#160;</p>
<p style="position:absolute;top:934px;left:87px;white-space:nowrap" class="ft32">better understanding of the microenvironment and long-</p>
<p style="position:absolute;top:952px;left:87px;white-space:nowrap" class="ft32">range aspects of aberrant growth control by endogenous&#160;</p>
<p style="position:absolute;top:970px;left:87px;white-space:nowrap" class="ft32">developmental&#160;patterning&#160;mechanisms&#160;would&#160;have&#160;</p>
<p style="position:absolute;top:988px;left:87px;white-space:nowrap" class="ft32">significant&#160;implications&#160;for&#160;design&#160;of&#160;novel&#160;therapeutic&#160;</p>
<p style="position:absolute;top:1006px;left:87px;white-space:nowrap" class="ft32">approaches to prevent and reprogram cancer.</p>
<p style="position:absolute;top:1024px;left:123px;white-space:nowrap" class="ft32">Here, we use mRNA&#160;encoding human tumor&#160;</p>
<p style="position:absolute;top:1042px;left:87px;white-space:nowrap" class="ft32">inducers&#160;(<i>Gli1,&#160;XRel3,&#160;KRAS</i>)&#160;in&#160;<i>Xenopus&#160;laevis</i>&#160;embryos&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft32">to&#160;initiate growth of tumor like structures (ITLS) that&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft32">highly resemble classic tumors. Remarkably, forced&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft32">hyperpolarization&#160;&#160;(by&#160;&#160;misexpression&#160;&#160;of&#160;&#160;specific&#160;&#160;ion&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft32">channels) is able to suppress ITLS formation, despite high&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft32">levels&#160;of oncogene&#160;protein,&#160;even&#160;when the&#160;hyperpolarized&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft32">cells are at a considerable distance from the oncogene-</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft32">expressing tumor site.&#160;The suppression effect can also be&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft32">exerted&#160;by&#160;native&#160;chloride&#160;intracellular&#160;channel&#160;1&#160;(CLIC1)-</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft32">mediated hyperpolarization, revealing an endogenous&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft32">target for bioelectric control of abnormal growth that&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft32">does not require transgene expression.&#160;We show that&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft32">the&#160;suppression&#160;effects&#160;of&#160;distant&#160;hyperpolarization&#160;are&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft32">mediated by voltage control of a butyrate and histone&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft32">deacetylase mechanism.&#160;Together, these data reveal the&#160;</p>
<p style="position:absolute;top:322px;left:487px;white-space:nowrap" class="ft32">first&#160;mechanistic&#160;details&#160;of&#160;V</p>
<p style="position:absolute;top:334px;left:665px;white-space:nowrap" class="ft33">mem&#160;as a powerful, tractable&#160;</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft32">regulator&#160;of&#160;long-range&#160;signaling between&#160;cancer&#160;cells&#160;</p>
<p style="position:absolute;top:358px;left:487px;white-space:nowrap" class="ft32">and&#160;the&#160;host and&#160;suggest&#160;several&#160;new&#160;entry&#160;points&#160;for&#160;</p>
<p style="position:absolute;top:376px;left:487px;white-space:nowrap" class="ft32">biomedical strategies.</p>
<p style="position:absolute;top:413px;left:487px;white-space:nowrap" class="ft35"><b>RESULTS</b></p>
<p style="position:absolute;top:470px;left:487px;white-space:nowrap" class="ft36"><b>Induced tumor-like structures (ITLS) exhibit&#160;</b></p>
<p style="position:absolute;top:490px;left:487px;white-space:nowrap" class="ft36"><b>striking key similarities to human tumors</b></p>
<p style="position:absolute;top:536px;left:523px;white-space:nowrap" class="ft32">To&#160;study&#160;the&#160;role&#160;of&#160;bioelectric&#160;events&#160;to&#160;oncogene-</p>
<p style="position:absolute;top:554px;left:487px;white-space:nowrap" class="ft32">mediated tumorigenesis, we took advantage of&#160;<i>Xenopus&#160;</i></p>
<p style="position:absolute;top:572px;left:487px;white-space:nowrap" class="ft32">laevis embryos – a model system that is ideal for&#160;</p>
<p style="position:absolute;top:590px;left:487px;white-space:nowrap" class="ft32">molecular biophysics approaches and&#160;also&#160;has been&#160;</p>
<p style="position:absolute;top:608px;left:487px;white-space:nowrap" class="ft32">increasingly used for cancer research[43, 61-66].&#160;We&#160;</p>
<p style="position:absolute;top:626px;left:487px;white-space:nowrap" class="ft32">injected mRNAs&#160;encoding&#160;Xrel3 and&#160;human&#160;<i>KRASG12D</i>&#160;into&#160;</p>
<p style="position:absolute;top:644px;left:487px;white-space:nowrap" class="ft34"><i>Xenopus</i>&#160;embryos;&#160;these oncogenes&#160;are&#160;known&#160;to cause&#160;</p>
<p style="position:absolute;top:662px;left:487px;white-space:nowrap" class="ft32">morphologically apparent ITLS in up to 50% of injected&#160;</p>
<p style="position:absolute;top:680px;left:487px;white-space:nowrap" class="ft32">embryos without any other developmental defects. ITLS&#160;</p>
<p style="position:absolute;top:698px;left:487px;white-space:nowrap" class="ft32">have previously been characterized as having some of&#160;</p>
<p style="position:absolute;top:716px;left:487px;white-space:nowrap" class="ft32">the hallmarks of human tumors – increased proliferation,&#160;</p>
<p style="position:absolute;top:734px;left:487px;white-space:nowrap" class="ft32">vasculature attraction, lack of differentiation, invasiveness&#160;</p>
<p style="position:absolute;top:752px;left:487px;white-space:nowrap" class="ft32">and transplantability to healthy recipients [43, 67-69].&#160;</p>
<p style="position:absolute;top:770px;left:487px;white-space:nowrap" class="ft32">We&#160;began&#160;by further&#160;investigating&#160;the&#160;pathology&#160;of the&#160;</p>
<p style="position:absolute;top:788px;left:487px;white-space:nowrap" class="ft32">affected&#160;tissue&#160;to&#160;confirm&#160;and&#160;expand&#160;the&#160;relevance&#160;of&#160;</p>
<p style="position:absolute;top:806px;left:487px;white-space:nowrap" class="ft34"><i>Xenopus</i>&#160;as a medically-relevant cancer model.</p>
<p style="position:absolute;top:824px;left:523px;white-space:nowrap" class="ft32">Clinically-relevant tumors exhibit a surplus of&#160;</p>
<p style="position:absolute;top:842px;left:487px;white-space:nowrap" class="ft32">proliferative capacity [70].&#160;To characterize the cell&#160;</p>
<p style="position:absolute;top:860px;left:487px;white-space:nowrap" class="ft32">proliferation dynamics in ITLS loci, we monitored&#160;</p>
<p style="position:absolute;top:878px;left:487px;white-space:nowrap" class="ft32">dynamic patterns of cell cycle progression in ITLS&#160;</p>
<p style="position:absolute;top:896px;left:487px;white-space:nowrap" class="ft32">and unaffected regions using FUCCI (<i>f</i>luorescent&#160;</p>
<p style="position:absolute;top:914px;left:487px;white-space:nowrap" class="ft34"><i>u</i>biquitination-based&#160;&#160;<i>c</i>ell&#160;&#160;<i>c</i>ycle&#160;&#160;<i>i</i>ndicator) pair: mKO2-</p>
<p style="position:absolute;top:932px;left:487px;white-space:nowrap" class="ft32">Cdt1 and mAG-Geminin [71, 72].&#160;The accumulation of&#160;</p>
<p style="position:absolute;top:950px;left:487px;white-space:nowrap" class="ft32">these&#160;two&#160;cell&#160;cycle&#160;regulators –&#160;in&#160;nuclei&#160;of&#160;transfected&#160;</p>
<p style="position:absolute;top:968px;left:487px;white-space:nowrap" class="ft32">cells – in a mutually&#160;exclusive&#160;manner between G1(Cdt1)&#160;</p>
<p style="position:absolute;top:986px;left:487px;white-space:nowrap" class="ft32">and G2/S/M (Geminin) phases, allowed us to monitor&#160;</p>
<p style="position:absolute;top:1004px;left:487px;white-space:nowrap" class="ft32">spatial dynamics of cell cycle progression: while the&#160;</p>
<p style="position:absolute;top:1022px;left:487px;white-space:nowrap" class="ft32">number of ITLS cells in G1 and control cells in G1&#160;</p>
<p style="position:absolute;top:1040px;left:487px;white-space:nowrap" class="ft32">and&#160;G2/S/M phases are statistically the same, twice as&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft40{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft41{font-size:11px;font-family:Times;color:#211f21;}
	.ft42{font-size:13px;font-family:Times;color:#211f21;}
	.ft43{font-size:13px;font-family:Times;color:#211f21;}
	.ft44{font-size:13px;font-family:Times;color:#211f21;}
	.ft45{font-size:11px;font-family:Times;color:#211f21;}
	.ft46{font-size:5px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page4-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft40">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft41">3289</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft40">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft42">many cells in G2/S/M phases were present in ITLS by&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft42">comparison (<i>N</i>=8 per category,&#160;ANOVA,&#160;<i>P&lt;0.001</i>) (Fig.&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft42">1A).&#160;</p>
<p style="position:absolute;top:124px;left:123px;white-space:nowrap" class="ft42">Next, we examined the extent of hypoxia within&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft42">ITLS&#160;loci,&#160;since&#160;hypoxia&#160;is&#160;known&#160;to&#160;be&#160;present&#160;in&#160;tumors&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft42">[73-75].&#160;Treatment of ITLS bearing embryos (<i>N</i>=7) with&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft42">the hypoxia marker pimonidazole revealed a 12-fold&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft42">increase (<i>t</i>-test; p&lt;0.0001) for immunoperoxidase staining&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft42">for hypoxia (Fig. 1B).&#160;This is consistent with data obtained&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft42">from pimonidazole-based qualitative and quantitative&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft42">assessment of tumor hypoxia, where an increase in the&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft42">frequency of detecting pimonidazole adducts is reported&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft42">[76-78].&#160;</p>
<p style="position:absolute;top:304px;left:123px;white-space:nowrap" class="ft42">We next examined histological features of the&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft42">ITLS using hematoxylin and eosin (H&amp;E) [79]. Cells&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft42">within the ITLS exhibited disorganized growth patterns,&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft42">including&#160;misplaced&#160;mesodermal&#160;and endodermal&#160;cells,&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft42">and mesodermal cells that were larger than those present&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft42">in&#160;unperturbed&#160;regions,&#160;revealing&#160;features&#160;consistent&#160;with&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft42">neoplasia (Fig. 1C).</p>
<p style="position:absolute;top:124px;left:523px;white-space:nowrap" class="ft42">We next examined a change in nuclear size, which&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft42">is another well-known aspect of tumor tissue [80, 81].&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft42">Computer-aided&#160;image&#160;analysis of the&#160;area&#160;of 2371 nuclei&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft42">each from 16 ITLS and 16 control regions of oncogene-</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft42">injected tadpoles showed on average a 10% increase in&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft42">nuclear size of ITLS, mirroring similar phenomenon&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft42">observed between different stages of human breast cancer&#160;</p>
<p style="position:absolute;top:396px;left:87px;white-space:nowrap" class="ft44"><b>Figure 1: Induced tumor-like structures (ITLS)&#160;exhibit&#160;</b></p>
<p style="position:absolute;top:414px;left:87px;white-space:nowrap" class="ft44"><b>characteristics reminiscent of human&#160;tumors.&#160;</b>(A)&#160;Rates&#160;</p>
<p style="position:absolute;top:432px;left:87px;white-space:nowrap" class="ft41">of proliferation&#160;were analyzed&#160;<i>in vivo</i>&#160;in&#160;fluorescent&#160;cell&#160;cycle&#160;</p>
<p style="position:absolute;top:449px;left:87px;white-space:nowrap" class="ft41">indicators&#160;(FUCCI pair:&#160;mKO2-zCdt1 and mAG-zGeminin)&#160;</p>
<p style="position:absolute;top:465px;left:87px;white-space:nowrap" class="ft41">injected,&#160;ITLS-bearing&#160;embryos at&#160;stage&#160;34. ITLS regions&#160;</p>
<p style="position:absolute;top:481px;left:87px;white-space:nowrap" class="ft41">(black&#160;bars) have&#160;&gt;65%&#160;more&#160;cells&#160;that&#160;are&#160;in&#160;G2/S/M phase&#160;</p>
<p style="position:absolute;top:497px;left:87px;white-space:nowrap" class="ft41">(green insert, mAG-zGeminin) than there are in G1&#160;phase (red&#160;</p>
<p style="position:absolute;top:513px;left:87px;white-space:nowrap" class="ft41">insert, mKO2-zCdt1). Unperturbed regions (grey bars) showed&#160;</p>
<p style="position:absolute;top:530px;left:87px;white-space:nowrap" class="ft41">no difference&#160;between the number of cells&#160;in G1 (red insert)&#160;</p>
<p style="position:absolute;top:546px;left:87px;white-space:nowrap" class="ft41">and&#160;G2/S/M (green&#160;insert)&#160;phases.&#160;<i>N</i>=8&#160;for all&#160;four categories.&#160;</p>
<p style="position:absolute;top:562px;left:87px;white-space:nowrap" class="ft45"><i>P</i>&lt;0.001, one-way&#160;ANOVA, tukey’s post hoc analysis;&#160;different&#160;</p>
<p style="position:absolute;top:578px;left:87px;white-space:nowrap" class="ft41">letters&#160;indicate&#160;statistically&#160;significant&#160;difference;&#160;scale&#160;bar&#160;=&#160;250&#160;</p>
<p style="position:absolute;top:594px;left:87px;white-space:nowrap" class="ft41">µm.(B) Immunoperoxidase analysis of hypoxia using detection&#160;</p>
<p style="position:absolute;top:611px;left:87px;white-space:nowrap" class="ft41">of&#160;pimonidazole&#160;protein&#160;adducts&#160;(black&#160;arrowhead)&#160;in&#160;cells&#160;</p>
<p style="position:absolute;top:627px;left:87px;white-space:nowrap" class="ft41">reveals a 12 fold increase for immunoperoxidase&#160;staining for&#160;</p>
<p style="position:absolute;top:643px;left:87px;white-space:nowrap" class="ft41">hypoxia per unit area in ITLS (yellow traces) than in surrounding&#160;</p>
<p style="position:absolute;top:659px;left:87px;white-space:nowrap" class="ft41">healthy&#160;tissue.&#160;<i>N</i>=7; *<i>P</i>&lt;0.0001 Student’s&#160;<i>t</i>-test;&#160;scale&#160;bar =&#160;</p>
<p style="position:absolute;top:675px;left:87px;white-space:nowrap" class="ft41">500 µm.(C) H&amp;E staining of&#160;<i>KRAS</i>G12D&#160;ITLS sections (yellow&#160;</p>
<p style="position:absolute;top:692px;left:87px;white-space:nowrap" class="ft41">circular trace, 40X)&#160;for evidence of features of neoplasia reveals&#160;</p>
<p style="position:absolute;top:708px;left:87px;white-space:nowrap" class="ft41">disorganized&#160;growth patterns,&#160;including misplaced&#160;mesodermal&#160;</p>
<p style="position:absolute;top:724px;left:87px;white-space:nowrap" class="ft41">and endodermal&#160;cells,&#160;and mesodermal&#160;cells&#160;that&#160;are larger than&#160;</p>
<p style="position:absolute;top:740px;left:87px;white-space:nowrap" class="ft41">those&#160;present&#160;in&#160;unperturbed&#160;regions. (D)&#160;Automated&#160;analysis&#160;of&#160;</p>
<p style="position:absolute;top:756px;left:87px;white-space:nowrap" class="ft41">the&#160;size&#160;of Hoechst Blue&#160;stained&#160;nuclei&#160;reveals&#160;a 10% increase&#160;</p>
<p style="position:absolute;top:773px;left:87px;white-space:nowrap" class="ft41">in the size of tumor nuclei compared to nuclei from unaffected&#160;</p>
<p style="position:absolute;top:789px;left:87px;white-space:nowrap" class="ft41">cells.&#160;A&#160;change&#160;in morpholology&#160;of the&#160;nuclei&#160;that&#160;includes&#160;a&#160;</p>
<p style="position:absolute;top:805px;left:87px;white-space:nowrap" class="ft41">progressive increase in nucleus size has been documented&#160;in&#160;</p>
<p style="position:absolute;top:821px;left:87px;white-space:nowrap" class="ft41">human breast cancer cells [82].&#160;<i>N</i>=16 (2371 nuclei)&#160;for both&#160;</p>
<p style="position:absolute;top:837px;left:87px;white-space:nowrap" class="ft41">ITLS and unaffected regions.(E) Intracellular&#160;pH measurements&#160;</p>
<p style="position:absolute;top:854px;left:87px;white-space:nowrap" class="ft41">in&#160;ITLS&#160;and&#160;Control&#160;regions&#160;were&#160;made&#160;using&#160;the&#160;fluorescent&#160;</p>
<p style="position:absolute;top:870px;left:87px;white-space:nowrap" class="ft41">pH&#160;&#160;reporter&#160;&#160;dye&#160;&#160;BCECF.&#160;&#160;(I)&#160;&#160;A&#160;&#160;decreased&#160;&#160;fluorescence&#160;&#160;is&#160;</p>
<p style="position:absolute;top:886px;left:87px;white-space:nowrap" class="ft41">observed&#160;in&#160;ITLS&#160;cells&#160;(T)&#160;compared&#160;to&#160;a&#160;normal&#160;region&#160;(N).&#160;</p>
<p style="position:absolute;top:902px;left:87px;white-space:nowrap" class="ft41">(II)&#160;&#160;Upon&#160;&#160;quantification,&#160;&#160;levels&#160;&#160;of&#160;&#160;fluorescence&#160;&#160;correspond&#160;&#160;to&#160;</p>
<p style="position:absolute;top:918px;left:87px;white-space:nowrap" class="ft41">pH values&#160;of&#160;6.6 in&#160;ITLS&#160;and&#160;7.41&#160;in&#160;control&#160;regions.&#160;<i>N</i>=8&#160;for&#160;</p>
<p style="position:absolute;top:935px;left:87px;white-space:nowrap" class="ft41">both treatments;&#160;*<i>P</i>&lt;0.05 Student’s&#160;<i>t</i>-test; scale bar = 1mm in&#160;</p>
<p style="position:absolute;top:951px;left:87px;white-space:nowrap" class="ft41">tail&#160;fragment;&#160;150&#160;µm&#160;in&#160;magnified&#160;inserts.(F)&#160;The&#160;response&#160;of&#160;</p>
<p style="position:absolute;top:967px;left:87px;white-space:nowrap" class="ft41">innate&#160;immunity&#160;to ITLS formation&#160;was investigated&#160;using anti-</p>
<p style="position:absolute;top:983px;left:87px;white-space:nowrap" class="ft41">XL2 immunohistochemistry&#160;to&#160;mark the&#160;presence&#160;of leukocytes:&#160;</p>
<p style="position:absolute;top:999px;left:87px;white-space:nowrap" class="ft41">leukocytes&#160;are&#160;primarily&#160;present&#160;around&#160;ITLS&#160;(white&#160;circular&#160;</p>
<p style="position:absolute;top:1016px;left:87px;white-space:nowrap" class="ft41">trace)&#160;and 1-3 grid (300 µM) away from ITLSs.&#160;<i>N</i>=12;&#160;<i>P</i>&lt;0.01,&#160;</p>
<p style="position:absolute;top:1032px;left:87px;white-space:nowrap" class="ft41">one-way&#160;ANOVA,&#160;Tukey’s post hoc analysis;&#160;different&#160;letters&#160;</p>
<p style="position:absolute;top:1048px;left:87px;white-space:nowrap" class="ft41">indicate&#160;statistically&#160;significant&#160;difference;&#160;scale&#160;bar&#160;=&#160;500&#160;µm.&#160;</p>
<p style="position:absolute;top:1064px;left:87px;white-space:nowrap" class="ft41">Error bars indicate ± 1 s.e.m in&#160;A, B, E, F.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft50{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft51{font-size:11px;font-family:Times;color:#211f21;}
	.ft52{font-size:13px;font-family:Times;color:#211f21;}
	.ft53{font-size:13px;font-family:Times;color:#211f21;}
	.ft54{font-size:14px;font-family:Times;color:#211f21;}
	.ft55{font-size:13px;font-family:Times;color:#211f21;}
	.ft56{font-size:11px;font-family:Times;color:#211f21;}
	.ft57{font-size:5px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page5-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft50">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft51">3290</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft50">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft52">cells [82]&#160;(Fig.&#160;1D).&#160;Another marker&#160;of tumorigenesis&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft52">is the abnormal acidity of tumor tissue [83, 84]. Using&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft52">BCECF,&#160;&#160;a&#160;&#160;dual&#160;&#160;excitation&#160;&#160;pH&#160;&#160;indicator,&#160;&#160;fluorescence&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft52">intensity ratios at two different wavelengths of ITLS and&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft52">control regions revealed that ITLS have a more acidic (pH&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft52">6.6) intracellular&#160;environment compared to that of control&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft52">regions, which have a pH average of 7.41 (<i>N</i>=8 for both&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft52">treatments,&#160;<i>t</i>-test,&#160;<i>P&lt;0.05</i>) (Fig. 1E).&#160;</p>
<p style="position:absolute;top:214px;left:123px;white-space:nowrap" class="ft52">Finally,&#160;to investigate&#160;host&#160;immune&#160;response to&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft52">tumor formation, immunohistochemistry with anti-</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft52">XL2 (anti-<i>Xenopus</i>&#160;leukocytes) was performed on cross&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft52">sections&#160;of&#160;tissue&#160;bearing&#160;ITLS.&#160;We&#160;observed&#160;recruitment&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft52">of leukocytes to the site of transformed cells (Fig 1F),&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft52">consistent with the known role of leukocyte migration as&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft52">an anti-tumor immune response [85].&#160;</p>
<p style="position:absolute;top:340px;left:123px;white-space:nowrap" class="ft52">Taken together, these characteristics of ITLS are&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft52">consistent&#160;with&#160;previous&#160;findings&#160;of&#160;increased&#160;proliferation&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft52">within ITLS, ability to form in internal tissues (not just&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft52">the epidermis), and propensity to attract vasculature[43],&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft52">and demonstrate the relevance of human oncogene-</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft52">induced tumors in&#160;<i>Xenopus</i>&#160;for understanding the basic&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft52">mechanisms of carcinogenesis&#160;<i>in vivo</i>.</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft54"><b>Long-range&#160;hyperpolarization suppresses&#160;the&#160;</b></p>
<p style="position:absolute;top:216px;left:487px;white-space:nowrap" class="ft54"><b>formation of ITLS</b></p>
<p style="position:absolute;top:263px;left:523px;white-space:nowrap" class="ft52">To test the hypothesis that hyperpolarization&#160;</p>
<p style="position:absolute;top:281px;left:487px;white-space:nowrap" class="ft52">affects oncogenic transformation of cells located at a&#160;</p>
<p style="position:absolute;top:299px;left:487px;white-space:nowrap" class="ft52">distance,&#160;we&#160;performed&#160;functional&#160;experiments&#160;using&#160;sets&#160;</p>
<p style="position:absolute;top:317px;left:487px;white-space:nowrap" class="ft52">of oncogenes and hyperpolarizing reagents.&#160;The use of&#160;</p>
<p style="position:absolute;top:335px;left:487px;white-space:nowrap" class="ft52">multiple oncogenes and hyperpolarizing agents allowed&#160;</p>
<p style="position:absolute;top:841px;left:87px;white-space:nowrap" class="ft55"><b>Figure 2: Long-range hyperpolarization suppresses the formation ITLSs.&#160;</b>(A)&#160;To visualize&#160;and track ITLSs, mRNA&#160;encoding&#160;</p>
<p style="position:absolute;top:859px;left:87px;white-space:nowrap" class="ft51">a fusion construct&#160;of&#160;<i>Xrel3</i>&#160;and tdTomato&#160;was injected&#160;into a single blastomere&#160;of 16-cell&#160;stage embryos. (I, II) ITLSs resulting&#160;from&#160;<i>Xrel3</i>-</p>
<p style="position:absolute;top:875px;left:87px;white-space:nowrap" class="ft51">2A-tdTomato&#160;injections&#160;were&#160;highly&#160;fluorescent&#160;when&#160;visualized&#160;under&#160;a&#160;TRITC&#160;filter&#160;set.&#160;(III)&#160;Overlay&#160;of&#160;bright&#160;field&#160;(BF)&#160;and&#160;TRITC&#160;</p>
<p style="position:absolute;top:891px;left:87px;white-space:nowrap" class="ft51">images&#160;shows&#160;the&#160;co-localization&#160;of&#160;ITLS&#160;and&#160;red&#160;fluorescent&#160;signal,&#160;confirming&#160;that&#160;foci&#160;of&#160;oncogene&#160;expression&#160;are&#160;the&#160;cells&#160;that&#160;make&#160;up&#160;</p>
<p style="position:absolute;top:908px;left:87px;white-space:nowrap" class="ft51">ITLS. Scale&#160;bar = 1 mm.(B)&#160;To test whether long-range hyperpolarization suppresses ITLS formation,&#160;a potassium based hyperpolarizing&#160;</p>
<p style="position:absolute;top:924px;left:87px;white-space:nowrap" class="ft51">channel&#160;(Kv1.5-GFP3) and&#160;<i>Xrel3</i>-2A-tdTomato&#160;were&#160;injected&#160;in&#160;distantly&#160;separated&#160;blastomeres&#160;of&#160;a&#160;16-cell&#160;stage&#160;embryo.&#160;(I)&#160;While&#160;</p>
<p style="position:absolute;top:940px;left:87px;white-space:nowrap" class="ft51">morphologically-apparent&#160;ITLSs were often missing from these embryos, the oncogenic&#160;protein was present as evidenced&#160;by the tdTomato&#160;</p>
<p style="position:absolute;top:956px;left:87px;white-space:nowrap" class="ft51">fluorescent&#160;signal&#160;(II,&#160;II).&#160;Robust&#160;expression&#160;of&#160;the&#160;hyperpolarizing&#160;channel&#160;protein&#160;(Kv1.5-GFP3)&#160;was&#160;observed&#160;in&#160;the&#160;head&#160;and&#160;gut&#160;regions&#160;</p>
<p style="position:absolute;top:972px;left:87px;white-space:nowrap" class="ft51">(IV,&#160;V), and away from Xrel3-2A-tdTomato expressing cells (VI). Scale bar = 1 mm.(C) Fold change in ITLS formation&#160;for oncogene&#160;</p>
<p style="position:absolute;top:989px;left:87px;white-space:nowrap" class="ft51">injected&#160;embryos with hyperpolarized treatments&#160;compared to oncogene-only injected&#160;embryos. Oncogene-only injected&#160;embryos with&#160;</p>
<p style="position:absolute;top:1005px;left:87px;white-space:nowrap" class="ft51">ITLS&#160;have a&#160;ratio&#160;of 1, and&#160;ratio&#160;values&#160;below&#160;and&#160;above&#160;one&#160;represent&#160;fewer and&#160;more&#160;embryos&#160;with&#160;ITLS,&#160;respectively.&#160;To show the&#160;</p>
<p style="position:absolute;top:1021px;left:87px;white-space:nowrap" class="ft51">effect&#160;of ITLS suppression due to change&#160;in&#160;V</p>
<p style="position:absolute;top:1031px;left:335px;white-space:nowrap" class="ft57">mem, three&#160;different&#160;oncogenes and hyperpolarizing&#160;reagents&#160;(based on Cl</p>
<p style="position:absolute;top:1022px;left:725px;white-space:nowrap" class="ft57">-</p>
<p style="position:absolute;top:1021px;left:727px;white-space:nowrap" class="ft51">&#160;and K+) were used.&#160;</p>
<p style="position:absolute;top:1037px;left:87px;white-space:nowrap" class="ft51">When Kv1.5 (K+&#160;hyperpolarizing&#160;channel)&#160;was introduced&#160;non-locally&#160;in&#160;<i>Xrel3</i>&#160;and&#160;<i>Gli1</i>&#160;injected&#160;embryos, 39.4% and 29.4% decreases,&#160;</p>
<p style="position:absolute;top:1053px;left:87px;white-space:nowrap" class="ft51">respectively, in ITLS formation&#160;were observed.&#160;A&#160;37.5% decrease&#160;in ITLS formation&#160;was also achieved&#160;using&#160;<i>KRAS</i>G12D&#160;as an oncogene&#160;</p>
<p style="position:absolute;top:1070px;left:87px;white-space:nowrap" class="ft51">and 70mM Cl-&#160;as a hyperpolarizing&#160;reagent.&#160;<i>N</i>=225-349 embryos for each treatment;&#160;*P&lt;0.01 Student’s t-test.&#160;Error bars indicate&#160;± 1 s.e.m.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft60{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft61{font-size:11px;font-family:Times;color:#211f21;}
	.ft62{font-size:13px;font-family:Times;color:#211f21;}
	.ft63{font-size:6px;font-family:Times;color:#211f21;}
	.ft64{font-size:13px;font-family:Times;color:#211f21;}
	.ft65{font-size:6px;font-family:Times;color:#211f21;}
	.ft66{font-size:14px;font-family:Times;color:#211f21;}
	.ft67{font-size:13px;font-family:Times;color:#231f20;}
	.ft68{font-size:13px;font-family:Times;color:#211f21;}
	.ft69{font-size:11px;font-family:Times;color:#211f21;}
	.ft610{font-size:5px;font-family:Times;color:#211f21;}
	.ft611{font-size:5px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page6-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft60">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft61">3291</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft60">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft62">us&#160;to&#160;confirm&#160;that&#160;there&#160;is&#160;a&#160;generalized&#160;suppression&#160;effect&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft62">due to changes in&#160;V</p>
<p style="position:absolute;top:100px;left:207px;white-space:nowrap" class="ft63">mem, one that is not tied to a particular&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft62">channel protein or ion.&#160;We used&#160;<i>Xrel3</i>&#160;tagged with&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft62">tdTomato&#160;to&#160;track&#160;the&#160;presence&#160;of&#160;oncogenic&#160;protein&#160;(Fig.&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft62">2A,&#160;I-III). To&#160;modulate V</p>
<p style="position:absolute;top:154px;left:243px;white-space:nowrap" class="ft63">mem, we used Kv1.5 (Potassium&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft62">voltage-gated&#160;channel,&#160;shaker-related&#160;subfamily,&#160;member&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft62">5) [86], a well-characterized hyperpolarizing channel,&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft62">whose overexpression in our model&#160;system has been used&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft62">to alter developmental patterning [87].&#160;</p>
<p style="position:absolute;top:232px;left:123px;white-space:nowrap" class="ft62">To probe the effects of long-range hyperpolarization&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft62">on tumor formation, we injected mRNA’s encoding Xrel3-</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft62">tdTomato and Kv1.5-GFP3 in two separate blastomeres&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft62">of 16-cell stage embryos, and scored for the presence of&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft62">ITLS and hyperpolarizing channel/oncogene protein by&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft62">stage 34. Compared to embryos receiving only oncogene&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft62">injections, embryos with a remote hyperpolarized region&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft62">(Fig. 2B, IV&amp;V) often&#160;displayed&#160;lack&#160;of morphologically&#160;</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft62">apparent ITLS (Fig. 2B, I) despite strong presence&#160;</p>
<p style="position:absolute;top:394px;left:87px;white-space:nowrap" class="ft62">Xrel3-2A-tdTomato protein (Fig. 2B, II&amp;III). Kv1.5-</p>
<p style="position:absolute;top:412px;left:87px;white-space:nowrap" class="ft62">induced long-distance hyperpolarization was also able to&#160;</p>
<p style="position:absolute;top:430px;left:87px;white-space:nowrap" class="ft62">significantly&#160;suppress&#160;<i>Xrel3</i>&#160;and&#160;<i>Gli1</i>&#160;ITLS formation by&#160;</p>
<p style="position:absolute;top:448px;left:87px;white-space:nowrap" class="ft62">34.9% (<i>N</i>=225;&#160;<i>t-</i>test,&#160;<i>P</i>&lt;0.05) and 29.4% (<i>N</i>=292;&#160;<i>t-</i>test,<i>&#160;</i></p>
<p style="position:absolute;top:466px;left:87px;white-space:nowrap" class="ft64"><i>P</i>&lt;0.05),&#160;respectively&#160;(Fig. 2C),&#160;suggesting&#160;the&#160;effect&#160;</p>
<p style="position:absolute;top:484px;left:87px;white-space:nowrap" class="ft62">is&#160;not&#160;specific&#160;for&#160;just&#160;one&#160;type&#160;of&#160;oncogene.&#160;Treatment&#160;</p>
<p style="position:absolute;top:502px;left:87px;white-space:nowrap" class="ft62">with high chloride (whose uptake by native Cl-&#160;channels&#160;</p>
<p style="position:absolute;top:520px;left:87px;white-space:nowrap" class="ft62">hyperpolarizes cells) resulted in a 37.5% decrease (<i>N</i>=349;&#160;</p>
<p style="position:absolute;top:538px;left:87px;white-space:nowrap" class="ft64"><i>t-</i>test&#160;&#160;<i>P&lt;0.05</i>)&#160;in&#160;<i>KRASG12D</i>&#160;ITLS,&#160;demonstrating&#160;that&#160;</p>
<p style="position:absolute;top:556px;left:87px;white-space:nowrap" class="ft62">the&#160;suppressive&#160;effect&#160;is&#160;not&#160;specific&#160;for&#160;Kv1.5&#160;nor&#160;for&#160;</p>
<p style="position:absolute;top:574px;left:87px;white-space:nowrap" class="ft62">potassium, as mediators of the crucial&#160;V</p>
<p style="position:absolute;top:586px;left:335px;white-space:nowrap" class="ft63">mem&#160;change (Fig.&#160;</p>
<p style="position:absolute;top:592px;left:87px;white-space:nowrap" class="ft62">2C).</p>
<p style="position:absolute;top:610px;left:123px;white-space:nowrap" class="ft62">Collectively, these data reveal a long-range signal&#160;</p>
<p style="position:absolute;top:628px;left:87px;white-space:nowrap" class="ft62">that&#160;&#160;is&#160;&#160;initiated&#160;&#160;by&#160;&#160;hyperpolarization&#160;&#160;and&#160;&#160;has&#160;&#160;influence&#160;</p>
<p style="position:absolute;top:646px;left:87px;white-space:nowrap" class="ft62">over tumorigenesis at remote sites in the tadpole.&#160;</p>
<p style="position:absolute;top:664px;left:87px;white-space:nowrap" class="ft62">Moreover, these results demonstrate that ITLS suppression&#160;</p>
<p style="position:absolute;top:682px;left:87px;white-space:nowrap" class="ft62">through V</p>
<p style="position:absolute;top:694px;left:149px;white-space:nowrap" class="ft63">mem&#160;modulation is possible to achieve by taking&#160;</p>
<p style="position:absolute;top:700px;left:87px;white-space:nowrap" class="ft62">advantage of endogenous channels that are not necessarily&#160;</p>
<p style="position:absolute;top:718px;left:87px;white-space:nowrap" class="ft62">located within oncogene expressing cells.</p>
<p style="position:absolute;top:69px;left:487px;white-space:nowrap" class="ft66"><b>Chloride-dependent hyperpolarization through&#160;</b></p>
<p style="position:absolute;top:89px;left:487px;white-space:nowrap" class="ft66"><b>endogenous chloride intracellular&#160;channel 1&#160;</b></p>
<p style="position:absolute;top:109px;left:487px;white-space:nowrap" class="ft66"><b>(CLIC1)&#160;</b></p>
<p style="position:absolute;top:156px;left:523px;white-space:nowrap" class="ft62">Having shown a functional role of long-range&#160;</p>
<p style="position:absolute;top:174px;left:487px;white-space:nowrap" class="ft62">hyperpolarization in the context of tumorigenesis, we&#160;</p>
<p style="position:absolute;top:192px;left:487px;white-space:nowrap" class="ft62">proceeded to characterize the native channel responsible&#160;</p>
<p style="position:absolute;top:210px;left:487px;white-space:nowrap" class="ft62">for chloride-based inhibition of ITLS formation.&#160;We&#160;</p>
<p style="position:absolute;top:228px;left:487px;white-space:nowrap" class="ft62">performed an inverse drug screen [88] with chloride&#160;</p>
<p style="position:absolute;top:246px;left:487px;white-space:nowrap" class="ft62">channel blockers to see which ones would abrogate the&#160;</p>
<p style="position:absolute;top:264px;left:487px;white-space:nowrap" class="ft62">chloride-dependent ITLS suppression:&#160;Anthracene-9-</p>
<p style="position:absolute;top:282px;left:487px;white-space:nowrap" class="ft62">Carboxylic&#160;Acid (ACA), inadyloxyacetic acid 94 (IAA),&#160;</p>
<p style="position:absolute;top:300px;left:487px;white-space:nowrap" class="ft62">and&#160;5-Nitro-2-(3-phenylpropylamino)&#160;benzoic&#160;acid&#160;</p>
<p style="position:absolute;top:318px;left:487px;white-space:nowrap" class="ft62">(NPPB) [89-92] (Fig. 3A).&#160;After the injection of&#160;<i>KRASG12D</i>&#160;</p>
<p style="position:absolute;top:336px;left:487px;white-space:nowrap" class="ft62">and treatment with high chloride (<i>N</i>=164),&#160;ITLS incidence&#160;</p>
<p style="position:absolute;top:354px;left:487px;white-space:nowrap" class="ft62">dropped&#160;&#160;significantly&#160;&#160;(χ2,&#160;&#160;<i>P</i>&lt;0.05) compared to their&#160;</p>
<p style="position:absolute;top:372px;left:487px;white-space:nowrap" class="ft62">counterparts in a low chloride concentration (<i>N</i>=162).&#160;</p>
<p style="position:absolute;top:390px;left:487px;white-space:nowrap" class="ft62">This anti-tumor effect of high chloride was&#160;completely&#160;</p>
<p style="position:absolute;top:408px;left:487px;white-space:nowrap" class="ft62">abolished&#160;with&#160;IAA&#160;treatment&#160;(N=186;&#160;χ2,&#160;<i>P</i>&lt;0.05) (Fig&#160;</p>
<p style="position:absolute;top:426px;left:487px;white-space:nowrap" class="ft62">3B), while the&#160;other two&#160;inhibitors&#160;did&#160;not&#160;significantly&#160;</p>
<p style="position:absolute;top:444px;left:487px;white-space:nowrap" class="ft62">affect the rate of ITLS incidence.&#160;We then proceeded to&#160;</p>
<p style="position:absolute;top:462px;left:487px;white-space:nowrap" class="ft62">validate this result using molecular reagents targeting&#160;</p>
<p style="position:absolute;top:480px;left:487px;white-space:nowrap" class="ft62">IAA-sensitive channels.</p>
<p style="position:absolute;top:498px;left:523px;white-space:nowrap" class="ft62">A&#160;known target of IAA&#160;is the intracellular chloride&#160;</p>
<p style="position:absolute;top:516px;left:487px;white-space:nowrap" class="ft62">channel 1 (CLIC1) [93]. Given its pharmacological&#160;</p>
<p style="position:absolute;top:534px;left:487px;white-space:nowrap" class="ft62">profile&#160;and&#160;ubiquitous&#160;presence&#160;during&#160;every&#160;stage&#160;of&#160;the&#160;</p>
<p style="position:absolute;top:551px;left:487px;white-space:nowrap" class="ft64"><i>Xenopus&#160;laevis</i>&#160;development [94], we focused on CLIC1&#160;</p>
<p style="position:absolute;top:570px;left:487px;white-space:nowrap" class="ft62">in this study.&#160;To test the hypothesis that CLIC1-mediated&#160;</p>
<p style="position:absolute;top:819px;left:87px;white-space:nowrap" class="ft68"><b>Figure 3:&#160;A&#160;suppression screen for&#160;chloride&#160;channels&#160;</b></p>
<p style="position:absolute;top:837px;left:87px;white-space:nowrap" class="ft68"><b>is employed to identify a channel responsible for&#160;long-</b></p>
<p style="position:absolute;top:855px;left:87px;white-space:nowrap" class="ft68"><b>range ITLS suppression.&#160;</b>(A) Oncogene injected&#160;embryos&#160;</p>
<p style="position:absolute;top:873px;left:87px;white-space:nowrap" class="ft61">were placed in a high chloride concentration&#160;(70mM) solution,&#160;</p>
<p style="position:absolute;top:890px;left:87px;white-space:nowrap" class="ft61">followed&#160;immediately&#160;by separate&#160;treatments&#160;with&#160;very&#160;well-</p>
<p style="position:absolute;top:906px;left:87px;white-space:nowrap" class="ft61">known chloride&#160;transport blockers:&#160;Anthracene-9-Carboxylic&#160;</p>
<p style="position:absolute;top:922px;left:87px;white-space:nowrap" class="ft61">Acid (ACA), indanyloxyacetic&#160;acid (IAA) and 5-Nitro-2-(3-</p>
<p style="position:absolute;top:938px;left:87px;white-space:nowrap" class="ft61">phenylpropylamino)&#160;benzoic&#160;acid&#160;(NPPB). (B) High chloride&#160;</p>
<p style="position:absolute;top:954px;left:87px;white-space:nowrap" class="ft61">treatment&#160;of oncogene-injected&#160;embryos results in ~31%%&#160;</p>
<p style="position:absolute;top:971px;left:87px;white-space:nowrap" class="ft61">decrease&#160;in&#160;<i>KRASG12D</i>&#160;ITLS incidence.&#160;While&#160;blocking&#160;chloride&#160;</p>
<p style="position:absolute;top:987px;left:87px;white-space:nowrap" class="ft61">channels&#160;using&#160;ACA&#160;and NPPB did&#160;not affect&#160;the&#160;rate&#160;of this&#160;</p>
<p style="position:absolute;top:1003px;left:87px;white-space:nowrap" class="ft61">suppression, IAA&#160;treatments&#160;in the presence of high Cl-&#160;restored&#160;</p>
<p style="position:absolute;top:1019px;left:87px;white-space:nowrap" class="ft61">ITLS incidence back to oncogene-only levels.&#160;<i>N</i>=162, 164, 186&#160;</p>
<p style="position:absolute;top:1035px;left:87px;white-space:nowrap" class="ft61">for oncogene only, oncogene + high Cl-, and oncogene + high Cl-&#160;</p>
<p style="position:absolute;top:1052px;left:87px;white-space:nowrap" class="ft61">+ IAA,&#160;respectively;&#160;*<i>P</i>&lt;0.05,&#160;χ2&#160;compared to tumor incidence&#160;</p>
<p style="position:absolute;top:1068px;left:87px;white-space:nowrap" class="ft61">in&#160;<i>KRASG12D&#160;</i>only injected embryos.&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft70{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft71{font-size:11px;font-family:Times;color:#211f21;}
	.ft72{font-size:13px;font-family:Times;color:#211f21;}
	.ft73{font-size:13px;font-family:Times;color:#211f21;}
	.ft74{font-size:6px;font-family:Times;color:#211f21;}
	.ft75{font-size:6px;font-family:Times;color:#211f21;}
	.ft76{font-size:14px;font-family:Times;color:#211f21;}
	.ft77{font-size:7px;font-family:Times;color:#211f21;}
	.ft78{font-size:13px;font-family:Times;color:#211f21;}
	.ft79{font-size:11px;font-family:Times;color:#211f21;}
	.ft710{font-size:5px;font-family:Times;color:#211f21;}
	.ft711{font-size:5px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page7-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft70">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft71">3292</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft70">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft72">hyperpolarization affects oncogenic transformation of&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft72">cells, we performed functional experiments involving&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft72">CLIC1 (wildtype and mutant) and&#160;<i>KRASG12D</i>&#160;injections.&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft72">Wildtype&#160;CLIC1&#160;was&#160;tagged&#160;with&#160;GFP,&#160;while&#160;a&#160;dominant&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft72">negative form of CLIC1 was generated by mutating&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft72">cysteine 24 to serine, in order to form an inactive multimer&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft72">channel [95], and tagged it with tdTomato to track&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft72">localization&#160;of&#160;the&#160;protein&#160;product.&#160;mRNA’s&#160;encoding&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft73"><i>CLIC1-2A-GFP3/KRASG12D-tdTomato</i>&#160;(Fig. 4B, I&amp;II)&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft72">and&#160;<i>CLIC1C24S-2A-tdTomato/KRASG12D-GFP3</i>&#160;(Fig. 4B,&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft72">III&amp;IV)&#160;were&#160;injected&#160;in&#160;two&#160;different blastomeres&#160;of&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft72">16-cell stage embryos, treated with high Cl-, and scored&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft72">for the presence of ITLS and CLIC1 channel/oncogene&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft72">proteins.&#160;As a control to which CLIC injected embryos&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft72">can be compared,&#160;<i>KRASG12D</i>-only injected embryos&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft72">were also treated with high Cl-&#160;&#160;(<i>N</i>=372), resulting in&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft72">31.5% fold decrease in ITLS incidence when compared&#160;</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft72">to&#160;&#160;<i>KRASG12D</i>-only injected embryos (<i>N</i>=341). The&#160;rate&#160;</p>
<p style="position:absolute;top:394px;left:87px;white-space:nowrap" class="ft72">of&#160;&#160;ITLS&#160;&#160;suppression&#160;&#160;was&#160;&#160;further&#160;&#160;amplified&#160;&#160;(44.3%&#160;</p>
<p style="position:absolute;top:412px;left:87px;white-space:nowrap" class="ft72">suppression) when the wildtype CLIC1 was overexpressed&#160;</p>
<p style="position:absolute;top:430px;left:87px;white-space:nowrap" class="ft72">non-locally in oncogene-injected embryos that were then&#160;</p>
<p style="position:absolute;top:448px;left:87px;white-space:nowrap" class="ft72">raised in 70mM Cl-&#160;(<i>N</i>=364). In contrast, overexpression&#160;</p>
<p style="position:absolute;top:466px;left:87px;white-space:nowrap" class="ft72">of the mutant CLIC1 (<i>N</i>=336) effectively blocked ITLS&#160;</p>
<p style="position:absolute;top:484px;left:87px;white-space:nowrap" class="ft72">suppression despite the presence of high Cl-&#160;(Fig 4C).&#160;</p>
<p style="position:absolute;top:502px;left:87px;white-space:nowrap" class="ft72">Together, these data suggest a role for native CLIC1 in&#160;</p>
<p style="position:absolute;top:520px;left:87px;white-space:nowrap" class="ft72">mediating hyperpolarization-induced long-range ITLS&#160;</p>
<p style="position:absolute;top:538px;left:87px;white-space:nowrap" class="ft72">suppression.</p>
<p style="position:absolute;top:69px;left:487px;white-space:nowrap" class="ft76"><b>Changes&#160;in V</b></p>
<p style="position:absolute;top:82px;left:591px;white-space:nowrap" class="ft77"><b>mem&#160;are transduced via HDAC1-</b></p>
<p style="position:absolute;top:89px;left:487px;white-space:nowrap" class="ft76"><b>dependent mechanisms</b></p>
<p style="position:absolute;top:136px;left:523px;white-space:nowrap" class="ft72">Bioelectric signals are transduced into&#160;</p>
<p style="position:absolute;top:154px;left:487px;white-space:nowrap" class="ft72">transcriptional and epigenetics responses via a number&#160;</p>
<p style="position:absolute;top:172px;left:487px;white-space:nowrap" class="ft72">of second-messenger pathways. In order to determine&#160;</p>
<p style="position:absolute;top:190px;left:487px;white-space:nowrap" class="ft72">the transduction mechanism by which hyperpolarization&#160;</p>
<p style="position:absolute;top:208px;left:487px;white-space:nowrap" class="ft72">inhibits tumorigenesis, we conducted a pharmacological&#160;</p>
<p style="position:absolute;top:226px;left:487px;white-space:nowrap" class="ft72">suppression screen [63] and molecular-genetic loss-of-</p>
<p style="position:absolute;top:244px;left:487px;white-space:nowrap" class="ft72">function of several well-characterized candidate pathways&#160;</p>
<p style="position:absolute;top:262px;left:487px;white-space:nowrap" class="ft72">that have been shown to mediate the actions of&#160;V</p>
<p style="position:absolute;top:273px;left:815px;white-space:nowrap" class="ft75">mem&#160;</p>
<p style="position:absolute;top:280px;left:487px;white-space:nowrap" class="ft72">change in other patterning contexts [96]. Our strategy&#160;</p>
<p style="position:absolute;top:298px;left:487px;white-space:nowrap" class="ft72">was to block, one at a time, the candidate transduction&#160;</p>
<p style="position:absolute;top:316px;left:487px;white-space:nowrap" class="ft72">mechanisms and see which ones abrogated the ability of&#160;</p>
<p style="position:absolute;top:334px;left:487px;white-space:nowrap" class="ft72">hyperpolarization to reduce tumor incidence.&#160;Targeted&#160;</p>
<p style="position:absolute;top:352px;left:487px;white-space:nowrap" class="ft72">pathways include: movement of serotonin through the&#160;</p>
<p style="position:absolute;top:596px;left:87px;white-space:nowrap" class="ft78"><b>Figure&#160;4:&#160;Hyperpolarization&#160;by&#160;the&#160;influx&#160;of&#160;Cl-&#160;through&#160;</b></p>
<p style="position:absolute;top:614px;left:87px;white-space:nowrap" class="ft78"><b>CLIC1 mediates long-range&#160;ITLS suppression.&#160;</b>(A) To&#160;</p>
<p style="position:absolute;top:632px;left:87px;white-space:nowrap" class="ft71">visualize&#160;and track ITLSs,&#160;<i>KRASG12D</i>&#160;mRNA&#160;was co-injected&#160;</p>
<p style="position:absolute;top:648px;left:87px;white-space:nowrap" class="ft71">with&#160;GFP3 (I)&#160;and&#160;tdTomato&#160;(II) into&#160;a&#160;single&#160;blastomere&#160;of&#160;</p>
<p style="position:absolute;top:665px;left:87px;white-space:nowrap" class="ft71">16-cell stage embryos.&#160;In both cases, ITLS co-localize&#160;with&#160;</p>
<p style="position:absolute;top:681px;left:87px;white-space:nowrap" class="ft71">the&#160;&#160;respective&#160;&#160;fluorescent&#160;&#160;signals,&#160;&#160;confirming&#160;&#160;that&#160;&#160;oncogene-</p>
<p style="position:absolute;top:697px;left:87px;white-space:nowrap" class="ft71">expressing cells&#160;make up ITLS. Scale&#160;bar = 1 mm.(B)&#160;When&#160;</p>
<p style="position:absolute;top:713px;left:87px;white-space:nowrap" class="ft71">mRNA&#160;encoding&#160;<i>Xenopus</i>&#160;wildtype&#160;CLIC1-GFP3 was injected&#160;</p>
<p style="position:absolute;top:729px;left:87px;white-space:nowrap" class="ft71">at a distance from&#160;<i>KRASG12D</i>&#160;-tdTomato, morphologically-</p>
<p style="position:absolute;top:746px;left:87px;white-space:nowrap" class="ft71">apparent&#160;ITLS formation&#160;was often suppressed despite the&#160;</p>
<p style="position:absolute;top:762px;left:87px;white-space:nowrap" class="ft71">presence of oncogenic protein&#160;(III).&#160;Whereas overexpression&#160;</p>
<p style="position:absolute;top:778px;left:87px;white-space:nowrap" class="ft71">of a CLIC1 dominant negative&#160;(CLIC1C24S-tdTomato) in non-</p>
<p style="position:absolute;top:794px;left:87px;white-space:nowrap" class="ft71">oncogene&#160;expressing&#160;cells&#160;prevents ITLS&#160;suppression despite&#160;</p>
<p style="position:absolute;top:810px;left:87px;white-space:nowrap" class="ft71">the&#160;presence&#160;of high Cl-&#160;in&#160;the&#160;media&#160;(IV). Scale&#160;bar&#160;= 1 mm.&#160;(C)&#160;</p>
<p style="position:absolute;top:827px;left:87px;white-space:nowrap" class="ft71">Changes in ITLS formation&#160;incidence&#160;for oncogene&#160;and CLIC1&#160;</p>
<p style="position:absolute;top:843px;left:87px;white-space:nowrap" class="ft71">(mutant&#160;or wildtype) injected&#160;embryos in 70mM Cl-&#160;media.&#160;</p>
<p style="position:absolute;top:859px;left:87px;white-space:nowrap" class="ft71">ITLS incidence&#160;from oncogene-only injection&#160;was normalized&#160;</p>
<p style="position:absolute;top:875px;left:87px;white-space:nowrap" class="ft71">to 1 so that it can be used to measure against the effects of other&#160;</p>
<p style="position:absolute;top:891px;left:87px;white-space:nowrap" class="ft71">treatments.&#160;Embryos injected&#160;with&#160;<i>KRASG12D</i>&#160;followed by a&#160;</p>
<p style="position:absolute;top:908px;left:87px;white-space:nowrap" class="ft71">high Cl-&#160;treatment showed a 31.5% decrease&#160;in ITLS incidence.&#160;</p>
<p style="position:absolute;top:924px;left:87px;white-space:nowrap" class="ft71">Overexpression of the wildtype CLIC1 and high Cl-&#160;bath also&#160;</p>
<p style="position:absolute;top:940px;left:87px;white-space:nowrap" class="ft71">lowered the number of embryos with ITLS by 44.3% while&#160;</p>
<p style="position:absolute;top:956px;left:87px;white-space:nowrap" class="ft71">resulting in smaller ITLS in escapees. Overexpression of the&#160;</p>
<p style="position:absolute;top:972px;left:87px;white-space:nowrap" class="ft71">mutant&#160;CLIC1, which encodes&#160;for defective&#160;multimer&#160;channels,&#160;</p>
<p style="position:absolute;top:989px;left:87px;white-space:nowrap" class="ft71">appeared&#160;to&#160;block&#160;ITLS&#160;suppression by&#160;a&#160;high&#160;Cl-&#160;treatment,&#160;</p>
<p style="position:absolute;top:1005px;left:87px;white-space:nowrap" class="ft71">implicating&#160;native&#160;CLIC1 channels in&#160;Vmem mediated,&#160;long-</p>
<p style="position:absolute;top:1021px;left:87px;white-space:nowrap" class="ft71">range suppression of ITLS. N= 336-364 embryos for each&#160;</p>
<p style="position:absolute;top:1037px;left:87px;white-space:nowrap" class="ft71">treatment;&#160;P=0.01, one-way&#160;ANOVA,&#160;Tukey’s post hoc&#160;analysis;&#160;</p>
<p style="position:absolute;top:1053px;left:87px;white-space:nowrap" class="ft71">different&#160;letters&#160;indicate&#160;statistically&#160;significant&#160;difference.&#160;Error&#160;</p>
<p style="position:absolute;top:1070px;left:87px;white-space:nowrap" class="ft71">bars indicate ± 1 s.e.m.&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft80{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft81{font-size:11px;font-family:Times;color:#211f21;}
	.ft82{font-size:13px;font-family:Times;color:#211f21;}
	.ft83{font-size:6px;font-family:Times;color:#211f21;}
	.ft84{font-size:13px;font-family:Times;color:#211f21;}
	.ft85{font-size:6px;font-family:Times;color:#211f21;}
	.ft86{font-size:13px;font-family:Times;color:#211f21;}
	.ft87{font-size:5px;font-family:Times;color:#211f21;}
	.ft88{font-size:11px;font-family:Times;color:#211f21;}
	.ft89{font-size:5px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page8-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft80">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft81">3293</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft80">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft82">V</p>
<p style="position:absolute;top:82px;left:98px;white-space:nowrap" class="ft83">mem-dependent serotonin transporter SERT&#160;[97] (inhibited&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft82">via&#160;10&#160;µM&#160;fluoxetine);&#160;V</p>
<p style="position:absolute;top:100px;left:237px;white-space:nowrap" class="ft83">mem-guided transport of signaling&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft82">molecules through gap junctions [98, 99] (disrupted by&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft82">0.5 ng injection of a dominant negative connexin H7);&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft82">voltage&#160;gated&#160;calcium&#160;channels&#160;[100,&#160;101]&#160;(blocked&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft82">via 0.1 mM cadmium chloride), and&#160;V</p>
<p style="position:absolute;top:172px;left:345px;white-space:nowrap" class="ft83">mem-modulated&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft82">transport of small molecule inhibitors of histone&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft82">deacetylase&#160;1&#160;[102-104]&#160;(targeted&#160;by&#160;0.5ng&#160;injection&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft82">of mRNA&#160;encoding a dominant negative HDAC1) (Fig&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft82">5A). HDAC1 is an especially attractive target because it&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft82">is known to control levels of histone acetylation, which&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft82">determines cell cycle progression, rates&#160;of proliferation,&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft82">apoptosis and differentiation of cancer cells [105-107].&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft82">Administering oncogene, hyperpolarizing agent, and&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft82">V</p>
<p style="position:absolute;top:118px;left:498px;white-space:nowrap" class="ft83">mem-sensing pathway disruptors (Fig 5B) showed that&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft82">blocking&#160;HDAC1&#160;activity&#160;had&#160;the&#160;most&#160;significant&#160;effect&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft82">(χ2<i>,&#160;P</i>&lt;0.05)&#160;on&#160;CLIC1-mediated&#160;suppression of&#160;tumors:&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft82">the rate of ITLS formation in DN-HDAC1 injected&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft82">embryos in high Cl-&#160;was similar to that of oncogene-only&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft82">injected embryos - introducing DN-HDAC1 non-locally to&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft82">the site of&#160;<i>KRASG12D</i>&#160;increased ITLS formation incidence&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft82">by&#160;35.6%&#160;(χ2<i>, P</i>&lt;0.05) (Fig. 5C), suggesting a role for&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft82">histone deacetylase 1 activity controlling cell behavior at&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft82">a distance.</p>
<p style="position:absolute;top:886px;left:87px;white-space:nowrap" class="ft86"><b>Figure 5: Long-range suppression of ITLS by hyperpolarization is HDAC1-dependent.&#160;</b>(A)Hyperpolarization&#160;can be&#160;</p>
<p style="position:absolute;top:904px;left:87px;white-space:nowrap" class="ft81">transduced&#160;into&#160;transcriptional&#160;pathways by processes that&#160;include&#160;V</p>
<p style="position:absolute;top:914px;left:452px;white-space:nowrap" class="ft87">mem-dependent&#160;transport&#160;of signaling&#160;molecules&#160;(e.g. serotonin&#160;transport&#160;</p>
<p style="position:absolute;top:920px;left:87px;white-space:nowrap" class="ft81">through SERT),&#160;electrophoresis&#160;of morphogenes&#160;through&#160;gap junctions&#160;(GJC), calcium&#160;signaling&#160;via&#160;voltage-gated&#160;Ca++&#160;channels&#160;(VGCC),&#160;</p>
<p style="position:absolute;top:936px;left:87px;white-space:nowrap" class="ft81">and voltage dependent butyrate transport that results in HDAC&#160;inhibition.&#160;To identify the responsible transduction mechanism,&#160;each process&#160;</p>
<p style="position:absolute;top:953px;left:87px;white-space:nowrap" class="ft81">was&#160;independently&#160;blocked:&#160;10&#160;µM&#160;fluoxetine&#160;shuts&#160;down&#160;SERT;&#160;H7,&#160;a&#160;dominant&#160;connexin&#160;disrupts&#160;the&#160;transport&#160;function&#160;of&#160;endogenous&#160;gap&#160;</p>
<p style="position:absolute;top:969px;left:87px;white-space:nowrap" class="ft81">junctions;&#160;0.1 mM cadmium&#160;chloride effectively&#160;blocks&#160;VGCCs; and a dominant&#160;negative&#160;0.5 ng HDAC1 injection&#160;inactivates&#160;endogenous&#160;</p>
<p style="position:absolute;top:985px;left:87px;white-space:nowrap" class="ft81">HDAC1.&#160;(B) In each case, a treatment&#160;used to probe a given transduction mechanism&#160;was targeted non-local to&#160;<i>KRASG12D</i>&#160;injected&#160;cells.&#160;</p>
<p style="position:absolute;top:1001px;left:87px;white-space:nowrap" class="ft88"><i>KRASG12D</i>&#160;injections&#160;and treatments&#160;were administered&#160;at the 16-cell stage, and embryos were then raised to stage 34 before scoring the&#160;</p>
<p style="position:absolute;top:1017px;left:87px;white-space:nowrap" class="ft81">presence of ITLS.(C)&#160;When analyzing&#160;ITLS incidences&#160;compared&#160;to oncogene only injected&#160;embryos – DN-HDAC1blocks&#160;the effects of&#160;</p>
<p style="position:absolute;top:1034px;left:87px;white-space:nowrap" class="ft81">CLIC1&#160;mediated&#160;hyperpolarization,&#160;thus brining&#160;ITLS formation&#160;to&#160;the&#160;level&#160;of oncogene-only&#160;injection.&#160;Introducing&#160;DN-HDAC1 at&#160;a&#160;</p>
<p style="position:absolute;top:1050px;left:87px;white-space:nowrap" class="ft81">distance from KRASG12D&#160;without hyperpolarization&#160;increases ITLS incidence&#160;by 35.6%, implicating&#160;a role for HDAC1&#160;in long-range ITLS&#160;</p>
<p style="position:absolute;top:1066px;left:87px;white-space:nowrap" class="ft81">suppression. N=164-251 embryos; *P&lt;0.05, χ2 compared to tumor incidence in KrasG12D&#160;only injected embryos.&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft90{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft91{font-size:11px;font-family:Times;color:#211f21;}
	.ft92{font-size:13px;font-family:Times;color:#211f21;}
	.ft93{font-size:6px;font-family:Times;color:#211f21;}
	.ft94{font-size:13px;font-family:Times;color:#211f21;}
	.ft95{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft96{font-size:13px;font-family:Times;color:#211f21;}
	.ft97{font-size:5px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page9-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft90">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft91">3294</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft90">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:123px;white-space:nowrap" class="ft92">Having&#160;&#160;previously&#160;&#160;identified&#160;&#160;butyrate&#160;&#160;as&#160;&#160;an&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft92">endogenous HDAC inhibitor involved in local ITLS&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft92">suppression [43], we sought to identify the source of&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft92">butyrate in this system. Reasoning that it would be&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft92">produced by native bacteria, we conducted a screen for&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft92">antibiotics that target butyrate producing bacteria.&#160;We&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft92">first&#160;&#160;tested&#160;&#160;novobiocin,&#160;&#160;which&#160;&#160;has&#160;&#160;been&#160;&#160;shown&#160;&#160;to&#160;&#160;be&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft92">effective&#160;against&#160;gram-positive&#160;bacteria&#160;[108].&#160;At&#160;78&#160;μM,&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft92">novobiocin&#160;sodium&#160;salt&#160;treatment&#160;significantly&#160;increased&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft92">ITLS&#160;incidence&#160;by&#160;32.1%&#160;(χ2<i>, P</i>&lt;0.01) (Fig. 6). It has been&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft92">determined in other studies that the mechanism of action&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft92">for&#160;novobiocin&#160;involves&#160;the&#160;inhibition&#160;of&#160;the&#160;bacterial&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft92">DNA&#160;gyrase [109, 110]. Given also nalidixic acid’s&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft92">well-known&#160;inhibition&#160;of&#160;DNA&#160;gyrase&#160;[111],&#160;we&#160;tested&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft92">its&#160;effect&#160;(at&#160;43&#160;μM)&#160;on&#160;ITLS&#160;incidence.&#160;While&#160;an&#160;8.2%&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft92">increase in ITLS was observed, it was not statistically&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft92">significantly&#160;different&#160;from&#160;ITLS&#160;incidence&#160;in&#160;oncogene-</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft92">only injected embryos (Fig. 6). Finally, a cocktail of&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft92">antibiotics (gentamicin, metrodinazole, vancomycin&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft92">hydrochloride, and clindamycin hydrochloride, all at&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft92">20&#160;&#160;μM&#160;&#160;concentration)&#160;&#160;targeting&#160;&#160;gram-positive&#160;&#160;bacteria&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft92">resulted&#160;&#160;in&#160;&#160;a&#160;&#160;significant&#160;&#160;increase&#160;&#160;in&#160;&#160;ITLS&#160;&#160;incidence&#160;&#160;by&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft92">26.2%&#160;(χ2<i>, P</i>&lt;0.05) (Fig. 6). Bulk analysis of embryos&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft92">exposed&#160;to&#160;this&#160;cocktail of&#160;antibiotics&#160;does indeed show&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft92">a&#160;significant&#160;drop&#160;in&#160;total&#160;butyrate&#160;concentration&#160;(data&#160;not&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft92">shown).&#160;</p>
<p style="position:absolute;top:232px;left:523px;white-space:nowrap" class="ft92">Together, these data suggest that the control of&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft92">tumorigenesis&#160;by V</p>
<p style="position:absolute;top:262px;left:616px;white-space:nowrap" class="ft93">mem&#160;is mediated by HDAC1, via&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft92">butyrate derived from gram-positive bacteria.</p>
<p style="position:absolute;top:305px;left:487px;white-space:nowrap" class="ft95"><b>DISCUSSION</b></p>
<p style="position:absolute;top:344px;left:523px;white-space:nowrap" class="ft92">It&#160;has&#160;been&#160;well-documented&#160;that&#160;bioelectric&#160;</p>
<p style="position:absolute;top:967px;left:87px;white-space:nowrap" class="ft96"><b>Figure&#160;6:&#160;Targeted&#160;killing&#160;of&#160;butyrate producing Bacteria&#160;increases ITLS incidence&#160;</b>To&#160;determine&#160;the&#160;source&#160;of&#160;butyrate,&#160;</p>
<p style="position:absolute;top:986px;left:87px;white-space:nowrap" class="ft92">which is responsible for ITLS suppression&#160;through HDAC&#160;inhibition, variety of antibiotics&#160;were used to target butyrate-</p>
<p style="position:absolute;top:1004px;left:87px;white-space:nowrap" class="ft92">producing&#160;Bacteria.&#160;Compared&#160;to&#160;KRASG12D-only injected&#160;embryos, novobiocin&#160;and antibiotic&#160;cocktail&#160;(gentamicin,&#160;metrodinazole,&#160;</p>
<p style="position:absolute;top:1021px;left:87px;white-space:nowrap" class="ft91">vancomycin,&#160;and&#160;clindamycin)&#160;treatments&#160;significantly&#160;increased&#160;ITLS&#160;formation&#160;by&#160;32.1%&#160;and&#160;26.8%,&#160;respectively.&#160;Adding&#160;nalidixic&#160;acid,&#160;</p>
<p style="position:absolute;top:1038px;left:87px;white-space:nowrap" class="ft91">which&#160;works&#160;by&#160;inhibiting&#160;DNA&#160;gyrase&#160;as&#160;novobiocin&#160;does,&#160;did&#160;not&#160;significantly&#160;alter&#160;ITLS&#160;formation,&#160;showing&#160;only&#160;an&#160;8.2%&#160;increase&#160;</p>
<p style="position:absolute;top:1054px;left:87px;white-space:nowrap" class="ft91">in ITLS incidence.&#160;N=537, 318, 431, 117 for KRASG12D, KRASG12D&#160;+ Nalidiixic&#160;Acid, KRASG12D&#160;+ Novobiocin, KRASG12D&#160;+ antibiotics&#160;</p>
<p style="position:absolute;top:1070px;left:87px;white-space:nowrap" class="ft91">cocktail; *P&lt;0.05, **P&lt;0.01, χ2 compared to ITLS incidence in KRASG12D-only injected embryos.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft100{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft101{font-size:11px;font-family:Times;color:#211f21;}
	.ft102{font-size:13px;font-family:Times;color:#211f21;}
	.ft103{font-size:13px;font-family:Times;color:#211f21;}
	.ft104{font-size:14px;font-family:Times;color:#211f21;}
	.ft105{font-size:7px;font-family:Times;color:#211f21;}
	.ft106{font-size:6px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page10-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft100">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft101">3295</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft100">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft102">properties control individual cell behaviors that are highly&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft102">relevant to the processes of cancer [35, 36, 96, 112,&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft102">113].&#160;For&#160;example,&#160;electric&#160;fields&#160;generated&#160;by&#160;voltage-</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft102">gated sodium channels (VGSC) provide motility cues&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft102">to highly metastatic rat prostate cells [114], and many&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft102">cancer cells are galvanotactic [115-119]. Distinct from&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft102">extracellular&#160;electric&#160;fields,&#160;resting&#160;membrane&#160;potentials&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft102">established by ion channels and pumps control cell&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft102">proliferation, transformation, and growth in number of&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft102">tumor forming cells [120-125]. Moreover, the&#160;actions&#160;of&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft102">these translocators have allowed for the development of&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft102">predictive physiological markers [43, 61, 125] and control&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft102">of proliferative and metastatic behaviors [39, 46, 60, 126].&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft102">Here,&#160;we&#160;show&#160;for&#160;the&#160;first&#160;time&#160;that&#160;resting&#160;potentials&#160;in&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft102">remote&#160;cells&#160;have&#160;a&#160;profound&#160;influence&#160;on&#160;whether&#160;or&#160;not&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft102">a cell expressing human oncogenes will go on to form a&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft102">tumor&#160;<i>in vivo</i>.&#160;</p>
<p style="position:absolute;top:376px;left:123px;white-space:nowrap" class="ft102">The induced tumor like structures (ITLS) were&#160;</p>
<p style="position:absolute;top:394px;left:87px;white-space:nowrap" class="ft102">shown to exhibit striking similarities with classic&#160;</p>
<p style="position:absolute;top:412px;left:87px;white-space:nowrap" class="ft102">tumors, including increased proliferation as monitored&#160;</p>
<p style="position:absolute;top:430px;left:87px;white-space:nowrap" class="ft102">by visualizing the cell cycle dynamics, disorganization&#160;</p>
<p style="position:absolute;top:448px;left:87px;white-space:nowrap" class="ft102">of the normal developmental architecture revealed by&#160;</p>
<p style="position:absolute;top:466px;left:87px;white-space:nowrap" class="ft102">H&amp;E stains, increased hypoxia, increased nuclear size,&#160;</p>
<p style="position:absolute;top:484px;left:87px;white-space:nowrap" class="ft102">acidic intracellular microenvironment, and ability to&#160;</p>
<p style="position:absolute;top:502px;left:87px;white-space:nowrap" class="ft102">illicit innate immune response (Fig. 1A-F). Given the&#160;</p>
<p style="position:absolute;top:520px;left:87px;white-space:nowrap" class="ft102">increased recognition of bioelectric signals as endogenous&#160;</p>
<p style="position:absolute;top:538px;left:87px;white-space:nowrap" class="ft102">patterning cues that keep cellular activities orchestrated&#160;</p>
<p style="position:absolute;top:556px;left:87px;white-space:nowrap" class="ft102">towards&#160;anatomical&#160;goals&#160;[32,&#160;33,&#160;127],&#160;our&#160;data&#160;confirm&#160;</p>
<p style="position:absolute;top:574px;left:87px;white-space:nowrap" class="ft103"><i>Xenopus</i>&#160;embryos as a tractable model system in which&#160;</p>
<p style="position:absolute;top:592px;left:87px;white-space:nowrap" class="ft102">to investigate&#160;the role of bioelectric&#160;signals in host:cancer&#160;</p>
<p style="position:absolute;top:610px;left:87px;white-space:nowrap" class="ft102">interaction, and in which to ask fundamental questions&#160;</p>
<p style="position:absolute;top:628px;left:87px;white-space:nowrap" class="ft102">about&#160;cancer&#160;as&#160;a&#160;disorder&#160;of&#160;developmental cues&#160;[5, 6,&#160;</p>
<p style="position:absolute;top:646px;left:87px;white-space:nowrap" class="ft102">10, 12, 128, 129].</p>
<p style="position:absolute;top:682px;left:87px;white-space:nowrap" class="ft104"><b>Long-range control of tumorigenic process by&#160;</b></p>
<p style="position:absolute;top:702px;left:87px;white-space:nowrap" class="ft104"><b>V</b></p>
<p style="position:absolute;top:715px;left:99px;white-space:nowrap" class="ft105"><b>mem</b></p>
<p style="position:absolute;top:749px;left:123px;white-space:nowrap" class="ft102">The spatial distance over which carcinogenesis&#160;</p>
<p style="position:absolute;top:767px;left:87px;white-space:nowrap" class="ft102">can be predicted and controlled have been addressed in&#160;</p>
<p style="position:absolute;top:785px;left:87px;white-space:nowrap" class="ft102">a few studies. One example is illustrated by the ability&#160;</p>
<p style="position:absolute;top:803px;left:87px;white-space:nowrap" class="ft102">to assess cancer risk of readily-inaccessible organs using&#160;</p>
<p style="position:absolute;top:821px;left:87px;white-space:nowrap" class="ft102">accessible surrogate sites – functionally or anatomically&#160;</p>
<p style="position:absolute;top:839px;left:87px;white-space:nowrap" class="ft102">similar, but not necessarily contiguous with the target&#160;</p>
<p style="position:absolute;top:857px;left:87px;white-space:nowrap" class="ft102">organ&#160;–&#160;that&#160;make&#160;up&#160;the&#160;cancer&#160;field&#160;[130-132].&#160;Another&#160;</p>
<p style="position:absolute;top:875px;left:87px;white-space:nowrap" class="ft102">is the activation of melanoma-like transformation in the&#160;</p>
<p style="position:absolute;top:893px;left:87px;white-space:nowrap" class="ft102">melanocyte population [60] by&#160;V</p>
<p style="position:absolute;top:904px;left:291px;white-space:nowrap" class="ft106">mem&#160;modulation of even&#160;</p>
<p style="position:absolute;top:911px;left:87px;white-space:nowrap" class="ft102">a&#160;few instructor cells at considerable distance from the&#160;</p>
<p style="position:absolute;top:929px;left:87px;white-space:nowrap" class="ft102">melanocytes&#160;themselves [61]. However, to our knowledge&#160;</p>
<p style="position:absolute;top:947px;left:87px;white-space:nowrap" class="ft102">this&#160;&#160;is&#160;&#160;the&#160;&#160;first&#160;&#160;time&#160;&#160;that&#160;&#160;modulation&#160;&#160;of&#160;&#160;distant&#160;&#160;cells’&#160;</p>
<p style="position:absolute;top:965px;left:87px;white-space:nowrap" class="ft102">resting potentials&#160;has been shown to impact&#160;the formation&#160;</p>
<p style="position:absolute;top:983px;left:87px;white-space:nowrap" class="ft102">of discrete tumor foci. It is tempting to speculate that the&#160;</p>
<p style="position:absolute;top:1001px;left:87px;white-space:nowrap" class="ft102">long-range connections are bi-directional: not only does&#160;</p>
<p style="position:absolute;top:1019px;left:87px;white-space:nowrap" class="ft102">remote electrical state of tissue matter for tumor growth,&#160;</p>
<p style="position:absolute;top:1037px;left:87px;white-space:nowrap" class="ft102">but perhaps tumors also emit bioelectrical information&#160;</p>
<p style="position:absolute;top:1055px;left:87px;white-space:nowrap" class="ft102">that could be detectable at a distance.&#160;This is compatible&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft102">with classical data [131, 133-135] and will be tested using&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft102">molecular reagents in the future.</p>
<p style="position:absolute;top:106px;left:523px;white-space:nowrap" class="ft102">In our previous work [43], we showed that&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft102">hyperpolarized cells were themselves resistant to&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft102">transformation&#160;[136-138].&#160;To analyze&#160;long-range effects&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft102">of hyperpolarization, we established an assay in which&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft103"><i>Xenopus</i>&#160;16-cell&#160;embryos&#160;were&#160;injected&#160;with&#160;oncogene&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft102">in&#160;one&#160;blastomere&#160;and&#160;subjected&#160;to&#160;a&#160;hyperpolarizing&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft102">treatment, non-locally, via ectopic-expression of&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft102">hyperpolarization channel or manipulation of ionic&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft102">contents of the media. Remarkably, the data show that&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft102">hyperpolarization&#160;significantly&#160;suppresses&#160;the&#160;formation&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft102">of ITLS, regardless of which oncogene was used (Fig. 2B,&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft102">C), even when the oncogene-bearing cells and the cells&#160;</p>
<p style="position:absolute;top:322px;left:487px;white-space:nowrap" class="ft102">that have been hyperpolarized&#160;are on opposite ends of the&#160;</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft102">body.&#160;Complete&#160;suppression of&#160;ITLS&#160;was&#160;not&#160;achieved,&#160;</p>
<p style="position:absolute;top:358px;left:487px;white-space:nowrap" class="ft102">because our reagents had to be tittered down to avoid&#160;</p>
<p style="position:absolute;top:376px;left:487px;white-space:nowrap" class="ft102">perturbing the normal developmental processes of the&#160;</p>
<p style="position:absolute;top:394px;left:487px;white-space:nowrap" class="ft102">organism.&#160;Future&#160;work&#160;is&#160;needed&#160;to&#160;refine&#160;the&#160;strategy&#160;for&#160;</p>
<p style="position:absolute;top:412px;left:487px;white-space:nowrap" class="ft102">optimal&#160;management&#160;of the bioelectric&#160;crosstalk that goes&#160;</p>
<p style="position:absolute;top:430px;left:487px;white-space:nowrap" class="ft102">awry&#160;in&#160;cancer;&#160;it&#160;is&#160;likely&#160;that&#160;a&#160;more&#160;nuanced&#160;strategy,&#160;</p>
<p style="position:absolute;top:448px;left:487px;white-space:nowrap" class="ft102">which manages spatial relationships at higher resolution,&#160;</p>
<p style="position:absolute;top:466px;left:487px;white-space:nowrap" class="ft102">will be required in clinical practice.&#160;Another important&#160;</p>
<p style="position:absolute;top:484px;left:487px;white-space:nowrap" class="ft102">area for future investigation is slow time-dependent&#160;</p>
<p style="position:absolute;top:502px;left:487px;white-space:nowrap" class="ft102">variability&#160;of V</p>
<p style="position:absolute;top:514px;left:585px;white-space:nowrap" class="ft106">mem, as we only explored continuously-</p>
<p style="position:absolute;top:520px;left:487px;white-space:nowrap" class="ft102">acting&#160;reagents&#160;and&#160;it&#160;is possible&#160;that&#160;important&#160;patterning&#160;</p>
<p style="position:absolute;top:538px;left:487px;white-space:nowrap" class="ft102">information&#160;&#160;is&#160;&#160;encoded&#160;&#160;in&#160;&#160;the&#160;&#160;time&#160;&#160;profile&#160;&#160;of&#160;&#160;slowly-</p>
<p style="position:absolute;top:556px;left:487px;white-space:nowrap" class="ft102">changing bioelectrical states [37, 139-142]. Optogenetics&#160;</p>
<p style="position:absolute;top:574px;left:487px;white-space:nowrap" class="ft102">– the use of light to regulate ion channels with high spatio-</p>
<p style="position:absolute;top:592px;left:487px;white-space:nowrap" class="ft102">temporal&#160;specificity&#160;-&#160;[143,&#160;144]&#160;is&#160;a&#160;promising&#160;technology&#160;</p>
<p style="position:absolute;top:610px;left:487px;white-space:nowrap" class="ft102">for both of these directions.</p>
<p style="position:absolute;top:628px;left:523px;white-space:nowrap" class="ft102">Resting&#160;potential&#160;changes can&#160;result&#160;from&#160;genomic,&#160;</p>
<p style="position:absolute;top:646px;left:487px;white-space:nowrap" class="ft102">transcriptional,&#160;or post-translation control&#160;of ion&#160;channels&#160;</p>
<p style="position:absolute;top:664px;left:487px;white-space:nowrap" class="ft102">and&#160;pumps.&#160;Importantly,&#160;we&#160;obtained&#160;tumor&#160;suppression&#160;</p>
<p style="position:absolute;top:682px;left:487px;white-space:nowrap" class="ft102">using either Cl-&#160;or K+-based hyperpolarization, just as we&#160;</p>
<p style="position:absolute;top:700px;left:487px;white-space:nowrap" class="ft102">showed previously for cell-autonomous tumorigenesis&#160;</p>
<p style="position:absolute;top:718px;left:487px;white-space:nowrap" class="ft102">and metastatic activation by depolarization [43, 46,&#160;</p>
<p style="position:absolute;top:736px;left:487px;white-space:nowrap" class="ft102">60, 61].&#160;This rules out signaling pathways triggered&#160;</p>
<p style="position:absolute;top:754px;left:487px;white-space:nowrap" class="ft102">by&#160;specific&#160;ion&#160;channels&#160;or&#160;even&#160;limited&#160;to&#160;specific&#160;ion&#160;</p>
<p style="position:absolute;top:772px;left:487px;white-space:nowrap" class="ft102">types.&#160;Thus, in complement to the gene-focused idea of&#160;</p>
<p style="position:absolute;top:790px;left:487px;white-space:nowrap" class="ft102">specific&#160;ion&#160;channels&#160;being&#160;intrinsic&#160;oncogenes&#160;or&#160;tumor&#160;</p>
<p style="position:absolute;top:808px;left:487px;white-space:nowrap" class="ft102">suppressors [44, 48, 145], we suggest that a systems-</p>
<p style="position:absolute;top:826px;left:487px;white-space:nowrap" class="ft102">level physiological property – resting potential&#160;– can be a&#160;</p>
<p style="position:absolute;top:844px;left:487px;white-space:nowrap" class="ft102">powerful causal factor in regulating these processes.</p>
<p style="position:absolute;top:880px;left:487px;white-space:nowrap" class="ft104"><b>CLIC1-dependent&#160;hyperpolarization:&#160;a&#160;native&#160;</b></p>
<p style="position:absolute;top:900px;left:487px;white-space:nowrap" class="ft104"><b>target underlying suppression&#160;</b></p>
<p style="position:absolute;top:947px;left:523px;white-space:nowrap" class="ft102">A&#160;large body of literature reveals differential ion&#160;</p>
<p style="position:absolute;top:965px;left:487px;white-space:nowrap" class="ft102">channel and transporter expression between tumor cells&#160;</p>
<p style="position:absolute;top:983px;left:487px;white-space:nowrap" class="ft102">and their untransformed counterparts [146-150].&#160;These&#160;</p>
<p style="position:absolute;top:1001px;left:487px;white-space:nowrap" class="ft102">native&#160;ion translocators&#160;are important&#160;not only as markers&#160;</p>
<p style="position:absolute;top:1019px;left:487px;white-space:nowrap" class="ft102">[52, 145, 151-153] but also as targets for interventions&#160;</p>
<p style="position:absolute;top:1037px;left:487px;white-space:nowrap" class="ft102">designed to manage the bioelectric state of cancer and&#160;</p>
<p style="position:absolute;top:1055px;left:487px;white-space:nowrap" class="ft102">surrounding tissue without needing gene therapy with&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft110{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft111{font-size:11px;font-family:Times;color:#211f21;}
	.ft112{font-size:13px;font-family:Times;color:#211f21;}
	.ft113{font-size:6px;font-family:Times;color:#211f21;}
	.ft114{font-size:13px;font-family:Times;color:#211f21;}
	.ft115{font-size:14px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page11-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft110">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft111">3296</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft110">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft112">heterologous channels. Exploiting native channels may&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft112">allow manipulation of bioelectric signals merely by&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft112">changing ionic composition of the cellular environment;&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft112">indeed, we observed that hyperpolarization by high Cl-&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft112">reduces ITLS incidences (Fig. 3B) without additional&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft112">channel misexpression.&#160;The alteration of tumorigenic&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft112">transformation by ionic conditions in the medium is&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft112">consistent with previous data showing an association&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft112">between&#160;the&#160;(depolarizing)&#160;level&#160;of&#160;sodium&#160;and&#160;cancer&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft112">[154-156], the control of cell differentiation by sodium&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft112">levels [157-159] and pH [160], and more recent work on&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft112">stem cell reprogramming by acid baths and streptolysin-</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft112">mediated membrane permeability change [161].&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft112">Reprogramming of cell state by physiological cues is&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft112">certainly&#160;of&#160;relevance&#160;to&#160;cancer&#160;[162-165].&#160;However,&#160;two&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft112">important novel aspects of our data are the focus on&#160;V</p>
<p style="position:absolute;top:352px;left:415px;white-space:nowrap" class="ft113">mem&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft114"><i>per&#160;se</i>,&#160;not&#160;specific&#160;ions&#160;as&#160;obligate&#160;signals,&#160;and&#160;the&#160;non-</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft112">local nature of the suppression mechanism.</p>
<p style="position:absolute;top:394px;left:123px;white-space:nowrap" class="ft112">A&#160;pharmacological loss-of-function experiment&#160;</p>
<p style="position:absolute;top:412px;left:87px;white-space:nowrap" class="ft112">using chloride channel blockers (Fig. 3A) and a gene-</p>
<p style="position:absolute;top:430px;left:87px;white-space:nowrap" class="ft112">specific&#160;dominant&#160;negative&#160;(Fig.&#160;4)&#160;implicated&#160;chloride&#160;</p>
<p style="position:absolute;top:448px;left:87px;white-space:nowrap" class="ft112">intracellular chloride channel 1 (CLIC1) as a likely&#160;</p>
<p style="position:absolute;top:466px;left:87px;white-space:nowrap" class="ft112">candidate for the channel required for hyperpolarization&#160;</p>
<p style="position:absolute;top:484px;left:87px;white-space:nowrap" class="ft112">in the long-range ITLS suppression. Roles for CLIC1&#160;</p>
<p style="position:absolute;top:502px;left:87px;white-space:nowrap" class="ft112">in&#160;carcinogenesis – albeit cell autonomous – have been&#160;</p>
<p style="position:absolute;top:520px;left:87px;white-space:nowrap" class="ft112">shown previously in several studies.&#160;A&#160;search for ion&#160;</p>
<p style="position:absolute;top:538px;left:87px;white-space:nowrap" class="ft112">channels&#160;&#160;in&#160;&#160;the&#160;&#160;cancer&#160;&#160;profiling&#160;&#160;database,&#160;&#160;Oncomine,&#160;</p>
<p style="position:absolute;top:556px;left:87px;white-space:nowrap" class="ft112">turns up CLIC1 as one of the most upregulated genes&#160;</p>
<p style="position:absolute;top:574px;left:87px;white-space:nowrap" class="ft112">[166], and chloride current associated with increased&#160;</p>
<p style="position:absolute;top:592px;left:87px;white-space:nowrap" class="ft112">CLIC1 expression is present in progenitor cells isolated&#160;</p>
<p style="position:absolute;top:610px;left:87px;white-space:nowrap" class="ft112">from human glioblastomas, and is responsible for&#160;</p>
<p style="position:absolute;top:628px;left:87px;white-space:nowrap" class="ft112">promoting proliferation, clonogenicity, and tumorigenic&#160;</p>
<p style="position:absolute;top:646px;left:87px;white-space:nowrap" class="ft112">capacity [167]. Channels like this are of high interest as&#160;</p>
<p style="position:absolute;top:664px;left:87px;white-space:nowrap" class="ft112">a therapeutic modality [56], but it should be noted that&#160;</p>
<p style="position:absolute;top:682px;left:87px;white-space:nowrap" class="ft112">it&#160;is&#160;not&#160;enough&#160;to&#160;look&#160;for&#160;blockers&#160;(a&#160;standard&#160;loss-of-</p>
<p style="position:absolute;top:700px;left:87px;white-space:nowrap" class="ft112">function genetic strategy) – the key is to modulate&#160;V</p>
<p style="position:absolute;top:712px;left:411px;white-space:nowrap" class="ft113">mem,&#160;</p>
<p style="position:absolute;top:718px;left:87px;white-space:nowrap" class="ft112">which&#160;&#160;may&#160;&#160;mean&#160;&#160;opening&#160;&#160;or&#160;&#160;closing&#160;&#160;specific&#160;&#160;channels&#160;</p>
<p style="position:absolute;top:736px;left:87px;white-space:nowrap" class="ft112">depending on the cells’&#160;surrounding milieu and its ion&#160;</p>
<p style="position:absolute;top:754px;left:87px;white-space:nowrap" class="ft112">gradients.&#160;An understanding&#160;of&#160;V</p>
<p style="position:absolute;top:766px;left:287px;white-space:nowrap" class="ft113">mem&#160;as a regulatory&#160;agent&#160;</p>
<p style="position:absolute;top:772px;left:87px;white-space:nowrap" class="ft112">may also explain the anti-cancer activity of a number of&#160;</p>
<p style="position:absolute;top:790px;left:87px;white-space:nowrap" class="ft112">agents&#160;such&#160;as&#160;ivermectin&#160;[57],&#160;bafilomycin&#160;[168,&#160;169],&#160;</p>
<p style="position:absolute;top:808px;left:87px;white-space:nowrap" class="ft112">and salinomycin [170].</p>
<p style="position:absolute;top:826px;left:123px;white-space:nowrap" class="ft112">In&#160;&#160;<i>Xenopus</i>, CLIC1 is expressed throughout&#160;</p>
<p style="position:absolute;top:844px;left:87px;white-space:nowrap" class="ft112">development, with progressive increase in expression from&#160;</p>
<p style="position:absolute;top:862px;left:87px;white-space:nowrap" class="ft112">mid-blastula transition to the tadpole stages; spatially,&#160;</p>
<p style="position:absolute;top:880px;left:87px;white-space:nowrap" class="ft112">CLIC1 transcripts are present primarily in the ectoderm&#160;</p>
<p style="position:absolute;top:898px;left:87px;white-space:nowrap" class="ft112">and ectodermally-originated organs [94]. Interestingly,&#160;</p>
<p style="position:absolute;top:916px;left:87px;white-space:nowrap" class="ft112">CLIC1 expression is missing from the gut region where we&#160;</p>
<p style="position:absolute;top:934px;left:87px;white-space:nowrap" class="ft112">frequently observe ITLS on the ectoderm.&#160;Thus, CLIC1&#160;</p>
<p style="position:absolute;top:952px;left:87px;white-space:nowrap" class="ft112">proteins are located at a distance from oncogene-induced&#160;</p>
<p style="position:absolute;top:970px;left:87px;white-space:nowrap" class="ft112">foci, showing that they can act like the overexpressed&#160;</p>
<p style="position:absolute;top:988px;left:87px;white-space:nowrap" class="ft112">potassium channels – in long-range hyperpolarization.&#160;</p>
<p style="position:absolute;top:1006px;left:87px;white-space:nowrap" class="ft112">By overexpressing wildtype&#160;<i>Xenopus</i>&#160;CLIC1 and raising&#160;</p>
<p style="position:absolute;top:1024px;left:87px;white-space:nowrap" class="ft112">extracellular chloride levels, we are able to achieve higher&#160;</p>
<p style="position:absolute;top:1042px;left:87px;white-space:nowrap" class="ft112">suppression of oncogenic transformation of cells located&#160;</p>
<p style="position:absolute;top:1060px;left:87px;white-space:nowrap" class="ft112">at a distance. Moreover, this suppression can be blocked&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft112">– despite the presence of high extracellular chloride levels&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft112">– by introducing a dominant negative chloride channel&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft112">mutant&#160;away&#160;from&#160;oncogene-expressing&#160;cells&#160;(Fig.&#160;4).&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft112">Interestingly,&#160;another&#160;study&#160;from&#160;our&#160;lab&#160;has&#160;documented&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft112">the endogenous presence of glycine-gated channels:&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft112">though not present in melanocytes their depolarization&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft112">confers highly proliferative and metastatic phenotype&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft112">in&#160;melanocytes in a long-range, serotonergic signaling&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft112">pathway [60, 61].&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft115"><b>Transducing hyperpolarization into cell&#160;</b></p>
<p style="position:absolute;top:270px;left:487px;white-space:nowrap" class="ft115"><b>responses: HDAC1 inhibition</b></p>
<p style="position:absolute;top:317px;left:523px;white-space:nowrap" class="ft112">How do resting potential changes&#160;such&#160;as&#160;</p>
<p style="position:absolute;top:335px;left:487px;white-space:nowrap" class="ft112">hyperpolarization impact&#160;on&#160;the transcriptional and&#160;</p>
<p style="position:absolute;top:353px;left:487px;white-space:nowrap" class="ft112">epigenetic pathways of cancer? Recent studies have&#160;</p>
<p style="position:absolute;top:371px;left:487px;white-space:nowrap" class="ft112">identified&#160;several&#160;mechanisms&#160;that&#160;transduce&#160;bioelectric&#160;</p>
<p style="position:absolute;top:389px;left:487px;white-space:nowrap" class="ft112">signals at the cell membrane into biochemical responses&#160;</p>
<p style="position:absolute;top:407px;left:487px;white-space:nowrap" class="ft112">(reviewed in [63, 104, 171]. Using a pharmacological&#160;</p>
<p style="position:absolute;top:425px;left:487px;white-space:nowrap" class="ft112">suppression and molecular loss of function (Fig.&#160;</p>
<p style="position:absolute;top:443px;left:487px;white-space:nowrap" class="ft112">5A,&#160;&#160;B),&#160;&#160;we&#160;&#160;identified&#160;&#160;possible&#160;&#160;roles&#160;&#160;for&#160;&#160;gap&#160;&#160;junction&#160;</p>
<p style="position:absolute;top:461px;left:487px;white-space:nowrap" class="ft112">communication (to be reported in a forthcoming study)&#160;</p>
<p style="position:absolute;top:479px;left:487px;white-space:nowrap" class="ft112">and HDAC1 inhibition as signaling elements required&#160;</p>
<p style="position:absolute;top:497px;left:487px;white-space:nowrap" class="ft112">for the long-range ITLS suppression.&#160;The introduction&#160;</p>
<p style="position:absolute;top:515px;left:487px;white-space:nowrap" class="ft112">of a dominant negative HDAC1 mRNA&#160;[102] in a&#160;</p>
<p style="position:absolute;top:533px;left:487px;white-space:nowrap" class="ft112">long-range&#160;&#160;manner&#160;&#160;was&#160;&#160;able&#160;&#160;to&#160;&#160;significantly&#160;&#160;increase&#160;</p>
<p style="position:absolute;top:551px;left:487px;white-space:nowrap" class="ft112">neoplastic&#160;conversions&#160;of&#160;oncogene-expressing&#160;distant&#160;</p>
<p style="position:absolute;top:569px;left:487px;white-space:nowrap" class="ft112">cells.&#160;The results are surprising relative to the well-</p>
<p style="position:absolute;top:587px;left:487px;white-space:nowrap" class="ft112">known function of HDAC inhibitors as having antitumor&#160;</p>
<p style="position:absolute;top:605px;left:487px;white-space:nowrap" class="ft112">activities, including reduced proliferation [172], increased&#160;</p>
<p style="position:absolute;top:623px;left:487px;white-space:nowrap" class="ft112">differentiation/apoptosis [173], and that a number of&#160;</p>
<p style="position:absolute;top:641px;left:487px;white-space:nowrap" class="ft112">them&#160;are&#160;on the&#160;clinical development pipeline&#160;for anti-</p>
<p style="position:absolute;top:659px;left:487px;white-space:nowrap" class="ft112">cancer therapeutics [174-177]. In fact, variants of well-</p>
<p style="position:absolute;top:677px;left:487px;white-space:nowrap" class="ft112">known HDAC inhibitors, such as vorinostat, (Merck)&#160;</p>
<p style="position:absolute;top:695px;left:487px;white-space:nowrap" class="ft112">and romidepsin (Celgene) have already been developed&#160;</p>
<p style="position:absolute;top:713px;left:487px;white-space:nowrap" class="ft112">and approved by the Food and Drug&#160;Administration for&#160;</p>
<p style="position:absolute;top:731px;left:487px;white-space:nowrap" class="ft112">treating&#160;cutaneous&#160;T-cell&#160;lymphoma&#160;[178,&#160;179].&#160;However,&#160;</p>
<p style="position:absolute;top:749px;left:487px;white-space:nowrap" class="ft112">consistent with our data, HDAC1 knock-down promotes&#160;</p>
<p style="position:absolute;top:767px;left:487px;white-space:nowrap" class="ft112">early tumorigenesis in oncogene expressing cells [180],&#160;</p>
<p style="position:absolute;top:785px;left:487px;white-space:nowrap" class="ft112">and&#160;genomic&#160;instability&#160;in&#160;a&#160;given&#160;cell&#160;can&#160;have&#160;a&#160;system-</p>
<p style="position:absolute;top:803px;left:487px;white-space:nowrap" class="ft112">wide&#160;effect mediated by&#160;the immune system and other&#160;</p>
<p style="position:absolute;top:821px;left:487px;white-space:nowrap" class="ft112">factors [181, 182]. Overall, this is consistent with our&#160;</p>
<p style="position:absolute;top:839px;left:487px;white-space:nowrap" class="ft112">proposal&#160;&#160;that&#160;&#160;what&#160;&#160;is&#160;&#160;disrupted&#160;&#160;in&#160;&#160;cancer&#160;&#160;is&#160;&#160;a&#160;&#160;specific&#160;</p>
<p style="position:absolute;top:857px;left:487px;white-space:nowrap" class="ft112">and highly modulated pattern of resting potentials - it&#160;</p>
<p style="position:absolute;top:875px;left:487px;white-space:nowrap" class="ft112">is likely that the desired signaling cannot be achieved&#160;</p>
<p style="position:absolute;top:893px;left:487px;white-space:nowrap" class="ft112">by universally increasing “anti-cancer” gene products.&#160;</p>
<p style="position:absolute;top:911px;left:487px;white-space:nowrap" class="ft112">Depending on other factors that vary widely in different&#160;</p>
<p style="position:absolute;top:929px;left:487px;white-space:nowrap" class="ft112">systems (such as ion concentrations, butyrate&#160;availability,&#160;</p>
<p style="position:absolute;top:947px;left:487px;white-space:nowrap" class="ft112">and spatial arrangement of tumor and tissue), disbalance&#160;</p>
<p style="position:absolute;top:965px;left:487px;white-space:nowrap" class="ft112">of voltage-dependent signaling in either direction could&#160;</p>
<p style="position:absolute;top:983px;left:487px;white-space:nowrap" class="ft112">promote or suppress tumorigenesis.&#160;</p>
<p style="position:absolute;top:1001px;left:523px;white-space:nowrap" class="ft112">We sought to understand how&#160;V</p>
<p style="position:absolute;top:1012px;left:731px;white-space:nowrap" class="ft113">mem&#160;changes and&#160;</p>
<p style="position:absolute;top:1019px;left:487px;white-space:nowrap" class="ft112">acetylation state of chromatins could control tumor growth&#160;</p>
<p style="position:absolute;top:1037px;left:487px;white-space:nowrap" class="ft112">in&#160;a&#160;non-cell&#160;autonomous&#160;manner. Given&#160;the&#160;link&#160;between&#160;</p>
<p style="position:absolute;top:1055px;left:487px;white-space:nowrap" class="ft112">V</p>
<p style="position:absolute;top:1066px;left:498px;white-space:nowrap" class="ft113">mem-guided butyrate transport and HDAC activities the&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft120{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft121{font-size:11px;font-family:Times;color:#211f21;}
	.ft122{font-size:13px;font-family:Times;color:#211f21;}
	.ft123{font-size:13px;font-family:Times;color:#211f21;}
	.ft124{font-size:13px;font-family:Times;color:#211f21;}
	.ft125{font-size:6px;font-family:Times;color:#211f21;}
	.ft126{font-size:5px;font-family:Times;color:#211f21;}
	.ft127{font-size:11px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page12-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft120">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft121">3297</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft120">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft122">control cell behavior during regeneration [62] and local&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft122">tumorigenesis [43], we tested the effect of targeting&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft122">butyrate-producing bacteria on ITLS formation. Both&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft122">novobiocin, an antibiotic against gram-positive bacteria,&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft122">and a cocktail of antibiotics (gentamicin, metrodinazole,&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft122">vancomycin, and clindamycin, data not shown) that have&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft122">been&#160;verified&#160;to&#160;reduce&#160;levels&#160;of&#160;butyrate,&#160;significantly&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft122">increased the rate of ITLS formation (Fig. 6). Our data&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft122">are consistent with, and provide a novel mechanism&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft122">explaining, several studies that investigated the effects&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft122">of antibiotics on the gut microbiota, including butyrate-</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft122">producing bacteria species, and their subsequent&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft122">implications in increased cancer risks and incidences [183-</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft122">186].&#160;</p>
<p style="position:absolute;top:322px;left:123px;white-space:nowrap" class="ft122">Our analysis was limited in two main ways: the&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft122">lack of a technology for monitoring location of butyrate&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft123"><i>in&#160;vivo</i>, and the inability to isolate and culture butyrate&#160;</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft122">producing bacteria (which&#160;are highly anaerobic and do&#160;</p>
<p style="position:absolute;top:394px;left:87px;white-space:nowrap" class="ft122">not grow under standard&#160;culture&#160;conditions&#160;[187]). Future&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft122">work using GFP-expressing strains of appropriately&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft122">engineered&#160;bacterial&#160;model&#160;species&#160;will&#160;further&#160;refine&#160;our&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft122">understanding of the role of native microbiota on cancer&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft122">progression and bioelectric signaling.&#160;</p>
<p style="position:absolute;top:142px;left:523px;white-space:nowrap" class="ft122">Collectively, the data presented here suggest a&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft122">possible model (Fig.&#160;7). Pharmacologically/molecular-</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft122">genetically hyperpolarized cells have membrane that is&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft122">negative&#160;on the inside, which creates&#160;a positively-charged&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft122">cell surface environment.&#160;While bacteria&#160;– whether gram-</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft122">positive&#160;or&#160;gram-negative&#160;–&#160;readily&#160;attach&#160;to&#160;a&#160;positively-</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft122">charged surface, their viability is greatly diminished due&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft122">to strong electrostatic interaction [188, 189].&#160;As a result,&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft122">distribution of butyrate producing-bacteria is skewed&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft122">away from hyperpolarized cells in favor of oncogene-</p>
<p style="position:absolute;top:322px;left:487px;white-space:nowrap" class="ft122">expressing cells, which are known to be depolarized pre-</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft122">neoplastic&#160;transformation&#160;[43].&#160;Availability&#160;of&#160;butyrate&#160;to&#160;</p>
<p style="position:absolute;top:358px;left:487px;white-space:nowrap" class="ft122">these prospective tumor sites leads to HDAC inhibition&#160;</p>
<p style="position:absolute;top:376px;left:487px;white-space:nowrap" class="ft122">and increased hyperacetylation of histones, which promote&#160;</p>
<p style="position:absolute;top:394px;left:487px;white-space:nowrap" class="ft122">cell&#160;cycle&#160;arrest,&#160;leading&#160;to&#160;reduced&#160;rates&#160;of&#160;proliferation,&#160;</p>
<p style="position:absolute;top:963px;left:87px;white-space:nowrap" class="ft124"><b>Figure&#160;7:&#160;A&#160;model&#160;for&#160;V</b></p>
<p style="position:absolute;top:975px;left:246px;white-space:nowrap" class="ft125"><b>mem&#160;–&#160;mediated,&#160;HDAC1-dependent, long-range&#160;control&#160;of&#160;cell&#160;dynamics during neoplastic&#160;</b></p>
<p style="position:absolute;top:981px;left:87px;white-space:nowrap" class="ft124"><b>transformation&#160;</b>It is known that HDAC1&#160;inhibition&#160;leads to the altered transcriptional of regulation&#160;of several ion channel&#160;</p>
<p style="position:absolute;top:1000px;left:87px;white-space:nowrap" class="ft122">genes including&#160;NaV&#160;1.2 [197] – a voltage&#160;gated&#160;sodium channel encoding&#160;<b>gene.&#160;</b>One model consistent&#160;with our data&#160;is that the&#160;</p>
<p style="position:absolute;top:1017px;left:87px;white-space:nowrap" class="ft121">resulting&#160;Na+&#160;gradient&#160;(more positive&#160;charge) would attract&#160;butyrate&#160;producing bacteria&#160;away from oncogene expressing cells&#160;(illustrated&#160;</p>
<p style="position:absolute;top:1034px;left:87px;white-space:nowrap" class="ft121">using&#160;<i>Escherichia&#160;coli</i>&#160;in Supp. Fig 1). Gram-positive&#160;bacteria&#160;are&#160;necessary&#160;for the&#160;production&#160;of butyrate,&#160;which gets imported&#160;into&#160;cells&#160;</p>
<p style="position:absolute;top:1050px;left:87px;white-space:nowrap" class="ft121">via SLC5A8 to reduce proliferation&#160;rate by inducing cell&#160;cycle&#160;arrest in tumor cells. Driving these bacteria&#160;away from ITLS cells would&#160;</p>
<p style="position:absolute;top:1066px;left:87px;white-space:nowrap" class="ft121">reduce the number of butyrate molecules available near oncogene cells, thus blocking ITLS suppression.&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft130{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft131{font-size:11px;font-family:Times;color:#211f21;}
	.ft132{font-size:13px;font-family:Times;color:#211f21;}
	.ft133{font-size:6px;font-family:Times;color:#211f21;}
	.ft134{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft135{font-size:14px;font-family:Times;color:#211f21;}
	.ft136{font-size:13px;font-family:Times;color:#211f21;}
	.ft137{font-size:6px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page13-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft130">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft131">3298</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft130">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft132">apoptosis, and differentiation of cancer cells lines [105-</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft132">107].&#160;</p>
<p style="position:absolute;top:106px;left:123px;white-space:nowrap" class="ft132">While the spatial dynamics of butyrate and&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft132">bacteria remain to be investigated, our data reveal a&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft132">novel long-range pathway regulating oncogene-mediated&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft132">tumorigenesis at a distance.&#160;We do not yet know the&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft132">maximum&#160;extent,&#160;in&#160;a&#160;large&#160;organism,&#160;of&#160;such&#160;long-range&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft132">signaling by hyperpolarization. Future work must also&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft132">examine&#160;the&#160;roles of&#160;remote&#160;endogenous&#160;bioelectric&#160;states&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft132">in mammalian cancer models; if conserved, these data&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft132">suggest&#160;a&#160;number&#160;of detection&#160;and&#160;treatment&#160;modalities&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft132">focused&#160;on V</p>
<p style="position:absolute;top:280px;left:175px;white-space:nowrap" class="ft133">mem&#160;modulation. Because such strategies&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft132">could be designed using ion channel drugs [190, 191]&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft132">already&#160;approved&#160;for&#160;human&#160;use&#160;(as&#160;anti-epileptic&#160;agents),&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft132">exciting opportunities for biomedicine may be presented&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft132">by&#160;investigations&#160;of&#160;bioelectric&#160;signaling&#160;in&#160;cancer&#160;at&#160;a&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft132">level beyond that of single cells.</p>
<p style="position:absolute;top:395px;left:87px;white-space:nowrap" class="ft134"><b>MATERIALS AND&#160;METHODS</b></p>
<p style="position:absolute;top:452px;left:87px;white-space:nowrap" class="ft135"><b>Animal Husbandry&#160;</b></p>
<p style="position:absolute;top:498px;left:123px;white-space:nowrap" class="ft136"><i>Xenopus&#160;&#160;laevis&#160;&#160;</i>embryos were collected and&#160;</p>
<p style="position:absolute;top:517px;left:87px;white-space:nowrap" class="ft132">fertilized&#160;<i>in vitro</i>&#160;according to standard protocols [192], in&#160;</p>
<p style="position:absolute;top:535px;left:87px;white-space:nowrap" class="ft132">0.1X&#160;Modified&#160;Marc’s&#160;Ringers&#160;(MMR;&#160;pH&#160;7.8)&#160;with&#160;0.1%&#160;</p>
<p style="position:absolute;top:553px;left:87px;white-space:nowrap" class="ft132">Gentamicin.&#160;<i>Xenopus&#160;</i>embryos were housed at 14-18°C&#160;</p>
<p style="position:absolute;top:571px;left:87px;white-space:nowrap" class="ft132">and staged according to Nieuwkoop and Faber [193].&#160;All&#160;</p>
<p style="position:absolute;top:589px;left:87px;white-space:nowrap" class="ft132">experimental procedures involving the use of animals for&#160;</p>
<p style="position:absolute;top:607px;left:87px;white-space:nowrap" class="ft132">experimental&#160;purposes were&#160;approved&#160;by&#160;the&#160;Institutional&#160;</p>
<p style="position:absolute;top:625px;left:87px;white-space:nowrap" class="ft132">Animal Care and Use Committees (IACUC) and&#160;Tufts&#160;</p>
<p style="position:absolute;top:643px;left:87px;white-space:nowrap" class="ft132">University&#160;Department&#160;of&#160;Lab&#160;Animal&#160;Medicine&#160;(DLAM)&#160;</p>
<p style="position:absolute;top:661px;left:87px;white-space:nowrap" class="ft132">under the protocol number M2011-70.&#160;</p>
<p style="position:absolute;top:697px;left:87px;white-space:nowrap" class="ft135"><b>Microinjection</b></p>
<p style="position:absolute;top:743px;left:123px;white-space:nowrap" class="ft132">Fertilized<i>&#160;Xenopus</i>&#160;embryos were transferred into&#160;</p>
<p style="position:absolute;top:761px;left:87px;white-space:nowrap" class="ft132">mesh-bottomed dishes with 3% Ficoll and injected with&#160;</p>
<p style="position:absolute;top:779px;left:87px;white-space:nowrap" class="ft132">capped, synthetic mRNAs (made using the&#160;Ambion&#160;</p>
<p style="position:absolute;top:797px;left:87px;white-space:nowrap" class="ft132">Message Machine kit) dissolved in water at the stages&#160;</p>
<p style="position:absolute;top:815px;left:87px;white-space:nowrap" class="ft132">indicated. 2 hours post injection, embryos were transferred&#160;</p>
<p style="position:absolute;top:833px;left:87px;white-space:nowrap" class="ft132">into 0.75x MMR for 45 minutes&#160;before they were washed&#160;</p>
<p style="position:absolute;top:851px;left:87px;white-space:nowrap" class="ft132">and cultured in 0.1X MMR until desired stage was&#160;</p>
<p style="position:absolute;top:869px;left:87px;white-space:nowrap" class="ft132">reached. Constructs used included: FUCCI (<i>f</i>luorescent&#160;</p>
<p style="position:absolute;top:887px;left:87px;white-space:nowrap" class="ft136"><i>u</i>biquitination-based&#160;&#160;<i>c</i>ell&#160;&#160;<i>c</i>ycle&#160;&#160;<i>i</i>ndicator) pair: mKO2-</p>
<p style="position:absolute;top:905px;left:87px;white-space:nowrap" class="ft132">Cdt1 and mAG-Geminin [71, 72]; Gli1 [68], Xrel3 [194],&#160;</p>
<p style="position:absolute;top:923px;left:87px;white-space:nowrap" class="ft136"><i>KRASG12D</i>&#160;[69], and Kv1.5 [86]; CLIC1-2A-GFP3 and&#160;</p>
<p style="position:absolute;top:941px;left:87px;white-space:nowrap" class="ft132">CLIC1C24S-tdTomato; DN-HDAC1 [102].</p>
<p style="position:absolute;top:977px;left:87px;white-space:nowrap" class="ft135"><b>Drug treatments&#160;</b></p>
<p style="position:absolute;top:1024px;left:123px;white-space:nowrap" class="ft132">Embryos were exposed in 0.1× MMR for the&#160;</p>
<p style="position:absolute;top:1042px;left:87px;white-space:nowrap" class="ft132">stages&#160;indicated&#160;to: Anthracene-9-Carboxylic Acid&#160;</p>
<p style="position:absolute;top:1060px;left:87px;white-space:nowrap" class="ft132">(ACA)&#160;67&#160;μM;&#160;indanyloxyacetic&#160;acid&#160;(<i>IAA</i>-94),&#160;55&#160;μM;&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft132">5-Nitro-2-(3-phenylpropylamino) benzoic acid (NPPB,&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft132">Tocaris Bioscience, Bristol, UK), 8.5 nM; nalidixic acid&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft132">43&#160;μM;&#160;novobiocin&#160;sodium&#160;salt&#160;78&#160;μM;&#160;gentamicin,&#160;20&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft132">μM;&#160;metrodinazole,&#160;20&#160;μM;&#160;vancomycin&#160;hydrochloride&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft132">(Santacruz&#160;Biotechnology,&#160;Texas,&#160;USA)&#160;20&#160;μM;&#160;Choline&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft132">chloride,&#160;70mM&#160;and&#160;clindamycin&#160;hydrochloride,&#160;20&#160;μM.&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft132">All compounds were obtained from Sigma-Aldrich, St.&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft132">Louis, MO unless otherwise noted.</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft135"><b>Immunohistochemistry</b></p>
<p style="position:absolute;top:279px;left:523px;white-space:nowrap" class="ft132">Spatial analysis of leukocyte presence was&#160;</p>
<p style="position:absolute;top:297px;left:487px;white-space:nowrap" class="ft132">performed&#160;by&#160;immunohistochemistry&#160;in&#160;paraffin&#160;sections,&#160;</p>
<p style="position:absolute;top:315px;left:487px;white-space:nowrap" class="ft132">using&#160;an&#160;anti-XL2&#160;antibody&#160;[195].&#160;Briefly,&#160;embryos&#160;were&#160;</p>
<p style="position:absolute;top:333px;left:487px;white-space:nowrap" class="ft132">fixed&#160;overnight&#160;in&#160;MEMFA&#160;[192],&#160;embedded&#160;in&#160;paraffin&#160;</p>
<p style="position:absolute;top:351px;left:487px;white-space:nowrap" class="ft132">and&#160;sectioned&#160;at&#160;5&#160;μm&#160;using&#160;a&#160;Leica&#160;microtome.&#160;After&#160;</p>
<p style="position:absolute;top:369px;left:487px;white-space:nowrap" class="ft132">deparaffinizing&#160;&#160;and&#160;&#160;rehydrating,&#160;&#160;tissue&#160;&#160;sections&#160;&#160;were&#160;</p>
<p style="position:absolute;top:387px;left:487px;white-space:nowrap" class="ft132">permeabilized&#160;in&#160;phosphate&#160;buffered&#160;saline&#160;(PBS)&#160;+&#160;0.1X&#160;</p>
<p style="position:absolute;top:405px;left:487px;white-space:nowrap" class="ft132">Triton X-100 for 30 minutes, blocked with 10% goat&#160;</p>
<p style="position:absolute;top:423px;left:487px;white-space:nowrap" class="ft132">serum&#160;in&#160;PBS +&#160;0.1%&#160;tween-20&#160;for&#160;1&#160;hour,&#160;and&#160;incubated&#160;</p>
<p style="position:absolute;top:441px;left:487px;white-space:nowrap" class="ft132">at 40C overnight with anti-XL2 primary antibody. Sections&#160;</p>
<p style="position:absolute;top:459px;left:487px;white-space:nowrap" class="ft132">were then washed six times with PBST&#160;(30 minutes&#160;</p>
<p style="position:absolute;top:477px;left:487px;white-space:nowrap" class="ft132">each at room temperature) and incubated with&#160;Alexa-</p>
<p style="position:absolute;top:495px;left:487px;white-space:nowrap" class="ft132">Fluor-555-conjugated&#160;secondary&#160;antibody&#160;at&#160;1:1000&#160;in&#160;</p>
<p style="position:absolute;top:513px;left:487px;white-space:nowrap" class="ft132">PBST&#160;+ 10% goat serum overnight at 40C.&#160;After&#160;&#160;five&#160;</p>
<p style="position:absolute;top:531px;left:487px;white-space:nowrap" class="ft132">30-minute&#160;washes&#160;in&#160;PBST,&#160;sections&#160;were&#160;mounted&#160;on&#160;a&#160;</p>
<p style="position:absolute;top:549px;left:487px;white-space:nowrap" class="ft132">slide&#160;and&#160;photographed&#160;using&#160;the&#160;TRITC&#160;filter&#160;set&#160;on&#160;an&#160;</p>
<p style="position:absolute;top:567px;left:487px;white-space:nowrap" class="ft132">Olympus BX61 spinning-disk confocal microscope with&#160;</p>
<p style="position:absolute;top:585px;left:487px;white-space:nowrap" class="ft132">Hamamatsu ORCA&#160;digital CCD camera.</p>
<p style="position:absolute;top:621px;left:487px;white-space:nowrap" class="ft135"><b>Hypoxia detection</b></p>
<p style="position:absolute;top:668px;left:523px;white-space:nowrap" class="ft132">Immunochemical detection of tissue hypoxia was&#160;</p>
<p style="position:absolute;top:686px;left:487px;white-space:nowrap" class="ft132">performed&#160;&#160;by&#160;&#160;immunoperoxidase&#160;&#160;reaction&#160;&#160;in&#160;&#160;paraffin&#160;</p>
<p style="position:absolute;top:704px;left:487px;white-space:nowrap" class="ft132">sections,&#160;using&#160;the&#160;HypoxyTM-1&#160;Plus&#160;Kit&#160;(Hypoxyprobe,&#160;</p>
<p style="position:absolute;top:722px;left:487px;white-space:nowrap" class="ft132">Inc, MA, USA). St.34 embryos with&#160;<i>KRASG12D</i>&#160;ITLS&#160;</p>
<p style="position:absolute;top:740px;left:487px;white-space:nowrap" class="ft132">were incubated in 300 µM of pimonidazol HCl&#160;</p>
<p style="position:absolute;top:758px;left:487px;white-space:nowrap" class="ft132">(HypoxyprobeTM-1).&#160;&#160;Paraffin&#160;&#160;sections&#160;&#160;were&#160;&#160;prepared&#160;</p>
<p style="position:absolute;top:776px;left:487px;white-space:nowrap" class="ft132">for immunostaining as described above.&#160;Tissue sections&#160;</p>
<p style="position:absolute;top:794px;left:487px;white-space:nowrap" class="ft132">were then incubated using 1:50 dilution of FITC-MAB1,&#160;</p>
<p style="position:absolute;top:812px;left:487px;white-space:nowrap" class="ft132">which binds to protein adducts of pimonidazole in&#160;</p>
<p style="position:absolute;top:830px;left:487px;white-space:nowrap" class="ft132">hypoxic&#160;regions,&#160;and&#160;counterstained&#160;with&#160;1:50&#160;dilution&#160;of&#160;</p>
<p style="position:absolute;top:848px;left:487px;white-space:nowrap" class="ft132">horseradish peroxidase conjugated anti-FITC secondary.&#160;</p>
<p style="position:absolute;top:884px;left:487px;white-space:nowrap" class="ft135"><b>pH measurements&#160;</b></p>
<p style="position:absolute;top:931px;left:523px;white-space:nowrap" class="ft132">pH measurements were calculated from&#160;</p>
<p style="position:absolute;top:949px;left:487px;white-space:nowrap" class="ft132">BCECF&#160;&#160;fluorescent&#160;&#160;signals&#160;&#160;as&#160;&#160;described&#160;&#160;previously&#160;</p>
<p style="position:absolute;top:967px;left:487px;white-space:nowrap" class="ft132">in&#160;&#160;[196].&#160;&#160;Briefly,&#160;&#160;embryos&#160;&#160;were&#160;&#160;incubated&#160;&#160;in&#160;&#160;a&#160;&#160;5&#160;&#160;µM&#160;</p>
<p style="position:absolute;top:985px;left:487px;white-space:nowrap" class="ft132">BCECF, AM&#160;(2’,7’-Bis-(2-Carboxyethyl)-5-(and-</p>
<p style="position:absolute;top:1003px;left:487px;white-space:nowrap" class="ft132">6)-Carboxyfluorescein,&#160;&#160;Acetoxymethyl&#160;&#160;Ester&#160;&#160;(Life&#160;</p>
<p style="position:absolute;top:1021px;left:487px;white-space:nowrap" class="ft132">Technologies, NY, USA&#160;) solution. Excess dye was&#160;</p>
<p style="position:absolute;top:1039px;left:487px;white-space:nowrap" class="ft132">washed out, and embryos were anesthetized&#160;with MS222.&#160;</p>
<p style="position:absolute;top:1057px;left:487px;white-space:nowrap" class="ft132">To&#160;image&#160;BCECF,&#160;a&#160;dual&#160;excitation&#160;dye,&#160;filters&#160;were&#160;EX&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft140{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft141{font-size:11px;font-family:Times;color:#211f21;}
	.ft142{font-size:13px;font-family:Times;color:#211f21;}
	.ft143{font-size:14px;font-family:Times;color:#211f21;}
	.ft144{font-size:13px;font-family:Times;color:#211f21;}
	.ft145{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft146{font-size:13px;font-family:Times;color:#231f20;}
	.ft147{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page14-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft140">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft141">3299</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft140">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft142">450/20, D 460, EM 535/30 (the isobestic point) and EX&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft142">500/20, D 515, EM 535/30.&#160;To calibrate BCECF in our&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft142">system,&#160;a&#160;prototonophore,&#160;CCCP,&#160;and&#160;NaOH&#160;were&#160;used&#160;to&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft142">drive pH values to 4 (limiting minimum) and 9 (limiting&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft142">maximum), respectively, by observing gradual decrease&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft142">and&#160;&#160;increase&#160;&#160;of&#160;&#160;fluorescence.&#160;&#160;A&#160;&#160;plot&#160;&#160;profile&#160;&#160;of&#160;&#160;pixel&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft142">intensities was&#160;then taken from ITLS and control regions,&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft142">and conversions to pH values were made as described in&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft142">[196]&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft143"><b>Nuclear&#160;morphometry</b></p>
<p style="position:absolute;top:297px;left:123px;white-space:nowrap" class="ft142">Sections taken through ITLS and control regions&#160;</p>
<p style="position:absolute;top:315px;left:87px;white-space:nowrap" class="ft142">were stained with Hoechst Blue (Life&#160;Technologies,&#160;</p>
<p style="position:absolute;top:333px;left:87px;white-space:nowrap" class="ft142">NY,&#160;&#160;USA),&#160;&#160;imaged&#160;&#160;using&#160;&#160;the&#160;&#160;DAPI&#160;&#160;filter&#160;&#160;set&#160;&#160;on&#160;&#160;an&#160;</p>
<p style="position:absolute;top:351px;left:87px;white-space:nowrap" class="ft142">Olympus BX61 spinning-disk confocal microscope with&#160;</p>
<p style="position:absolute;top:369px;left:87px;white-space:nowrap" class="ft142">Hamamatsu&#160;ORCA&#160;digital&#160;CCD camera,&#160;and analyzed&#160;by&#160;</p>
<p style="position:absolute;top:387px;left:87px;white-space:nowrap" class="ft142">using ImageJ.&#160;The threshold and analyze particle tools in&#160;</p>
<p style="position:absolute;top:405px;left:87px;white-space:nowrap" class="ft142">ImageJ were used to interactively outline each nucleus and&#160;</p>
<p style="position:absolute;top:423px;left:87px;white-space:nowrap" class="ft142">determine its size and shape.&#160;</p>
<p style="position:absolute;top:459px;left:87px;white-space:nowrap" class="ft143"><b>Statistical analysis</b></p>
<p style="position:absolute;top:506px;left:123px;white-space:nowrap" class="ft142">All statistical analyses were performed using&#160;</p>
<p style="position:absolute;top:524px;left:87px;white-space:nowrap" class="ft142">GraphPad InStat v. 3.10 (GraphPad Software, La Jolla,&#160;</p>
<p style="position:absolute;top:542px;left:87px;white-space:nowrap" class="ft142">CA, USA). Data were expressed as the mean unless&#160;</p>
<p style="position:absolute;top:560px;left:87px;white-space:nowrap" class="ft142">otherwise noted. Error bars represent standard error.&#160;The&#160;</p>
<p style="position:absolute;top:578px;left:87px;white-space:nowrap" class="ft142">differences between treatment groups were analyzed using&#160;</p>
<p style="position:absolute;top:596px;left:87px;white-space:nowrap" class="ft142">Student’s&#160;<i>t</i>-test,&#160;Chi-squared&#160;test&#160;or&#160;One-way&#160;ANOVA,&#160;</p>
<p style="position:absolute;top:614px;left:87px;white-space:nowrap" class="ft142">(tukey’s post hoc comparisons), and the null hypothesis&#160;</p>
<p style="position:absolute;top:632px;left:87px;white-space:nowrap" class="ft142">was rejected at the 0.05 level.</p>
<p style="position:absolute;top:668px;left:87px;white-space:nowrap" class="ft145"><b>ACKNOWLEDGEMENTS</b></p>
<p style="position:absolute;top:707px;left:123px;white-space:nowrap" class="ft142">This paper is dedicated to Bjorn Nordenstrom, a&#160;</p>
<p style="position:absolute;top:725px;left:87px;white-space:nowrap" class="ft142">pioneer of long-range bioelectrical signaling in cancer.&#160;</p>
<p style="position:absolute;top:743px;left:87px;white-space:nowrap" class="ft142">We thank Leonard Zon for the KRAS mutant construct,&#160;</p>
<p style="position:absolute;top:761px;left:87px;white-space:nowrap" class="ft142">Florian Lang&#160;for the Kv1.5 construct,&#160;Ariel Ruiz&#160;Altaba&#160;</p>
<p style="position:absolute;top:779px;left:87px;white-space:nowrap" class="ft142">for the Gli1 construct, John&#160;Wallingford for the Xrel3&#160;</p>
<p style="position:absolute;top:797px;left:87px;white-space:nowrap" class="ft142">construct,&#160;Atsushi Miyawaki for the FUCCI plasmid pair&#160;</p>
<p style="position:absolute;top:815px;left:87px;white-space:nowrap" class="ft142">(mKO2-zCdt1 and mAG-zGeminin), and Saburo Nagata&#160;</p>
<p style="position:absolute;top:833px;left:87px;white-space:nowrap" class="ft142">for the XL-2 antibody.&#160;We thank Jeff&#160;Wolf for H&amp;E&#160;</p>
<p style="position:absolute;top:851px;left:87px;white-space:nowrap" class="ft142">analysis of ITLS sections.&#160;We thank&#160;Amber Currier, Erin&#160;</p>
<p style="position:absolute;top:869px;left:87px;white-space:nowrap" class="ft142">Switzer, and&#160;Amanda&#160;Allen for general lab assistance&#160;</p>
<p style="position:absolute;top:887px;left:87px;white-space:nowrap" class="ft142">and frog husbandry, and Joan Lemire and&#160;Jean-Francois&#160;</p>
<p style="position:absolute;top:905px;left:87px;white-space:nowrap" class="ft146">Pare&#160;for molecular biology assistance.&#160;We are grateful to&#160;</p>
<p style="position:absolute;top:923px;left:87px;white-space:nowrap" class="ft142">Douglas Brash, Robert Gillies, and the members of the&#160;</p>
<p style="position:absolute;top:941px;left:87px;white-space:nowrap" class="ft142">Levin lab for many useful discussions on these topics.&#160;</p>
<p style="position:absolute;top:959px;left:87px;white-space:nowrap" class="ft142">M.L. is grateful for support of the G. Harold and Leila&#160;Y.&#160;</p>
<p style="position:absolute;top:977px;left:87px;white-space:nowrap" class="ft142">Mathers Charitable Foundation, NIH R01-AR055993, and&#160;</p>
<p style="position:absolute;top:995px;left:87px;white-space:nowrap" class="ft142">of DARPA&#160;(subaward&#160;W911NF-09-1-0125).</p>
<p style="position:absolute;top:69px;left:487px;white-space:nowrap" class="ft143"><b>CONFLICT&#160;OF&#160;INTEREST</b></p>
<p style="position:absolute;top:116px;left:523px;white-space:nowrap" class="ft142">The authors declare that there are no competing&#160;</p>
<p style="position:absolute;top:134px;left:487px;white-space:nowrap" class="ft142">financial interests of the work described.</p>
<p style="position:absolute;top:170px;left:487px;white-space:nowrap" class="ft145"><b>REFERENCES</b></p>
<p style="position:absolute;top:211px;left:487px;white-space:nowrap" class="ft141">1.&#160;&#160;Soto AM and Sonnenschein C. The somatic mutation theory&#160;</p>
<p style="position:absolute;top:229px;left:514px;white-space:nowrap" class="ft147">of cancer: growing problems with the paradigm? Bioessays.&#160;<br/>2004; 26(10): p. 1097-107.</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft141">2.&#160;&#160;Rowlatt&#160;C.&#160;Some&#160;consequences&#160;of&#160;defining&#160;the&#160;neoplasm&#160;</p>
<p style="position:absolute;top:286px;left:514px;white-space:nowrap" class="ft147">as focal self-perpetuating tissue disorganization. in New&#160;<br/>Frontiers in Cancer Causation. O.H. Iversen, Editor. 1994;&#160;<br/>Taylor &amp; Francis: Washington, DC. p. 45–58.</p>
<p style="position:absolute;top:343px;left:487px;white-space:nowrap" class="ft141">3.&#160;&#160;Waddington CH. Cancer and the theory of organisers.&#160;</p>
<p style="position:absolute;top:361px;left:514px;white-space:nowrap" class="ft141">Nature. 1935; 135: p. 606-608.</p>
<p style="position:absolute;top:382px;left:487px;white-space:nowrap" class="ft141">4.&#160;&#160;Clark WH, Jr. The nature of cancer: morphogenesis&#160;</p>
<p style="position:absolute;top:400px;left:514px;white-space:nowrap" class="ft147">and progressive (self)-disorganization in neoplastic&#160;<br/>development and progression. Acta Oncol. 1995; 34(1): p.&#160;<br/>3-21.</p>
<p style="position:absolute;top:457px;left:487px;white-space:nowrap" class="ft141">5.&#160;&#160;Rubin H. Cancer as a dynamic developmental disorder.&#160;</p>
<p style="position:absolute;top:475px;left:514px;white-space:nowrap" class="ft141">Cancer Res. 1985; 45(7): p. 2935-42.</p>
<p style="position:absolute;top:496px;left:487px;white-space:nowrap" class="ft141">6.&#160;&#160;Levin&#160;&#160;M.&#160;&#160;Morphogenetic&#160;&#160;fields&#160;&#160;in&#160;&#160;embryogenesis,&#160;</p>
<p style="position:absolute;top:514px;left:514px;white-space:nowrap" class="ft147">regeneration, and cancer: non-local control of complex&#160;<br/>patterning. Bio Systems. 2012; 109(3): p. 243-61.</p>
<p style="position:absolute;top:553px;left:487px;white-space:nowrap" class="ft141">7.&#160;&#160;Capp JP. Stochastic gene expression, disruption of tissue&#160;</p>
<p style="position:absolute;top:571px;left:514px;white-space:nowrap" class="ft147">averaging effects and cancer as a disease of development.&#160;<br/>Bioessays. 2005; 27(12): p. 1277-85.</p>
<p style="position:absolute;top:610px;left:487px;white-space:nowrap" class="ft141">8.&#160;&#160;Potter JD. Morphostats: a missing concept in cancer&#160;</p>
<p style="position:absolute;top:628px;left:514px;white-space:nowrap" class="ft147">biology. Cancer Epidemiol Biomarkers Prev. 2001; 10(3):&#160;<br/>p. 161-70.</p>
<p style="position:absolute;top:667px;left:487px;white-space:nowrap" class="ft141">9.&#160;&#160;Potter JD. Morphogens, morphostats, microarchitecture and&#160;</p>
<p style="position:absolute;top:685px;left:514px;white-space:nowrap" class="ft141">malignancy. Nat Rev Cancer. 2007; 7(6): p. 464-74.</p>
<p style="position:absolute;top:706px;left:487px;white-space:nowrap" class="ft141">10.&#160;&#160;Soto&#160;AM&#160;and&#160;Sonnenschein&#160;C.&#160;The&#160;tissue&#160;organization&#160;field&#160;</p>
<p style="position:absolute;top:724px;left:514px;white-space:nowrap" class="ft147">theory of cancer: a testable replacement for the somatic&#160;<br/>mutation theory. Bioessays. 2011; 33(5): p. 332-40.</p>
<p style="position:absolute;top:763px;left:487px;white-space:nowrap" class="ft141">11.&#160;&#160;Soto AM and Sonnenschein C. Emergentism as a default:&#160;</p>
<p style="position:absolute;top:781px;left:514px;white-space:nowrap" class="ft147">cancer as a problem of tissue organization. J Biosci. 2005;&#160;<br/>30(1): p. 103-18.</p>
<p style="position:absolute;top:820px;left:487px;white-space:nowrap" class="ft141">12.&#160;&#160;Tarin D. Clinical&#160;and Biological&#160;Implications&#160;of the Tumor&#160;</p>
<p style="position:absolute;top:838px;left:514px;white-space:nowrap" class="ft147">Microenvironment.&#160;&#160;Cancer&#160;&#160;microenvironment&#160;&#160;:&#160;&#160;official&#160;<br/>journal&#160;of&#160;the&#160;International&#160;Cancer&#160;Microenvironment&#160;<br/>Society. 2012.</p>
<p style="position:absolute;top:895px;left:487px;white-space:nowrap" class="ft141">13.&#160;&#160;Ingber&#160;DE.&#160;Can&#160;cancer&#160;be&#160;reversed&#160;by&#160;engineering&#160;the&#160;</p>
<p style="position:absolute;top:913px;left:514px;white-space:nowrap" class="ft147">tumor microenvironment? Semin Cancer Biol. 2008; 18(5):&#160;<br/>p. 356-64.</p>
<p style="position:absolute;top:952px;left:487px;white-space:nowrap" class="ft141">14.&#160;&#160;Bissell&#160;MJ&#160;and&#160;Labarge&#160;MA. Context, tissue&#160;plasticity,&#160;</p>
<p style="position:absolute;top:970px;left:514px;white-space:nowrap" class="ft147">and cancer: are tumor stem cells also regulated by the&#160;<br/>microenvironment? Cancer Cell. 2005; 7(1): p. 17-23.</p>
<p style="position:absolute;top:1009px;left:487px;white-space:nowrap" class="ft141">15.&#160;&#160;Mintz B and Illmensee K. Normal genetically&#160;mosaic mice&#160;</p>
<p style="position:absolute;top:1027px;left:514px;white-space:nowrap" class="ft147">produced from malignant teratocarcinoma cells. Proc Natl&#160;<br/>Acad Sci U S A. 1975; 72(9): p. 3585-9.</p>
<p style="position:absolute;top:1066px;left:487px;white-space:nowrap" class="ft141">16.&#160;Illmensee K and Mintz B. Totipotency and normal&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft150{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft151{font-size:11px;font-family:Times;color:#211f21;}
	.ft152{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page15-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft150">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft151">3300</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft150">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:114px;white-space:nowrap" class="ft152">differentiation of single teratocarcinoma cells cloned by&#160;<br/>injection&#160;into&#160;blastocysts.&#160;Proc Natl&#160;Acad Sci&#160;U S A. 1976;&#160;<br/>73(2): p. 549-53.</p>
<p style="position:absolute;top:128px;left:87px;white-space:nowrap" class="ft151">17.&#160;&#160;Astigiano S, Damonte P, Fossati S, Boni L, and Barbieri&#160;</p>
<p style="position:absolute;top:146px;left:114px;white-space:nowrap" class="ft152">O. Fate of embryonal carcinoma cells injected into&#160;<br/>postimplantation mouse embryos. Differentiation. 2005;&#160;<br/>73(9-10): p. 484-90.</p>
<p style="position:absolute;top:203px;left:87px;white-space:nowrap" class="ft151">18.&#160;&#160;Webb CG, Gootwine E, and Sachs L. Developmental&#160;</p>
<p style="position:absolute;top:221px;left:114px;white-space:nowrap" class="ft152">potential of myeloid leukemia cells injected into&#160;<br/>midgestation embryos. Dev Biol. 1984; 101(1): p. 221-4.</p>
<p style="position:absolute;top:260px;left:87px;white-space:nowrap" class="ft151">19.&#160;&#160;Li L, Connelly MC, Wetmore C, Curran T, and Morgan&#160;</p>
<p style="position:absolute;top:278px;left:114px;white-space:nowrap" class="ft152">JI. Mouse&#160;embryos&#160;cloned&#160;from&#160;brain&#160;tumors.&#160;Cancer&#160;Res.&#160;<br/>2003; 63(11): p. 2733-6.</p>
<p style="position:absolute;top:317px;left:87px;white-space:nowrap" class="ft151">20.&#160;&#160;Pierce GB and Wells RS. The blastocyst in control of&#160;</p>
<p style="position:absolute;top:335px;left:114px;white-space:nowrap" class="ft152">embryonal carcinoma. Prog Clin Biol Res. 1982; 85 Pt B:&#160;<br/>p. 593-600.</p>
<p style="position:absolute;top:374px;left:87px;white-space:nowrap" class="ft151">21.&#160;&#160;Pierce GB, Arechaga J, and Wells RS. Embryonic control&#160;</p>
<p style="position:absolute;top:392px;left:114px;white-space:nowrap" class="ft151">of cancer. Prog Clin Biol Res. 1986; 226: p. 67-77.</p>
<p style="position:absolute;top:413px;left:87px;white-space:nowrap" class="ft151">22.&#160;&#160;Podesta AH, Mullins J, Pierce GB, and Wells RS. The&#160;</p>
<p style="position:absolute;top:431px;left:114px;white-space:nowrap" class="ft152">neurula stage mouse embryo in control of neuroblastoma.&#160;<br/>Proc Natl Acad Sci U S A. 1984; 81(23): p. 7608-11.</p>
<p style="position:absolute;top:470px;left:87px;white-space:nowrap" class="ft151">23.&#160;Pierce GB, Aguilar D, Hood G, and Wells RS.&#160;</p>
<p style="position:absolute;top:488px;left:114px;white-space:nowrap" class="ft152">Trophectoderm&#160;in control&#160;of murine&#160;embryonal&#160;carcinoma.&#160;<br/>Cancer Res. 1984; 44(9): p. 3987-96.</p>
<p style="position:absolute;top:527px;left:87px;white-space:nowrap" class="ft151">24.&#160;&#160;Pierce GB. The cancer cell and its control by the embryo.&#160;</p>
<p style="position:absolute;top:545px;left:114px;white-space:nowrap" class="ft152">Rous-Whipple Award lecture. Am J Pathol. 1983; 113(1):&#160;<br/>p. 117-24.</p>
<p style="position:absolute;top:584px;left:87px;white-space:nowrap" class="ft151">25.&#160;&#160;Pierce GB, Pantazis CG, Caldwell JE, and Wells RS.&#160;</p>
<p style="position:absolute;top:602px;left:114px;white-space:nowrap" class="ft152">Specificity&#160;&#160;of&#160;&#160;the&#160;&#160;control&#160;&#160;of&#160;&#160;tumor&#160;&#160;formation&#160;&#160;by&#160;&#160;the&#160;<br/>blastocyst. Cancer Res. 1982; 42(3): p. 1082-7.</p>
<p style="position:absolute;top:641px;left:87px;white-space:nowrap" class="ft151">26.&#160;&#160;Haldi M, Ton C, Seng WL, and McGrath P. Human&#160;</p>
<p style="position:absolute;top:659px;left:114px;white-space:nowrap" class="ft152">melanoma&#160;&#160;cells&#160;&#160;transplanted&#160;&#160;into&#160;&#160;zebrafish&#160;&#160;proliferate,&#160;<br/>migrate, produce melanin, form masses and stimulate&#160;<br/>angiogenesis&#160;in&#160;zebrafish.&#160;Angiogenesis.&#160;2006;&#160;9(3):&#160;p.&#160;139-<br/>51.</p>
<p style="position:absolute;top:734px;left:87px;white-space:nowrap" class="ft151">27.&#160;&#160;Lee LM, Seftor EA, Bonde G, Cornell RA, and Hendrix MJ.&#160;</p>
<p style="position:absolute;top:752px;left:114px;white-space:nowrap" class="ft152">The fate of human malignant melanoma cells transplanted&#160;<br/>into&#160;zebrafish&#160;embryos:&#160;assessment&#160;of&#160;migration&#160;and&#160;cell&#160;<br/>division in the absence of tumor formation. Dev Dyn. 2005;&#160;<br/>233(4): p. 1560-70.</p>
<p style="position:absolute;top:827px;left:87px;white-space:nowrap" class="ft151">28.&#160;&#160;Kasemeier-Kulesa JC,&#160;Teddy JM,&#160;Postovit LM, Seftor EA,&#160;</p>
<p style="position:absolute;top:845px;left:114px;white-space:nowrap" class="ft152">Seftor RE,&#160;Hendrix MJ, and Kulesa PM. Reprogramming&#160;<br/>multipotent tumor cells with the embryonic neural crest&#160;<br/>microenvironment. Dev Dyn. 2008; 237(10): p. 2657-66.</p>
<p style="position:absolute;top:902px;left:87px;white-space:nowrap" class="ft151">29.&#160;&#160;Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J,&#160;</p>
<p style="position:absolute;top:920px;left:114px;white-space:nowrap" class="ft152">Kulesa PM, and Postovit LM. Reprogramming metastatic&#160;<br/>tumour cells with embryonic microenvironments. Nat Rev&#160;<br/>Cancer. 2007; 7(4): p. 246-55.</p>
<p style="position:absolute;top:977px;left:87px;white-space:nowrap" class="ft151">30.&#160;Kulesa PM, Kasemeier-Kulesa JC, Teddy JM,&#160;</p>
<p style="position:absolute;top:995px;left:114px;white-space:nowrap" class="ft152">Margaryan NV, Seftor EA, Seftor RE, and Hendrix MJ.&#160;<br/>Reprogramming metastatic melanoma cells to assume&#160;<br/>a neural crest cell-like phenotype in an embryonic&#160;<br/>microenvironment. Proc Natl Acad Sci U S A. 2006;&#160;<br/>103(10): p. 3752-7.</p>
<p style="position:absolute;top:71px;left:487px;white-space:nowrap" class="ft151">31.&#160;&#160;Coleman WB, Wennerberg AE, Smith GJ, and Grisham&#160;</p>
<p style="position:absolute;top:89px;left:514px;white-space:nowrap" class="ft152">JW.&#160;Regulation of the differentiation of diploid and some&#160;<br/>aneuploid&#160;rat liver epithelial&#160;(stemlike)&#160;cells by the hepatic&#160;<br/>microenvironment.&#160;Am J&#160;Pathol. 1993; 142(5): p. 1373-82.</p>
<p style="position:absolute;top:146px;left:487px;white-space:nowrap" class="ft151">32.&#160;&#160;Tseng A and Levin M. Cracking the bioelectric code:&#160;</p>
<p style="position:absolute;top:164px;left:514px;white-space:nowrap" class="ft152">Probing endogenous ionic controls of pattern formation.&#160;<br/>Communicative &amp; Integrative Biology. 2013; 6(1): p. 1-8.</p>
<p style="position:absolute;top:203px;left:487px;white-space:nowrap" class="ft151">33.&#160;&#160;Levin M. Reprogramming cells and tissue patterning&#160;</p>
<p style="position:absolute;top:221px;left:514px;white-space:nowrap" class="ft152">via bioelectrical pathways: molecular mechanisms and&#160;<br/>biomedical&#160;opportunities.&#160;Wiley&#160;Interdisciplinary&#160;Reviews:&#160;<br/>Systems Biology and Medicine. 2013; 5(6): p. 657-676.</p>
<p style="position:absolute;top:278px;left:487px;white-space:nowrap" class="ft151">34.&#160;McCaig CD, Rajnicek AM, Song B, and Zhao M.&#160;</p>
<p style="position:absolute;top:296px;left:514px;white-space:nowrap" class="ft152">Controlling cell behavior electrically: current views and&#160;<br/>future potential. Physiol Rev. 2005; 85(3): p. 943-78.</p>
<p style="position:absolute;top:335px;left:487px;white-space:nowrap" class="ft151">35.&#160;&#160;Levin M. Bioelectric mechanisms in regeneration: Unique&#160;</p>
<p style="position:absolute;top:353px;left:514px;white-space:nowrap" class="ft152">aspects and future perspectives. Semin Cell Dev Biol. 2009;&#160;<br/>20(5): p. 543-56.</p>
<p style="position:absolute;top:392px;left:487px;white-space:nowrap" class="ft151">36.&#160;McCaig CD, Song B, and Rajnicek AM. Electrical&#160;</p>
<p style="position:absolute;top:410px;left:514px;white-space:nowrap" class="ft152">dimensions&#160;in cell science. J&#160;Cell Sci. 2009; 122(Pt 23): p.&#160;<br/>4267-76.</p>
<p style="position:absolute;top:449px;left:487px;white-space:nowrap" class="ft151">37.&#160;&#160;Blackiston DJ, McLaughlin KA, and Levin M. Bioelectric&#160;</p>
<p style="position:absolute;top:467px;left:514px;white-space:nowrap" class="ft152">controls of cell proliferation: ion channels, membrane&#160;<br/>voltage and the cell cycle. Cell Cycle. 2009; 8(21): p. 3519-<br/>28.</p>
<p style="position:absolute;top:524px;left:487px;white-space:nowrap" class="ft151">38.&#160;Sundelacruz S, Levin M, and Kaplan DL. Role of&#160;</p>
<p style="position:absolute;top:542px;left:514px;white-space:nowrap" class="ft152">membrane potential in the regulation of cell proliferation&#160;<br/>and differentiation. Stem Cell Rev Rep. 2009; 5(3): p. 231-<br/>46.</p>
<p style="position:absolute;top:599px;left:487px;white-space:nowrap" class="ft151">39.&#160;&#160;Yang&#160;M and&#160;Brackenbury&#160;WJ.&#160;Membrane&#160;potential&#160;and&#160;</p>
<p style="position:absolute;top:617px;left:514px;white-space:nowrap" class="ft151">cancer progression. Frontiers in physiology. 2013; 4: p. 185.</p>
<p style="position:absolute;top:638px;left:487px;white-space:nowrap" class="ft151">40.&#160;&#160;Fricke&#160;H and&#160;Morse S. The&#160;Electric&#160;Capacity&#160;of&#160;Tumors&#160;of&#160;</p>
<p style="position:absolute;top:656px;left:514px;white-space:nowrap" class="ft152">the&#160;Breast.&#160;The&#160;Journal&#160;of&#160;Cancer&#160;Research.&#160;1926;&#160;10(3):&#160;p.&#160;<br/>340-376.</p>
<p style="position:absolute;top:695px;left:487px;white-space:nowrap" class="ft151">41.&#160;Binggeli R and Cameron IL. Cellular potentials of&#160;</p>
<p style="position:absolute;top:713px;left:514px;white-space:nowrap" class="ft152">normal&#160;and&#160;cancerous&#160;fibroblasts&#160;and&#160;hepatocytes.&#160;Cancer&#160;<br/>Research. 1980; 40(6): p. 1830-5.</p>
<p style="position:absolute;top:752px;left:487px;white-space:nowrap" class="ft151">42.&#160;&#160;Morimoto T, Kimura S, Konishi Y, Komaki K, Uyama&#160;</p>
<p style="position:absolute;top:770px;left:514px;white-space:nowrap" class="ft152">T, Monden Y, Kinouchi Y, and Iritani T. A study of the&#160;<br/>electrical bio-impedance of tumors. J Invest Surg. 1993;&#160;<br/>6(1): p. 25-32.</p>
<p style="position:absolute;top:827px;left:487px;white-space:nowrap" class="ft151">43.&#160;&#160;Chernet BT and Levin M. Transmembrane voltage potential&#160;</p>
<p style="position:absolute;top:845px;left:514px;white-space:nowrap" class="ft152">is an essential cellular parameter for the detection and&#160;<br/>control of tumor development in a Xenopus model. Dis&#160;<br/>Model Mech. 2013; 6(3): p. 595-607.</p>
<p style="position:absolute;top:902px;left:487px;white-space:nowrap" class="ft151">44.&#160;&#160;Than BL, Goos JA, Sarver AL, O’Sullivan MG, Rod A,&#160;</p>
<p style="position:absolute;top:920px;left:514px;white-space:nowrap" class="ft152">Starr TK, Fijneman RJ, Meijer GA, Zhao L, Zhang Y,&#160;<br/>Largaespada DA, Scott PM, and Cormier RT. The role&#160;<br/>of KCNQ1 in mouse and human gastrointestinal cancers.&#160;<br/>Oncogene. 2013.</p>
<p style="position:absolute;top:995px;left:487px;white-space:nowrap" class="ft151">45.&#160;&#160;Roepke TK, Purtell K, King EC, La Perle KM, Lerner DJ,&#160;</p>
<p style="position:absolute;top:1013px;left:514px;white-space:nowrap" class="ft152">and Abbott GW. Targeted deletion of Kcne2 causes gastritis&#160;<br/>cystica profunda and gastric neoplasia. PLoS One. 2010;&#160;<br/>5(7): p. e11451.</p>
<p style="position:absolute;top:1070px;left:487px;white-space:nowrap" class="ft151">46.&#160;&#160;Morokuma J, Blackiston D, Adams DS, Seebohm G,&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft160{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft161{font-size:11px;font-family:Times;color:#211f21;}
	.ft162{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
	.ft163{font-size:11px;line-height:17px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page16-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft160">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft161">3301</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft160">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:114px;white-space:nowrap" class="ft162">Trimmer B, and Levin M. Modulation of potassium channel&#160;<br/>function confers a hyperproliferative invasive phenotype on&#160;<br/>embryonic stem cells. Proc Natl Acad Sci U S A. 2008;&#160;<br/>105(43): p. 16608-13.</p>
<p style="position:absolute;top:146px;left:87px;white-space:nowrap" class="ft161">47.&#160;&#160;Lallet-Daher&#160;H,&#160;Wiel&#160;C,&#160;Gitenay&#160;D,&#160;Navaratnam&#160;N,&#160;Augert&#160;</p>
<p style="position:absolute;top:164px;left:114px;white-space:nowrap" class="ft162">A, Le Calve B, Verbeke S, Carling D, Aubert S, Vindrieux&#160;<br/>D, and Bernard D. Potassium channel KCNA1 modulates&#160;<br/>oncogene-induced senescence and transformation. Cancer&#160;<br/>research. 2013; 73(16): p. 5253-65.</p>
<p style="position:absolute;top:239px;left:87px;white-space:nowrap" class="ft161">48.&#160;&#160;House CD, Vaske CJ,&#160;Schwartz AM, Obias V, Frank&#160;B, Luu&#160;</p>
<p style="position:absolute;top:257px;left:114px;white-space:nowrap" class="ft162">T, Sarvazyan N, Irby R, Strausberg RL, Hales TG, Stuart&#160;<br/>JM,&#160;and Lee NH. Voltage-gated Na+ channel SCN5A is a&#160;<br/>key regulator of a gene transcriptional network that controls&#160;<br/>colon cancer invasion. Cancer Res. 2010; 70(17): p. 6957-<br/>67.</p>
<p style="position:absolute;top:350px;left:87px;white-space:nowrap" class="ft161">49.&#160;&#160;Weksberg R, Shuman C, Caluseriu O, Smith AC, Fei YL,&#160;</p>
<p style="position:absolute;top:368px;left:114px;white-space:nowrap" class="ft162">Nishikawa J, Stockley TL, Best L, Chitayat D, Olney A,&#160;<br/>Ives E, Schneider A, Bestor TH, Li M, Sadowski P, and&#160;<br/>Squire J. Discordant KCNQ1OT1 imprinting in sets of&#160;<br/>monozygotic twins discordant for Beckwith-Wiedemann&#160;<br/>syndrome.&#160;Human&#160;Molecular&#160;Genetics.&#160;2002;&#160;11(11):&#160;p.&#160;<br/>1317-25.</p>
<p style="position:absolute;top:479px;left:87px;white-space:nowrap" class="ft161">50.&#160;&#160;Pei L, Wiser&#160;O,&#160;Slavin&#160;A,&#160;Mu D, Powers&#160;S,&#160;Jan&#160;LY,&#160;and&#160;</p>
<p style="position:absolute;top:497px;left:114px;white-space:nowrap" class="ft162">Hoey T. Oncogenic potential of TASK3 (Kcnk9) depends&#160;<br/>on K+ channel function. Proc Natl Acad Sci U S A. 2003;&#160;<br/>100(13): p. 7803-7.</p>
<p style="position:absolute;top:554px;left:87px;white-space:nowrap" class="ft161">51.&#160;&#160;Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann&#160;</p>
<p style="position:absolute;top:572px;left:114px;white-space:nowrap" class="ft162">A, Beckh S, and Stuhmer W. Oncogenic potential of EAG&#160;<br/>K(+) channels. Embo J. 1999; 18(20): p. 5540-7.</p>
<p style="position:absolute;top:611px;left:87px;white-space:nowrap" class="ft161">52.&#160;&#160;Onkal R&#160;and&#160;Djamgoz MB.&#160;Molecular&#160;pharmacology&#160;of&#160;</p>
<p style="position:absolute;top:629px;left:114px;white-space:nowrap" class="ft162">voltage-gated sodium channel expression in metastatic&#160;<br/>disease: Clinical potential of neonatal Nav1.5 in breast&#160;<br/>cancer. Eur J Pharmacol. 2009.</p>
<p style="position:absolute;top:686px;left:87px;white-space:nowrap" class="ft161">53.&#160;&#160;Teh JL and Chen S. Glutamatergic signaling in cellular&#160;</p>
<p style="position:absolute;top:704px;left:114px;white-space:nowrap" class="ft162">transformation. Pigment Cell &amp; Melanoma Research. 2012;&#160;<br/>25(3): p. 331-42.</p>
<p style="position:absolute;top:743px;left:87px;white-space:nowrap" class="ft161">54.&#160;&#160;Saito T, Schlegel R, Andresson T, Yuge L, Yamamoto&#160;</p>
<p style="position:absolute;top:761px;left:114px;white-space:nowrap" class="ft162">M, and Yamasaki H. Induction of cell transformation by&#160;<br/>mutated 16K vacuolar H+-atpase (ductin) is accompanied&#160;<br/>by&#160;down-regulation&#160;of&#160;gap&#160;junctional&#160;intercellular&#160;<br/>communication and translocation of connexin 43 in&#160;<br/>NIH3T3 cells. Oncogene. 1998; 17(13): p. 1673-80.</p>
<p style="position:absolute;top:854px;left:87px;white-space:nowrap" class="ft161">55.&#160;&#160;Frede J, Fraser SP, Oskay-Ozcelik G, Hong Y, Ioana Braicu&#160;</p>
<p style="position:absolute;top:872px;left:114px;white-space:nowrap" class="ft162">E, Sehouli J, Gabra H, and Djamgoz MB. Ovarian cancer:&#160;<br/>Ion channel and aquaporin expression as novel targets&#160;<br/>of clinical potential. European Journal of Cancer. 2013;&#160;<br/>49(10): p. 2331-44.</p>
<p style="position:absolute;top:947px;left:87px;white-space:nowrap" class="ft161">56.&#160;&#160;Arcangeli&#160;A,&#160;Pillozzi&#160;S,&#160;and&#160;Becchetti&#160;A.&#160;Targeting&#160;ion&#160;</p>
<p style="position:absolute;top:965px;left:114px;white-space:nowrap" class="ft162">channels in leukemias: a new challenge for treatment.&#160;<br/>Current Medicinal Chemistry. 2012; 19(5): p. 683-96.</p>
<p style="position:absolute;top:1004px;left:87px;white-space:nowrap" class="ft161">57.&#160;&#160;Sharmeen S, Skrtic M, Sukhai MA, Hurren R, Gronda&#160;</p>
<p style="position:absolute;top:1022px;left:114px;white-space:nowrap" class="ft162">M, Wang X, Fonseca SB, Sun H, Wood TE, Ward R,&#160;<br/>Minden MD, Batey RA, Datti A, Wrana J, Kelley SO, and&#160;<br/>Schimmer AD. The antiparasitic agent ivermectin induces&#160;</p>
<p style="position:absolute;top:71px;left:514px;white-space:nowrap" class="ft162">chloride-dependent membrane hyperpolarization and cell&#160;<br/>death&#160;in leukemia cells. Blood. 2010; 116(18): p. 3593-603.</p>
<p style="position:absolute;top:110px;left:487px;white-space:nowrap" class="ft161">58.&#160;&#160;Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi&#160;</p>
<p style="position:absolute;top:128px;left:514px;white-space:nowrap" class="ft162">S, and Becchetti A. Targeting ion channels in cancer: a&#160;<br/>novel frontier in antineoplastic therapy. Current medicinal&#160;<br/>chemistry. 2009; 16(1): p. 66-93.</p>
<p style="position:absolute;top:185px;left:487px;white-space:nowrap" class="ft161">59.&#160;&#160;Chernet B and Levin M. Bioelectric signaling in cancer.&#160;</p>
<p style="position:absolute;top:203px;left:514px;white-space:nowrap" class="ft162">Journal of Experimental and Clinical Oncology. 2014; in&#160;<br/>press.</p>
<p style="position:absolute;top:242px;left:487px;white-space:nowrap" class="ft161">60.&#160;&#160;Blackiston D, Adams DS, Lemire JM, Lobikin M, and&#160;</p>
<p style="position:absolute;top:260px;left:514px;white-space:nowrap" class="ft162">Levin M. Transmembrane potential&#160;of GlyCl-expressing&#160;<br/>instructor&#160;cells&#160;induces&#160;a&#160;neoplastic-like&#160;conversion of&#160;<br/>melanocytes&#160;via&#160;a&#160;serotonergic&#160;pathway.&#160;Dis&#160;Model&#160;Mech.&#160;<br/>2011; 4(1): p. 67-85.</p>
<p style="position:absolute;top:335px;left:487px;white-space:nowrap" class="ft161">61.&#160;&#160;Lobikin M, Chernet B, Lobo D, and&#160;Levin M.&#160;Resting&#160;</p>
<p style="position:absolute;top:353px;left:514px;white-space:nowrap" class="ft162">potential, oncogene-induced tumorigenesis, and metastasis:&#160;<br/>the bioelectric basis of cancer in vivo. Phys Biol. 2012;&#160;<br/>9(6): p. 065002.</p>
<p style="position:absolute;top:410px;left:487px;white-space:nowrap" class="ft161">62.&#160;&#160;Tseng AS and Levin M. Transducing bioelectric signals&#160;</p>
<p style="position:absolute;top:428px;left:514px;white-space:nowrap" class="ft162">into epigenetic pathways during tadpole tail regeneration.&#160;<br/>Anatomical Record. 2012; 295(10): p. 1541-51.</p>
<p style="position:absolute;top:467px;left:487px;white-space:nowrap" class="ft161">63.&#160;&#160;Adams DS and Levin M. Endogenous voltage gradients&#160;</p>
<p style="position:absolute;top:485px;left:514px;white-space:nowrap" class="ft163">as mediators of cell-cell communication: strategies for&#160;<br/>investigating&#160;bioelectrical&#160;signals&#160;during&#160;pattern&#160;formation.&#160;<br/>Cell Tissue Res. 2013; 352(1): p. 95-122.</p>
<p style="position:absolute;top:542px;left:487px;white-space:nowrap" class="ft161">64.&#160;&#160;Nutt&#160;LK.&#160;The Xenopus oocyte:&#160;a&#160;model&#160;for&#160;studying&#160;the&#160;</p>
<p style="position:absolute;top:560px;left:514px;white-space:nowrap" class="ft162">metabolic regulation of cancer cell death. Semin Cell Dev&#160;<br/>Biol. 2012; 23(4): p. 412-8.</p>
<p style="position:absolute;top:599px;left:487px;white-space:nowrap" class="ft161">65.&#160;&#160;Nedelkovska H and Robert J. Hsp72 mediates stronger&#160;</p>
<p style="position:absolute;top:617px;left:514px;white-space:nowrap" class="ft162">antigen-dependent non-classical MHC class Ib anti-tumor&#160;<br/>responses than hsc73 in Xenopus laevis. Cancer Immun.&#160;<br/>2013; 13: p. 4.</p>
<p style="position:absolute;top:674px;left:487px;white-space:nowrap" class="ft161">66.&#160;&#160;Liu&#160;X,&#160;Ji&#160;XM,&#160;Du XN,&#160;Zong&#160;XC,&#160;Liang DF,&#160;Ma&#160;L,&#160;Wu&#160;</p>
<p style="position:absolute;top:692px;left:514px;white-space:nowrap" class="ft162">HT, and Zhang SQ. Molecular cloning, expression,&#160;<br/>bioinformatics analysis, and bioactivity of TNFSF13&#160;<br/>(APRIL) in the South African clawed frog (Xenopus&#160;<br/>laevis): a new model to study immunological diseases.&#160;<br/>OMICS. 2013; 17(7): p. 384-92.</p>
<p style="position:absolute;top:785px;left:487px;white-space:nowrap" class="ft161">67.&#160;&#160;Wallingford JB, Seufert DW, Virta VC, and Vize PD. p53&#160;</p>
<p style="position:absolute;top:803px;left:514px;white-space:nowrap" class="ft162">activity&#160;is&#160;essential&#160;for&#160;normal&#160;development&#160;in&#160;Xenopus.&#160;<br/>Curr Biol. 1997; 7(10): p. 747-57.</p>
<p style="position:absolute;top:842px;left:487px;white-space:nowrap" class="ft161">68.&#160;&#160;Dahmane N, Lee J, Robins P, Heller P, and Ruiz i Altaba&#160;</p>
<p style="position:absolute;top:860px;left:514px;white-space:nowrap" class="ft162">A. Activation&#160;of the&#160;transcription&#160;factor&#160;Gli1&#160;and the&#160;Sonic&#160;<br/>hedgehog&#160;signalling&#160;pathway&#160;in&#160;skin&#160;tumours.&#160;Nature.&#160;<br/>1997; 389(6653): p. 876-81.</p>
<p style="position:absolute;top:917px;left:487px;white-space:nowrap" class="ft161">69.&#160;&#160;Le X, Langenau DM, Keefe MD, Kutok JL, Neuberg DS,&#160;</p>
<p style="position:absolute;top:935px;left:514px;white-space:nowrap" class="ft162">and Zon LI. Heat shock-inducible Cre/Lox approaches to&#160;<br/>induce diverse types of tumors and hyperplasia in transgenic&#160;<br/>zebrafish.&#160;Proc&#160;Natl&#160;Acad&#160;Sci&#160;U&#160;S&#160;A.&#160;2007;&#160;104(22):&#160;p.&#160;<br/>9410-5.</p>
<p style="position:absolute;top:1010px;left:487px;white-space:nowrap" class="ft161">70.&#160;&#160;Bast RC and American Cancer Society. Cancer medicine 5.&#160;</p>
<p style="position:absolute;top:1028px;left:514px;white-space:nowrap" class="ft162">2000, Hamilton, Ont. ; London: B.C. Decker. xxix, 2546 p.,&#160;<br/>48 p. of plates.</p>
<p style="position:absolute;top:1067px;left:487px;white-space:nowrap" class="ft161">71.&#160;&#160;Sugiyama M, Sakaue-Sawano&#160;A,&#160;Iimura T,&#160;Fukami&#160;K,&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft170{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft171{font-size:11px;font-family:Times;color:#211f21;}
	.ft172{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
	.ft173{font-size:11px;line-height:17px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page17-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft170">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft171">3302</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft170">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:114px;white-space:nowrap" class="ft172">Kitaguchi T, Kawakami K, Okamoto H, Higashijima S,&#160;<br/>and&#160;Miyawaki&#160;A.&#160;Illuminating&#160;cell-cycle&#160;progression&#160;in&#160;the&#160;<br/>developing&#160;zebrafish&#160;embryo.&#160;Proc&#160;Natl&#160;Acad&#160;Sci&#160;U&#160;S&#160;A.&#160;<br/>2009; 106(49): p. 20812-7.</p>
<p style="position:absolute;top:146px;left:87px;white-space:nowrap" class="ft171">72.&#160;&#160;Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A,&#160;</p>
<p style="position:absolute;top:164px;left:114px;white-space:nowrap" class="ft172">Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T,&#160;<br/>Miyoshi H, Imamura T, Ogawa M, Masai H, and Miyawaki&#160;<br/>A.&#160;Visualizing spatiotemporal dynamics of multicellular&#160;<br/>cell-cycle progression. Cell. 2008; 132(3): p. 487-98.</p>
<p style="position:absolute;top:239px;left:87px;white-space:nowrap" class="ft171">73.&#160;&#160;Hockel&#160;M&#160;and&#160;Vaupel&#160;P.&#160;Biological&#160;consequences&#160;of&#160;tumor&#160;</p>
<p style="position:absolute;top:257px;left:114px;white-space:nowrap" class="ft171">hypoxia. Semin Oncol. 2001; 28(2 Suppl 8): p. 36-41.</p>
<p style="position:absolute;top:278px;left:87px;white-space:nowrap" class="ft171">74.&#160;Vaupel P, Kallinowski F, and Okunieff P. Blood&#160;</p>
<p style="position:absolute;top:296px;left:114px;white-space:nowrap" class="ft172">flow,&#160;&#160;oxygen&#160;&#160;and&#160;&#160;nutrient&#160;&#160;supply,&#160;&#160;and&#160;&#160;metabolic&#160;<br/>microenvironment&#160;of&#160;human&#160;tumors:&#160;a&#160;review.&#160;Cancer&#160;Res.&#160;<br/>1989; 49(23): p. 6449-65.</p>
<p style="position:absolute;top:353px;left:87px;white-space:nowrap" class="ft171">75.&#160;&#160;Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M,&#160;</p>
<p style="position:absolute;top:371px;left:114px;white-space:nowrap" class="ft172">Arbeit JM, and Johnson RS. Hypoxia-inducible factor-<br/>1alpha is a positive factor in solid tumor growth. Cancer&#160;<br/>Res. 2000; 60(15): p. 4010-5.</p>
<p style="position:absolute;top:428px;left:87px;white-space:nowrap" class="ft171">76.&#160;&#160;Varia MA, Calkins-Adams DP, Rinker LH, Kennedy&#160;</p>
<p style="position:absolute;top:446px;left:114px;white-space:nowrap" class="ft172">AS, Novotny DB, Fowler WC, Jr., and Raleigh JA.&#160;<br/>Pimonidazole: a novel hypoxia marker for complementary&#160;<br/>study of tumor hypoxia and cell proliferation in cervical&#160;<br/>carcinoma. Gynecol Oncol. 1998; 71(2): p. 270-7.</p>
<p style="position:absolute;top:521px;left:87px;white-space:nowrap" class="ft171">77.&#160;&#160;Kaanders&#160;JH, Wijffels&#160;KI, Marres HA, Ljungkvist&#160;AS, Pop&#160;</p>
<p style="position:absolute;top:539px;left:114px;white-space:nowrap" class="ft172">LA, van den Hoogen FJ, de Wilde PC, Bussink J, Raleigh&#160;<br/>JA,&#160;and van der Kogel AJ. Pimonidazole binding and tumor&#160;<br/>vascularity&#160;predict&#160;for treatment&#160;outcome&#160;in head and neck&#160;<br/>cancer. Cancer Res. 2002; 62(23): p. 7066-74.</p>
<p style="position:absolute;top:614px;left:87px;white-space:nowrap" class="ft171">78.&#160;&#160;McPhail LD and Robinson SP. Intrinsic susceptibility&#160;</p>
<p style="position:absolute;top:632px;left:114px;white-space:nowrap" class="ft172">MR imaging of chemically induced rat mammary tumors:&#160;<br/>relationship to histologic assessment of hypoxia and&#160;<br/>fibrosis. Radiology. 2010; 254(1): p. 110-8.</p>
<p style="position:absolute;top:689px;left:87px;white-space:nowrap" class="ft171">79.&#160;&#160;Ross MH and Pawlina W. Histology : a text and atlas :&#160;</p>
<p style="position:absolute;top:707px;left:114px;white-space:nowrap" class="ft172">with correlated cell and molecular biology. 6th ed.&#160;2010,&#160;<br/>Philadelphia, Pa. ; London: Lippincott Williams &amp; Wilkins.</p>
<p style="position:absolute;top:746px;left:87px;white-space:nowrap" class="ft171">80.&#160;Pienta KJ and Coffey DS. Correlation of nuclear&#160;</p>
<p style="position:absolute;top:764px;left:114px;white-space:nowrap" class="ft172">morphometry with progression of breast cancer. Cancer.&#160;<br/>1991; 68(9): p. 2012-6.</p>
<p style="position:absolute;top:803px;left:87px;white-space:nowrap" class="ft171">81.&#160;&#160;Baak JP, Van Dop H, Kurver PH, and Hermans J. The value&#160;</p>
<p style="position:absolute;top:821px;left:114px;white-space:nowrap" class="ft172">of morphometry to classic prognosticators in breast cancer.&#160;<br/>Cancer. 1985; 56(2): p. 374-82.</p>
<p style="position:absolute;top:860px;left:87px;white-space:nowrap" class="ft171">82.&#160;&#160;Abdalla F, Boder J, Markus R, Hashmi H, Buhmeida A,&#160;</p>
<p style="position:absolute;top:878px;left:114px;white-space:nowrap" class="ft172">and Collan Y. Correlation of nuclear morphometry of breast&#160;<br/>cancer&#160;in&#160;histological&#160;sections&#160;with&#160;clinicopathological&#160;<br/>features and prognosis. Anticancer Res. 2009; 29(5): p.&#160;<br/>1771-6.</p>
<p style="position:absolute;top:953px;left:87px;white-space:nowrap" class="ft171">83.&#160;&#160;De Milito A and Fais S. Tumor acidity, chemoresistance&#160;</p>
<p style="position:absolute;top:971px;left:114px;white-space:nowrap" class="ft172">and proton pump inhibitors. Future Oncol. 2005; 1(6): p.&#160;<br/>779-86.</p>
<p style="position:absolute;top:1010px;left:87px;white-space:nowrap" class="ft171">84.&#160;&#160;Tannock IF and Rotin D. Acid pH in tumors and its&#160;</p>
<p style="position:absolute;top:1028px;left:114px;white-space:nowrap" class="ft172">potential for therapeutic exploitation. Cancer Res. 1989;&#160;<br/>49(16): p. 4373-84.</p>
<p style="position:absolute;top:1067px;left:87px;white-space:nowrap" class="ft171">85.&#160;&#160;Entschladen F, Lang K, Drell TL, Joseph J, and Zaenker&#160;</p>
<p style="position:absolute;top:71px;left:514px;white-space:nowrap" class="ft172">KS. Neurotransmitters are regulators for the migration of&#160;<br/>tumor cells and leukocytes. Cancer Immunol Immunother.&#160;<br/>2002; 51(9): p. 467-82.</p>
<p style="position:absolute;top:128px;left:487px;white-space:nowrap" class="ft171">86.&#160;&#160;Strutz-Seebohm N, Gutcher I, Decher N, Steinmeyer K,&#160;</p>
<p style="position:absolute;top:146px;left:514px;white-space:nowrap" class="ft172">Lang F, and Seebohm G. Comparison of potent Kv1.5&#160;<br/>potassium channel inhibitors reveals the molecular basis for&#160;<br/>blocking kinetics and binding mode. Cell Physiol Biochem.&#160;<br/>2007; 20(6): p. 791-800.</p>
<p style="position:absolute;top:221px;left:487px;white-space:nowrap" class="ft171">87.&#160;&#160;Pai VP, Aw S, Shomrat T, Lemire JM, and Levin M.&#160;</p>
<p style="position:absolute;top:239px;left:514px;white-space:nowrap" class="ft172">Transmembrane voltage potential controls embryonic&#160;eye&#160;<br/>patterning in Xenopus laevis. Development. 2011.</p>
<p style="position:absolute;top:278px;left:487px;white-space:nowrap" class="ft171">88.&#160;&#160;Adams DS and Levin M. Inverse drug screens: a rapid&#160;</p>
<p style="position:absolute;top:296px;left:514px;white-space:nowrap" class="ft172">and inexpensive method for implicating molecular targets.&#160;<br/>Genesis. 2006; 44(11): p. 530-40.</p>
<p style="position:absolute;top:335px;left:487px;white-space:nowrap" class="ft171">89.&#160;&#160;Landry DW, Reitman M, Cragoe EJ, Jr., and Al-Awqati&#160;</p>
<p style="position:absolute;top:353px;left:514px;white-space:nowrap" class="ft172">Q. Epithelial chloride channel. Development of inhibitory&#160;<br/>ligands. J Gen Physiol. 1987; 90(6): p. 779-98.</p>
<p style="position:absolute;top:392px;left:487px;white-space:nowrap" class="ft171">90.&#160;Welsh MJ. Anthracene-9-carboxylic acid inhibits an&#160;</p>
<p style="position:absolute;top:410px;left:514px;white-space:nowrap" class="ft172">apical membrane chloride conductance in canine tracheal&#160;<br/>epithelium. J Membr Biol. 1984; 78(1): p. 61-71.</p>
<p style="position:absolute;top:449px;left:487px;white-space:nowrap" class="ft171">91.&#160;Pope AJ, Richardson SK, Ife RJ, and Keeling DJ.&#160;</p>
<p style="position:absolute;top:467px;left:514px;white-space:nowrap" class="ft173">Characterisation of the effects of anthranilic and&#160;<br/>(indanyloxy) acetic acid derivatives on chloride transport in&#160;<br/>membrane&#160;vesicles.&#160;Biochim&#160;Biophys&#160;Acta.&#160;1991;&#160;1067(1):&#160;<br/>p. 51-63.</p>
<p style="position:absolute;top:542px;left:487px;white-space:nowrap" class="ft171">92.&#160;&#160;Keeling DJ, Taylor AG, and Smith PL. Effects of NPPB&#160;</p>
<p style="position:absolute;top:560px;left:514px;white-space:nowrap" class="ft172">(5-nitro-2-(3-phenylpropylamino)benzoic&#160;acid)&#160;on&#160;chloride&#160;<br/>transport in intestinal tissues and the T84 cell line. Biochim&#160;<br/>Biophys Acta. 1991; 1115(1): p. 42-8.</p>
<p style="position:absolute;top:617px;left:487px;white-space:nowrap" class="ft171">93.&#160;Li X and Weinman SA. Chloride channels and&#160;</p>
<p style="position:absolute;top:635px;left:514px;white-space:nowrap" class="ft172">hepatocellular function: prospects for molecular&#160;<br/>identification. Annu Rev Physiol. 2002; 64: p. 609-33.</p>
<p style="position:absolute;top:674px;left:487px;white-space:nowrap" class="ft171">94.&#160;&#160;Shorning BY, Wilson DB, Meehan RR, and Ashley RH.&#160;</p>
<p style="position:absolute;top:692px;left:514px;white-space:nowrap" class="ft172">Molecular cloning and developmental expression of two&#160;<br/>Chloride Intracellular Channel (CLIC) genes in Xenopus&#160;<br/>laevis. Dev Genes Evol. 2003; 213(10): p. 514-8.</p>
<p style="position:absolute;top:749px;left:487px;white-space:nowrap" class="ft171">95.&#160;&#160;Singh H and Ashley RH. Redox regulation of CLIC1 by&#160;</p>
<p style="position:absolute;top:767px;left:514px;white-space:nowrap" class="ft172">cysteine&#160;residues&#160;associated&#160;with&#160;the&#160;putative&#160;channel&#160;pore.&#160;<br/>Biophys J. 2006; 90(5): p. 1628-38.</p>
<p style="position:absolute;top:806px;left:487px;white-space:nowrap" class="ft171">96.&#160;&#160;Levin M and Stevenson CG. Regulation of cell behavior&#160;</p>
<p style="position:absolute;top:824px;left:514px;white-space:nowrap" class="ft172">and tissue patterning by bioelectrical signals: challenges&#160;<br/>and opportunities for biomedical engineering. Annu Rev&#160;<br/>Biomed Eng. 2012; 14: p. 295-323.</p>
<p style="position:absolute;top:881px;left:487px;white-space:nowrap" class="ft171">97.&#160;&#160;Fukumoto T, Blakely R, and Levin M. Serotonin transporter&#160;</p>
<p style="position:absolute;top:899px;left:514px;white-space:nowrap" class="ft172">function&#160;is&#160;an&#160;early&#160;step&#160;in&#160;left-right&#160;patterning&#160;in&#160;chick&#160;and&#160;<br/>frog embryos. Dev Neurosci. 2005; 27(6): p. 349-63.</p>
<p style="position:absolute;top:938px;left:487px;white-space:nowrap" class="ft171">98.&#160;&#160;Fukumoto T, Kema IP, and Levin M. Serotonin signaling is&#160;</p>
<p style="position:absolute;top:956px;left:514px;white-space:nowrap" class="ft172">a very early step in patterning&#160;of the left-right&#160;axis in chick&#160;<br/>and frog embryos. Curr Biol. 2005; 15(9): p. 794-803.</p>
<p style="position:absolute;top:995px;left:487px;white-space:nowrap" class="ft171">99.&#160;&#160;Adams&#160;DS,&#160;Robinson&#160;KR,&#160;Fukumoto&#160;T,&#160;Yuan&#160;S,&#160;Albertson&#160;</p>
<p style="position:absolute;top:1013px;left:514px;white-space:nowrap" class="ft172">RC, Yelick P, Kuo L, McSweeney M, and Levin M.&#160;<br/>Early,&#160;H+-V-ATPase-dependent&#160;proton&#160;flux&#160;is&#160;necessary&#160;<br/>for&#160;consistent&#160;left-right&#160;patterning&#160;of&#160;non-mammalian&#160;<br/>vertebrates. Development. 2006; 133: p. 1657-1671.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft180{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft181{font-size:11px;font-family:Times;color:#211f21;}
	.ft182{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
	.ft183{font-size:11px;line-height:17px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page18-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft180">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft181">3303</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft180">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:87px;white-space:nowrap" class="ft181">100.&#160;Munaron L, Antoniotti S, Fiorio Pla A, and Lovisolo D.&#160;</p>
<p style="position:absolute;top:89px;left:114px;white-space:nowrap" class="ft182">Blocking Ca2+ entry: a way to control cell proliferation.&#160;<br/>Curr Med Chem. 2004; 11(12): p. 1533-43.</p>
<p style="position:absolute;top:128px;left:87px;white-space:nowrap" class="ft181">101.&#160;Munaron L, Antoniotti S, and Lovisolo D. Intracellular&#160;</p>
<p style="position:absolute;top:146px;left:114px;white-space:nowrap" class="ft182">calcium&#160;signals&#160;and&#160;control&#160;of&#160;cell&#160;proliferation:&#160;how&#160;many&#160;<br/>mechanisms? J Cell Mol Med. 2004; 8(2): p. 161-8.</p>
<p style="position:absolute;top:185px;left:87px;white-space:nowrap" class="ft181">102.&#160;Carneiro&#160;K,&#160;Donnet&#160;C,&#160;Rejtar&#160;T,&#160;Karger&#160;BL,&#160;Barisone&#160;GA,&#160;</p>
<p style="position:absolute;top:203px;left:114px;white-space:nowrap" class="ft182">Diaz&#160;E,&#160;Kortagere&#160;S,&#160;Lemire&#160;JM,&#160;and&#160;Levin&#160;M.&#160;Histone&#160;<br/>deacetylase activity is necessary for left-right patterning&#160;<br/>during vertebrate development. BMC Dev Biol. 2011; 11:&#160;<br/>p. 29.</p>
<p style="position:absolute;top:278px;left:87px;white-space:nowrap" class="ft181">103.&#160;Tseng AS, Carneiro K, Lemire JM, and Levin M. HDAC&#160;</p>
<p style="position:absolute;top:296px;left:114px;white-space:nowrap" class="ft182">activity&#160;is required during Xenopus tail&#160;regeneration.&#160;PLoS&#160;<br/>ONE. 2011; 6(10): p. e26382.</p>
<p style="position:absolute;top:335px;left:87px;white-space:nowrap" class="ft181">104.&#160;Levin M. Reprogramming cells and tissue patterning&#160;</p>
<p style="position:absolute;top:353px;left:114px;white-space:nowrap" class="ft182">via bioelectrical pathways: molecular mechanisms and&#160;<br/>biomedical opportunities. Wiley Interdiscip Rev Syst Biol&#160;<br/>Med. 2013.</p>
<p style="position:absolute;top:410px;left:87px;white-space:nowrap" class="ft181">105.&#160;Davie JR. Inhibition of histone deacetylase activity by&#160;</p>
<p style="position:absolute;top:428px;left:114px;white-space:nowrap" class="ft181">butyrate. J Nutr. 2003; 133(7 Suppl): p. 2485S-2493S.</p>
<p style="position:absolute;top:449px;left:87px;white-space:nowrap" class="ft181">106.&#160;Orchel&#160;A,&#160;Dzierzewicz&#160;Z,&#160;Parfiniewicz&#160;B,&#160;Weglarz&#160;L,&#160;and&#160;</p>
<p style="position:absolute;top:467px;left:114px;white-space:nowrap" class="ft182">Wilczok T. Butyrate-induced differentiation of colon cancer&#160;<br/>cells is PKC and JNK dependent.&#160;Dig Dis Sci. 2005; 50(3):&#160;<br/>p. 490-8.</p>
<p style="position:absolute;top:524px;left:87px;white-space:nowrap" class="ft181">107.&#160;Hague A, Elder&#160;DJ, Hicks DJ, and&#160;Paraskeva&#160;C. Apoptosis&#160;</p>
<p style="position:absolute;top:542px;left:114px;white-space:nowrap" class="ft182">in colorectal tumour cells: induction by the short chain fatty&#160;<br/>acids butyrate, propionate and acetate and by the bile salt&#160;<br/>deoxycholate. Int J Cancer. 1995; 60(3): p. 400-6.</p>
<p style="position:absolute;top:599px;left:87px;white-space:nowrap" class="ft181">108.&#160;Rutenburg AM, Shapiro P, and Schweinburg F. Novobiocin&#160;</p>
<p style="position:absolute;top:617px;left:114px;white-space:nowrap" class="ft182">in&#160;the&#160;treatment&#160;of&#160;surgical&#160;infections&#160;due&#160;to&#160;staphylococci&#160;<br/>and other gram-positive bacteria. N Engl J Med. 1956;&#160;<br/>255(7): p. 325-30.</p>
<p style="position:absolute;top:674px;left:87px;white-space:nowrap" class="ft181">109.&#160;Gellert M, O’Dea MH, Itoh T, and Tomizawa J. Novobiocin&#160;</p>
<p style="position:absolute;top:692px;left:114px;white-space:nowrap" class="ft182">and coumermycin inhibit DNA supercoiling catalyzed by&#160;<br/>DNA gyrase. Proc Natl Acad Sci U S A. 1976; 73(12): p.&#160;<br/>4474-8.</p>
<p style="position:absolute;top:749px;left:87px;white-space:nowrap" class="ft181">110.&#160;Burlison JA,&#160;Neckers L, Smith AB, Maxwell A, and Blagg&#160;</p>
<p style="position:absolute;top:767px;left:114px;white-space:nowrap" class="ft182">BS. Novobiocin: redesigning a DNA gyrase inhibitor&#160;<br/>for selective inhibition of hsp90. J Am Chem Soc. 2006;&#160;<br/>128(48): p. 15529-36.</p>
<p style="position:absolute;top:824px;left:87px;white-space:nowrap" class="ft181">111.&#160;Shen LL&#160;and&#160;Pernet&#160;AG. Mechanism&#160;of inhibition&#160;of DNA&#160;</p>
<p style="position:absolute;top:842px;left:114px;white-space:nowrap" class="ft182">gyrase by analogues of nalidixic acid: the target of the drugs&#160;<br/>is&#160;DNA.&#160;Proc&#160;Natl&#160;Acad&#160;Sci&#160;U&#160;S&#160;A.&#160;1985;&#160;82(2):&#160;p.&#160;307-11.</p>
<p style="position:absolute;top:881px;left:87px;white-space:nowrap" class="ft181">112.&#160;Kunzelmann K. Ion channels and cancer. J Membr Biol.&#160;</p>
<p style="position:absolute;top:899px;left:114px;white-space:nowrap" class="ft181">2005; 205(3): p. 159-73.</p>
<p style="position:absolute;top:920px;left:87px;white-space:nowrap" class="ft181">113.&#160;Becchetti&#160;A. Ion channels&#160;and&#160;transporters&#160;in&#160;cancer.&#160;1. Ion&#160;</p>
<p style="position:absolute;top:938px;left:114px;white-space:nowrap" class="ft182">channels&#160;and&#160;cell&#160;proliferation&#160;in&#160;cancer.&#160;Am&#160;J&#160;Physiol&#160;Cell&#160;<br/>Physiol. 2011; 301(2): p. C255-65.</p>
<p style="position:absolute;top:977px;left:87px;white-space:nowrap" class="ft181">114.&#160;Borys P. On the biophysics of cathodal galvanotaxis in&#160;</p>
<p style="position:absolute;top:995px;left:114px;white-space:nowrap" class="ft182">rat prostate cancer cells: Poisson-Nernst-Planck equation&#160;<br/>approach. Eur Biophys J. 2012; 41(6): p. 527-34.</p>
<p style="position:absolute;top:1034px;left:87px;white-space:nowrap" class="ft181">115.&#160;Tsai HF, Huang CW, Chang HF, Chen JJ, Lee CH, and&#160;</p>
<p style="position:absolute;top:1052px;left:114px;white-space:nowrap" class="ft182">Cheng JY. Evaluation of EGFR and RTK signaling in the&#160;<br/>electrotaxis of lung adenocarcinoma cells under direct-</p>
<p style="position:absolute;top:71px;left:514px;white-space:nowrap" class="ft182">current&#160;electric&#160;field&#160;stimulation.&#160;PLoS&#160;ONE.&#160;2013;&#160;8(8):&#160;p.&#160;<br/>e73418.</p>
<p style="position:absolute;top:110px;left:487px;white-space:nowrap" class="ft181">116.&#160;Stock C, Ludwig FT, Hanley PJ, and Schwab A. Roles of&#160;</p>
<p style="position:absolute;top:128px;left:514px;white-space:nowrap" class="ft183">Ion Transport in Control of Cell Motility. Comprehensive&#160;<br/>Physiology. 2013; 3(1): p. 59-119.</p>
<p style="position:absolute;top:167px;left:487px;white-space:nowrap" class="ft181">117.&#160;Sun YS, Peng&#160;SW,&#160;Lin KH, and&#160;Cheng&#160;JY.&#160;Electrotaxis&#160;</p>
<p style="position:absolute;top:185px;left:514px;white-space:nowrap" class="ft182">of&#160;lung&#160;cancer&#160;cells&#160;in&#160;ordered&#160;three-dimensional&#160;scaffolds.&#160;<br/>Biomicrofluidics. 2012; 6(1): p. 14102-1410214.</p>
<p style="position:absolute;top:224px;left:487px;white-space:nowrap" class="ft181">118.&#160;Huang CW, Chen HY, Yen MH, Chen JJ, Young TH, and&#160;</p>
<p style="position:absolute;top:242px;left:514px;white-space:nowrap" class="ft182">Cheng&#160;JY.&#160;Gene&#160;expression&#160;of&#160;human&#160;lung&#160;cancer&#160;cell&#160;line&#160;<br/>CL1-5&#160;in&#160;response&#160;to&#160;a&#160;direct&#160;current&#160;electric&#160;field.&#160;PLoS&#160;<br/>ONE. 2011; 6(10): p. e25928.</p>
<p style="position:absolute;top:299px;left:487px;white-space:nowrap" class="ft181">119.&#160;Yan X, Han J, Zhang Z, Wang J, Cheng Q, Gao K, Ni Y,&#160;</p>
<p style="position:absolute;top:317px;left:514px;white-space:nowrap" class="ft182">and&#160;Wang&#160;Y. Lung&#160;cancer&#160;A549 cells&#160;migrate&#160;directionally&#160;<br/>in&#160;DC&#160;electric&#160;fields&#160;with&#160;polarized&#160;and&#160;activated&#160;EGFRs.&#160;<br/>Bioelectromagnetics. 2009; 30(1): p. 29-35.</p>
<p style="position:absolute;top:374px;left:487px;white-space:nowrap" class="ft181">120.&#160;Pillozzi S, Brizzi MF, Balzi M, Crociani O, Cherubini&#160;</p>
<p style="position:absolute;top:392px;left:514px;white-space:nowrap" class="ft182">A, Guasti L, Bartolozzi B, Becchetti A, Wanke E,&#160;<br/>Bernabei PA, Olivotto&#160;M, Pegoraro L,&#160;and Arcangeli A.&#160;<br/>HERG potassium channels are constitutively expressed&#160;<br/>in primary human acute myeloid leukemias and regulate&#160;<br/>cell proliferation of normal and leukemic hemopoietic&#160;<br/>progenitors. Leukemia. 2002; 16(9): p. 1791-8.</p>
<p style="position:absolute;top:503px;left:487px;white-space:nowrap" class="ft181">121.&#160;Kamleiter M, Hanemann CO, Kluwe L, Rosenbaum&#160;</p>
<p style="position:absolute;top:521px;left:514px;white-space:nowrap" class="ft182">C, Wosch S, Mautner VF, Muller HW, and Grafe P.&#160;<br/>Voltage-dependent membrane currents of cultured human&#160;<br/>neurofibromatosis&#160;&#160;type&#160;&#160;2&#160;&#160;Schwann&#160;&#160;cells.&#160;&#160;GLIA.&#160;&#160;1998;&#160;<br/>24(3): p. 313-22.</p>
<p style="position:absolute;top:596px;left:487px;white-space:nowrap" class="ft181">122.&#160;Knutson P, Ghiani CA, Zhou JM, Gallo V, and McBain CJ.&#160;</p>
<p style="position:absolute;top:614px;left:514px;white-space:nowrap" class="ft182">K+ channel&#160;expression and cell proliferation are regulated&#160;<br/>by&#160;intracellular&#160;sodium&#160;and&#160;membrane&#160;depolarization&#160;in&#160;<br/>oligodendrocyte&#160;progenitor&#160;cells.&#160;Journal&#160;of&#160;Neuroscience.&#160;<br/>1997; 17(8): p. 2669-82.</p>
<p style="position:absolute;top:689px;left:487px;white-space:nowrap" class="ft181">123.&#160;Becchetti&#160;A. Ion channels&#160;and&#160;transporters&#160;in&#160;cancer.&#160;1. Ion&#160;</p>
<p style="position:absolute;top:707px;left:514px;white-space:nowrap" class="ft182">channels&#160;and&#160;cell&#160;proliferation&#160;in&#160;cancer.&#160;American&#160;journal&#160;<br/>of physiology. Cell physiology. 2011; 301(2): p. C255-65.</p>
<p style="position:absolute;top:746px;left:487px;white-space:nowrap" class="ft181">124.&#160;Arcangeli A. Ion channels and transporters in cancer. 3. Ion&#160;</p>
<p style="position:absolute;top:764px;left:514px;white-space:nowrap" class="ft182">channels in the tumor cell-microenvironment cross talk.&#160;<br/>American journal of physiology. Cell physiology. 2011;&#160;<br/>301(4): p. C762-71.</p>
<p style="position:absolute;top:821px;left:487px;white-space:nowrap" class="ft181">125.&#160;Prevarskaya N, Skryma R, and Shuba Y. Ion channels and&#160;</p>
<p style="position:absolute;top:839px;left:514px;white-space:nowrap" class="ft182">the hallmarks of cancer. Trends Mol Med. 2010; 16(3): p.&#160;<br/>107-21.</p>
<p style="position:absolute;top:878px;left:487px;white-space:nowrap" class="ft181">126.&#160;Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S,&#160;</p>
<p style="position:absolute;top:896px;left:514px;white-space:nowrap" class="ft182">and&#160;Becchetti&#160;A.&#160;Targeting&#160;ion&#160;channels&#160;in&#160;cancer:&#160;a&#160;novel&#160;<br/>frontier in antineoplastic therapy. Curr Med Chem. 2009;&#160;<br/>16(1): p. 66-93.</p>
<p style="position:absolute;top:953px;left:487px;white-space:nowrap" class="ft181">127.&#160;Pullar CE. The physiology of bioelectricity in development,&#160;</p>
<p style="position:absolute;top:971px;left:514px;white-space:nowrap" class="ft182">tissue regeneration,&#160;and&#160;cancer. Biological effects of&#160;<br/>electromagnetics series. 2011, Boca Raton: CRC Press.</p>
<p style="position:absolute;top:1010px;left:487px;white-space:nowrap" class="ft181">128.&#160;Tsonis PA. Embryogenesis and carcinogenesis: order and&#160;</p>
<p style="position:absolute;top:1028px;left:514px;white-space:nowrap" class="ft181">disorder. Anticancer Res. 1987; 7(4A): p. 617-23.</p>
<p style="position:absolute;top:1049px;left:487px;white-space:nowrap" class="ft181">129.&#160;Pierce GB and Speers WC. Tumors as caricatures of the&#160;</p>
<p style="position:absolute;top:1067px;left:514px;white-space:nowrap" class="ft181">process of tissue renewal: prospects for therapy by directing&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft190{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft191{font-size:11px;font-family:Times;color:#211f21;}
	.ft192{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
	.ft193{font-size:11px;line-height:17px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page19-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft190">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft191">3304</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft190">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:114px;white-space:nowrap" class="ft191">differentiation. Cancer Res. 1988; 48(8): p. 1996-2004.</p>
<p style="position:absolute;top:92px;left:87px;white-space:nowrap" class="ft191">130.&#160;Kopelovich L, Henson DE, Gazdar AF, Dunn B, Srivastava&#160;</p>
<p style="position:absolute;top:110px;left:114px;white-space:nowrap" class="ft193">S, Kelloff GJ, and Greenwald P. Surrogate anatomic/<br/>functional sites for evaluating cancer risk: an extension of&#160;<br/>the&#160;field&#160;effect.&#160;Clin&#160;Cancer&#160;Res.&#160;1999;&#160;5(12):&#160;p.&#160;3899-905.</p>
<p style="position:absolute;top:167px;left:87px;white-space:nowrap" class="ft191">131.&#160;Burr HS, Strong LC, and Smith&#160;GM. Bioelectric&#160;correlates&#160;</p>
<p style="position:absolute;top:185px;left:114px;white-space:nowrap" class="ft192">of methylcolantherene-induced tumors in mice. Yale J Biol.&#160;<br/>Med. 1938; 10: p. 539–544.</p>
<p style="position:absolute;top:224px;left:87px;white-space:nowrap" class="ft191">132.&#160;Backman V and Roy HK. Advances in biophotonics&#160;</p>
<p style="position:absolute;top:242px;left:114px;white-space:nowrap" class="ft192">detection&#160;&#160;of&#160;&#160;field&#160;&#160;carcinogenesis&#160;&#160;for&#160;&#160;colon&#160;&#160;cancer&#160;&#160;risk&#160;<br/>stratification. Journal of Cancer. 2013; 4(3): p. 251-61.</p>
<p style="position:absolute;top:281px;left:87px;white-space:nowrap" class="ft191">133.&#160;Burr HS. Biologic&#160;Organization&#160;and&#160;the&#160;Cancer&#160;Problem&#160;*.&#160;</p>
<p style="position:absolute;top:299px;left:114px;white-space:nowrap" class="ft192">The&#160;Yale&#160;Journal&#160;of&#160;Biology&#160;and&#160;Medicine.&#160;1940;&#160;12(3):&#160;p.&#160;<br/>277-82.</p>
<p style="position:absolute;top:338px;left:87px;white-space:nowrap" class="ft191">134.&#160;Burr&#160;&#160;HS.&#160;&#160;Changes&#160;&#160;in&#160;&#160;the&#160;&#160;field&#160;&#160;properties&#160;&#160;of&#160;&#160;mice&#160;&#160;with&#160;</p>
<p style="position:absolute;top:356px;left:114px;white-space:nowrap" class="ft192">transplanted tumors. Yale Journal of Biology &amp; Medicine.&#160;<br/>1941; 13: p. 783-788.</p>
<p style="position:absolute;top:395px;left:87px;white-space:nowrap" class="ft191">135.&#160;Nordenstrom BEW. Biologically Closed Electric Circuits:&#160;</p>
<p style="position:absolute;top:413px;left:114px;white-space:nowrap" class="ft191">Nordic Medical Publications.</p>
<p style="position:absolute;top:434px;left:87px;white-space:nowrap" class="ft191">136.&#160;Cone&#160;CD.&#160;Unified&#160;theory&#160;on&#160;the&#160;basic&#160;mechanism&#160;of&#160;normal&#160;</p>
<p style="position:absolute;top:452px;left:114px;white-space:nowrap" class="ft192">mitotic control and oncogenesis. Journal of Theoretical&#160;<br/>Biology. 1971; 30(1): p. 151-81.</p>
<p style="position:absolute;top:491px;left:87px;white-space:nowrap" class="ft191">137.&#160;Cone CD, Jr. Variation of the transmembrane potential level&#160;</p>
<p style="position:absolute;top:509px;left:114px;white-space:nowrap" class="ft193">as a basic mechanism of mitosis control. Oncology. 1970;&#160;<br/>24(6): p. 438-70.</p>
<p style="position:absolute;top:548px;left:87px;white-space:nowrap" class="ft191">138.&#160;Binggeli R and Weinstein R. Membrane potentials and&#160;</p>
<p style="position:absolute;top:566px;left:114px;white-space:nowrap" class="ft192">sodium channels: hypotheses for growth regulation and&#160;<br/>cancer&#160;formation based&#160;on&#160;changes&#160;in&#160;sodium&#160;channels&#160;and&#160;<br/>gap junctions. Journal of Theoretical Biology. 1986; 123: p.&#160;<br/>377-401.</p>
<p style="position:absolute;top:641px;left:87px;white-space:nowrap" class="ft191">139.&#160;Higashimori&#160;H and&#160;Sontheimer&#160;H. Role&#160;of&#160;Kir4.1&#160;channels&#160;</p>
<p style="position:absolute;top:659px;left:114px;white-space:nowrap" class="ft191">in growth control of glia. GLIA. 2007; 55(16): p. 1668-79.</p>
<p style="position:absolute;top:680px;left:87px;white-space:nowrap" class="ft191">140.&#160;Arcangeli A, Bianchi L, Becchetti A, Faravelli L,&#160;</p>
<p style="position:absolute;top:698px;left:114px;white-space:nowrap" class="ft192">Coronnello M,&#160;Mini E, Olivotto M,&#160;and Wanke E. A novel&#160;<br/>inward-rectifying&#160;K+&#160;current&#160;with&#160;a&#160;cell-cycle&#160;dependence&#160;<br/>governs the resting potential&#160;of mammalian&#160;neuroblastoma&#160;<br/>cells. Journal of Physiology. 1995; 489(Pt 2): p. 455-71.</p>
<p style="position:absolute;top:773px;left:87px;white-space:nowrap" class="ft191">141.&#160;Nilius B, Schwarz G, and Droogmans G. Control of&#160;</p>
<p style="position:absolute;top:791px;left:114px;white-space:nowrap" class="ft192">intracellular calcium by membrane potential in human&#160;<br/>melanoma cells. Am J Physiol. 1993; 265(6 Pt 1): p. C1501-<br/>10.</p>
<p style="position:absolute;top:848px;left:87px;white-space:nowrap" class="ft191">142.&#160;Yamashita&#160;M. Ion channel&#160;activities&#160;in neural&#160;stem cells&#160;of&#160;</p>
<p style="position:absolute;top:866px;left:114px;white-space:nowrap" class="ft192">the neuroepithelium. Stem cells international. 2012; 2012:&#160;<br/>p. 247670.</p>
<p style="position:absolute;top:905px;left:87px;white-space:nowrap" class="ft191">143.&#160;Fenno L, Yizhar O, and Deisseroth K. The development&#160;</p>
<p style="position:absolute;top:923px;left:114px;white-space:nowrap" class="ft192">and application of optogenetics. Annual Review of&#160;<br/>Neuroscience. 2011; 34: p. 389-412.</p>
<p style="position:absolute;top:962px;left:87px;white-space:nowrap" class="ft191">144.&#160;Adams DS, Tseng AS, and Levin M. Light-activation of the&#160;</p>
<p style="position:absolute;top:980px;left:114px;white-space:nowrap" class="ft192">Archaerhodopsin H(+)-pump reverses age-dependent loss&#160;<br/>of vertebrate regeneration: sparking system-level controls&#160;<br/>in vivo. Biology Open. 2013; 2(3): p. 306-13.</p>
<p style="position:absolute;top:1037px;left:87px;white-space:nowrap" class="ft191">145.&#160;Stuhmer W, Alves F, Hartung F, Zientkowska M, and Pardo&#160;</p>
<p style="position:absolute;top:1055px;left:114px;white-space:nowrap" class="ft192">LA. Potassium channels as tumour markers. FEBS Lett.&#160;<br/>2006; 580(12): p. 2850-2.</p>
<p style="position:absolute;top:71px;left:487px;white-space:nowrap" class="ft191">146.&#160;Killion JJ. Electrical properties of normal and transformed&#160;</p>
<p style="position:absolute;top:89px;left:514px;white-space:nowrap" class="ft192">mammalian cells. Biophysical Journal. 1984; 45(3): p. 523-<br/>8.</p>
<p style="position:absolute;top:128px;left:487px;white-space:nowrap" class="ft191">147.&#160;Bianchi&#160;L,&#160;Wible&#160;B, Arcangeli&#160;A, Taglialatela&#160;M, Morra F,&#160;</p>
<p style="position:absolute;top:146px;left:514px;white-space:nowrap" class="ft192">Castaldo P, Crociani O, Rosati B, Faravelli L, Olivotto M,&#160;<br/>and Wanke E. herg encodes a K+ current highly conserved&#160;<br/>in tumors of different histogenesis: a selective advantage for&#160;<br/>cancer cells? Cancer Research. 1998; 58(4): p. 815-22.</p>
<p style="position:absolute;top:221px;left:487px;white-space:nowrap" class="ft191">148.&#160;Wissenbach U, Niemeyer B, Himmerkus N, Fixemer T,&#160;</p>
<p style="position:absolute;top:239px;left:514px;white-space:nowrap" class="ft192">Bonkhoff H, and Flockerzi&#160;V. TRPV6 and prostate&#160;cancer:&#160;<br/>cancer growth beyond the prostate correlates with increased&#160;<br/>TRPV6 Ca2+ channel expression. Biochem Biophys Res&#160;<br/>Commun. 2004; 322(4): p. 1359-63.</p>
<p style="position:absolute;top:314px;left:487px;white-space:nowrap" class="ft191">149.&#160;Marino A, Morris D, Schwalke M, Iliev I, and Rogers S.&#160;</p>
<p style="position:absolute;top:332px;left:514px;white-space:nowrap" class="ft192">Electrical potential measurements in human breast cancer&#160;<br/>and benign lesions. Tumour Biology. 1994; 15(3): p. 147-<br/>52.</p>
<p style="position:absolute;top:389px;left:487px;white-space:nowrap" class="ft191">150.&#160;Fraser SP, Grimes JA, and Djamgoz MB. Effects of voltage-</p>
<p style="position:absolute;top:407px;left:514px;white-space:nowrap" class="ft192">gated ion channel modulators on rat prostatic cancer cell&#160;<br/>proliferation: comparison of strongly and weakly metastatic&#160;<br/>cell lines. Prostate. 2000; 44(1): p. 61-76.</p>
<p style="position:absolute;top:464px;left:487px;white-space:nowrap" class="ft191">151.&#160;Prevarskaya N, Zhang L, and Barritt G. TRP channels in&#160;</p>
<p style="position:absolute;top:482px;left:514px;white-space:nowrap" class="ft191">cancer. Biochim Biophys Acta. 2007; 1772(8): p. 937-46.</p>
<p style="position:absolute;top:503px;left:487px;white-space:nowrap" class="ft191">152.&#160;Fraser SP, Diss JK, Chioni AM, Mycielska ME, Pan H,&#160;</p>
<p style="position:absolute;top:521px;left:514px;white-space:nowrap" class="ft192">Yamaci&#160;RF,&#160;Pani&#160;F,&#160;Siwy&#160;Z,&#160;Krasowska&#160;M,&#160;Grzywna&#160;Z,&#160;<br/>Brackenbury WJ, Theodorou D, Koyuturk M, Kaya H,&#160;<br/>Battaloglu E, De Bella MT, et al. Voltage-gated sodium&#160;<br/>channel expression and potentiation of human breast cancer&#160;<br/>metastasis. Clin Cancer Res. 2005; 11(15): p. 5381-9.</p>
<p style="position:absolute;top:614px;left:487px;white-space:nowrap" class="ft191">153.&#160;Onkal R and Djamgoz MB. Molecular pharmacology of&#160;</p>
<p style="position:absolute;top:632px;left:514px;white-space:nowrap" class="ft192">voltage-gated sodium channel expression in metastatic&#160;<br/>disease: clinical potential of neonatal Nav1.5 in breast&#160;<br/>cancer. Eur J Pharmacol. 2009; 625(1-3): p. 206-19.</p>
<p style="position:absolute;top:689px;left:487px;white-space:nowrap" class="ft191">154.&#160;Ouwerkerk R, Jacobs MA, Macura KJ, Wolff AC, Stearns&#160;</p>
<p style="position:absolute;top:707px;left:514px;white-space:nowrap" class="ft192">V, Mezban SD, Khouri NF, Bluemke DA, and Bottomley&#160;<br/>PA. Elevated tissue sodium concentration in malignant&#160;<br/>breast lesions detected with non-invasive 23Na MRI. Breast&#160;<br/>Cancer Res Treat. 2007; 106(2): p. 151-60.</p>
<p style="position:absolute;top:782px;left:487px;white-space:nowrap" class="ft191">155.&#160;Jansson&#160;B.&#160;Potassium,&#160;sodium,&#160;and&#160;cancer:&#160;a&#160;review.&#160;J&#160;</p>
<p style="position:absolute;top:800px;left:514px;white-space:nowrap" class="ft191">Environ Pathol Toxicol Oncol. 1996; 15(2-4): p. 65-73.</p>
<p style="position:absolute;top:821px;left:487px;white-space:nowrap" class="ft191">156.&#160;Cameron IL, Smith NK, Pool TB, and Sparks RL.&#160;</p>
<p style="position:absolute;top:839px;left:514px;white-space:nowrap" class="ft192">Intracellular&#160;concentration&#160;of&#160;sodium&#160;and&#160;other&#160;elements&#160;as&#160;<br/>related to mitogenesis and oncogenesis in vivo. Cancer Res.&#160;<br/>1980; 40(5): p. 1493-500.</p>
<p style="position:absolute;top:896px;left:487px;white-space:nowrap" class="ft191">157.&#160;Barth LJ and Barth LG. Effect of the potassium ion on&#160;</p>
<p style="position:absolute;top:914px;left:514px;white-space:nowrap" class="ft192">induction of notochord from gastrula ectoderm of Rana&#160;<br/>pipiens. Biol Bull. 1974; 146(3): p. 313-25.</p>
<p style="position:absolute;top:953px;left:487px;white-space:nowrap" class="ft191">158.&#160;Barth LG and Barth LJ. Ionic regulation of embryonic&#160;</p>
<p style="position:absolute;top:971px;left:514px;white-space:nowrap" class="ft192">induction and cell differentiation in Rana pipiens. Dev Biol.&#160;<br/>1974; 39(1): p. 1-22.</p>
<p style="position:absolute;top:1010px;left:487px;white-space:nowrap" class="ft191">159.&#160;Barth LG and Barth LJ. The sodium dependence of&#160;</p>
<p style="position:absolute;top:1028px;left:514px;white-space:nowrap" class="ft192">embryonic&#160;induction.&#160;Developmental&#160;biology.&#160;1969;&#160;20(3):&#160;<br/>p. 236-62.</p>
<p style="position:absolute;top:1067px;left:487px;white-space:nowrap" class="ft191">160.&#160;Uzman JA, Patil S, Uzgare AR, and Sater AK. The role of&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft200{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft201{font-size:11px;font-family:Times;color:#211f21;}
	.ft202{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
	.ft203{font-size:11px;line-height:17px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page20-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft200">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft201">3305</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft200">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:114px;white-space:nowrap" class="ft202">intracellular alkalinization in the establishment of anterior&#160;<br/>neural fate in Xenopus. Developmental Biology. 1998;&#160;<br/>193(1): p. 10-20.</p>
<p style="position:absolute;top:128px;left:87px;white-space:nowrap" class="ft201">161.&#160;Obokata&#160;H,&#160;Wakayama&#160;T,&#160;Sasai&#160;Y,&#160;Kojima&#160;K,&#160;Vacanti&#160;MP,&#160;</p>
<p style="position:absolute;top:146px;left:114px;white-space:nowrap" class="ft202">Niwa H, Yamato M, and Vacanti CA. Stimulus-triggered&#160;<br/>fate conversion of somatic cells into pluripotency. Nature.&#160;<br/>2014; 505(7485): p. 641-7.</p>
<p style="position:absolute;top:203px;left:87px;white-space:nowrap" class="ft201">162.&#160;Raggi C, Factor VM, Seo D, Holczbauer A, Gillen MC,&#160;</p>
<p style="position:absolute;top:221px;left:114px;white-space:nowrap" class="ft202">Marquardt JU, Andersen JB, Durkin M, and Thorgeirsson&#160;<br/>SS. Epigenetic reprogramming modulates malignant&#160;<br/>properties of human liver cancer. Hepatology. 2014.</p>
<p style="position:absolute;top:278px;left:87px;white-space:nowrap" class="ft201">163.&#160;Ohnishi&#160;K,&#160;Semi&#160;K,&#160;Yamamoto&#160;T,&#160;Shimizu&#160;M, Tanaka&#160;</p>
<p style="position:absolute;top:296px;left:114px;white-space:nowrap" class="ft202">A, Mitsunaga K, Okita K, Osafune K, Arioka Y, Maeda&#160;<br/>T, Soejima H, Moriwaki H, Yamanaka S, Woltjen K, and&#160;<br/>Yamada Y. Premature termination of reprogramming in&#160;<br/>vivo leads to cancer development through altered epigenetic&#160;<br/>regulation. Cell. 2014; 156(4): p. 663-77.</p>
<p style="position:absolute;top:389px;left:87px;white-space:nowrap" class="ft201">164.&#160;Friedmann-Morvinski D and Verma IM. Dedifferentiation&#160;</p>
<p style="position:absolute;top:407px;left:114px;white-space:nowrap" class="ft202">and reprogramming: origins of cancer stem cells. EMBO&#160;<br/>reports. 2014.</p>
<p style="position:absolute;top:446px;left:87px;white-space:nowrap" class="ft201">165.&#160;Halley-Stott&#160;RP and Gurdon JB. Epigenetic&#160;memory&#160;in the&#160;</p>
<p style="position:absolute;top:464px;left:114px;white-space:nowrap" class="ft202">context&#160;of&#160;nuclear&#160;reprogramming&#160;and&#160;cancer.&#160;Briefings&#160;in&#160;<br/>functional genomics. 2013; 12(3): p. 164-73.</p>
<p style="position:absolute;top:503px;left:87px;white-space:nowrap" class="ft201">166.&#160;Wang P, Zhang C, Yu P, Tang B, Liu T, Cui H, and Xu J.&#160;</p>
<p style="position:absolute;top:521px;left:114px;white-space:nowrap" class="ft202">Regulation of colon cancer cell migration and invasion by&#160;<br/>CLIC1-mediated RVD. Mol Cell Biochem. 2012; 365(1-2):&#160;<br/>p. 313-21.</p>
<p style="position:absolute;top:578px;left:87px;white-space:nowrap" class="ft201">167.&#160;Setti&#160;M,&#160;Savalli&#160;N,&#160;Osti&#160;D,&#160;Richichi&#160;C,&#160;Angelini&#160;M,&#160;Brescia&#160;</p>
<p style="position:absolute;top:596px;left:114px;white-space:nowrap" class="ft202">P, Fornasari L, Carro MS, Mazzanti M, and Pelicci G.&#160;<br/>Functional&#160;role&#160;of&#160;CLIC1&#160;ion&#160;channel&#160;in&#160;glioblastoma-<br/>derived stem/progenitor cells. J Natl Cancer Inst. 2013;&#160;<br/>105(21): p. 1644-55.</p>
<p style="position:absolute;top:671px;left:87px;white-space:nowrap" class="ft201">168.&#160;Bowman EJ, Gustafson KR, Bowman BJ, and Boyd MR.&#160;</p>
<p style="position:absolute;top:689px;left:114px;white-space:nowrap" class="ft202">Identification&#160;&#160;of&#160;&#160;a&#160;&#160;new&#160;&#160;chondropsin&#160;&#160;class&#160;&#160;of&#160;&#160;antitumor&#160;<br/>compound&#160;that selectively inhibits V-ATPases. J Biol&#160;<br/>Chem. 2003.</p>
<p style="position:absolute;top:746px;left:87px;white-space:nowrap" class="ft201">169.&#160;Sennoune SR, Luo D, and Martinez-Zaguilan R.&#160;</p>
<p style="position:absolute;top:764px;left:114px;white-space:nowrap" class="ft202">Plasmalemmal vacuolar-type H+-ATPase in cancer biology.&#160;<br/>Cell Biochem Biophys. 2004; 40(2): p. 185-206.</p>
<p style="position:absolute;top:803px;left:87px;white-space:nowrap" class="ft201">170.&#160;Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C,&#160;</p>
<p style="position:absolute;top:821px;left:114px;white-space:nowrap" class="ft202">Weinberg&#160;RA,&#160;and&#160;Lander&#160;ES.&#160;Identification&#160;of&#160;selective&#160;<br/>inhibitors of cancer stem cells by high-throughput&#160;<br/>screening. Cell. 2009; 138(4): p. 645-59.</p>
<p style="position:absolute;top:878px;left:87px;white-space:nowrap" class="ft201">171.&#160;Levin&#160;&#160;M.&#160;&#160;Large-scale&#160;&#160;biophysics:&#160;&#160;ion&#160;&#160;flows&#160;&#160;and&#160;</p>
<p style="position:absolute;top:896px;left:114px;white-space:nowrap" class="ft201">regeneration. Trends Cell Biol. 2007; 17(6): p. 261-70.</p>
<p style="position:absolute;top:917px;left:87px;white-space:nowrap" class="ft201">172.&#160;Lagger G, O’Carroll D, Rembold M, Khier H, Tischler&#160;</p>
<p style="position:absolute;top:935px;left:114px;white-space:nowrap" class="ft202">J,&#160;Weitzer&#160;G,&#160;Schuettengruber&#160;B,&#160;Hauser&#160;C, Brunmeir&#160;R,&#160;<br/>Jenuwein T, and Seiser C. Essential function of histone&#160;<br/>deacetylase&#160;1&#160;in&#160;proliferation&#160;control&#160;and&#160;CDK&#160;inhibitor&#160;<br/>repression. EMBO J. 2002; 21(11): p. 2672-81.</p>
<p style="position:absolute;top:1010px;left:87px;white-space:nowrap" class="ft201">173.&#160;Marks PA, Richon VM, and Rifkind RA. Histone&#160;</p>
<p style="position:absolute;top:1028px;left:114px;white-space:nowrap" class="ft202">deacetylase inhibitors: inducers of differentiation or&#160;<br/>apoptosis of transformed cells. J Natl Cancer Inst. 2000;&#160;<br/>92(15): p. 1210-6.</p>
<p style="position:absolute;top:71px;left:487px;white-space:nowrap" class="ft201">174.&#160;Tan J, Cang S, Ma Y, Petrillo RL, and Liu D. Novel histone&#160;</p>
<p style="position:absolute;top:89px;left:514px;white-space:nowrap" class="ft202">deacetylase inhibitors in clinical trials as anti-cancer agents.&#160;<br/>J Hematol Oncol. 2010; 3: p. 5.</p>
<p style="position:absolute;top:128px;left:487px;white-space:nowrap" class="ft201">175.&#160;Wagner JM, Hackanson B, Lubbert M, and Jung M. Histone&#160;</p>
<p style="position:absolute;top:146px;left:514px;white-space:nowrap" class="ft202">deacetylase (HDAC) inhibitors in recent clinical trials for&#160;<br/>cancer&#160;therapy. Clin Epigenetics.&#160;2010; 1(3-4): p. 117-136.</p>
<p style="position:absolute;top:185px;left:487px;white-space:nowrap" class="ft201">176.&#160;Marks PA and Xu WS. Histone deacetylase inhibitors:&#160;</p>
<p style="position:absolute;top:203px;left:514px;white-space:nowrap" class="ft202">Potential in cancer&#160;therapy. J Cell Biochem. 2009; 107(4):&#160;<br/>p. 600-8.</p>
<p style="position:absolute;top:242px;left:487px;white-space:nowrap" class="ft201">177.&#160;Qiu T, Zhou L, Zhu W, Wang T, Wang J, Shu Y, and Liu&#160;</p>
<p style="position:absolute;top:260px;left:514px;white-space:nowrap" class="ft202">P. Effects of treatment with histone deacetylase inhibitors&#160;<br/>in solid tumors:&#160;a review&#160;based on 30 clinical&#160;trials.&#160;Future&#160;<br/>Oncol. 2013; 9(2): p. 255-69.</p>
<p style="position:absolute;top:317px;left:487px;white-space:nowrap" class="ft201">178.&#160;Marks PA. The clinical development of histone deacetylase&#160;</p>
<p style="position:absolute;top:335px;left:514px;white-space:nowrap" class="ft202">inhibitors as targeted anticancer drugs. Expert Opin Investig&#160;<br/>Drugs. 2010; 19(9): p. 1049-66.</p>
<p style="position:absolute;top:374px;left:487px;white-space:nowrap" class="ft201">179.&#160;Khan&#160;O&#160;and&#160;La&#160;Thangue&#160;NB.&#160;HDAC&#160;inhibitors&#160;in&#160;cancer&#160;</p>
<p style="position:absolute;top:392px;left:514px;white-space:nowrap" class="ft202">biology: emerging mechanisms and clinical applications.&#160;<br/>Immunol Cell Biol. 2012; 90(1): p. 85-94.</p>
<p style="position:absolute;top:431px;left:487px;white-space:nowrap" class="ft201">180.&#160;Santoro F, Botrugno OA, Dal Zuffo R, Pallavicini I,&#160;</p>
<p style="position:absolute;top:449px;left:514px;white-space:nowrap" class="ft203">Matthews GM, Cluse L, Barozzi I, Senese S, Fornasari&#160;<br/>L, Moretti S, Altucci L, Pelicci PG, Chiocca S, Johnstone&#160;<br/>RW, and Minucci S. A dual role for Hdac1: oncosuppressor&#160;<br/>in tumorigenesis, oncogene in tumor maintenance. Blood.&#160;<br/>2013; 121(17): p. 3459-68.</p>
<p style="position:absolute;top:542px;left:487px;white-space:nowrap" class="ft201">181.&#160;Ermolaeva MA, Segref A, Dakhovnik A, Ou HL, Schneider&#160;</p>
<p style="position:absolute;top:560px;left:514px;white-space:nowrap" class="ft202">JI, Utermohlen O, Hoppe T, and Schumacher B. DNA&#160;<br/>damage in germ cells induces an innate immune response&#160;<br/>that triggers systemic stress resistance. Nature. 2013;&#160;<br/>501(7467): p. 416-20.</p>
<p style="position:absolute;top:635px;left:487px;white-space:nowrap" class="ft201">182.&#160;Martin OA, Redon CE, Nakamura AJ, Dickey JS,&#160;</p>
<p style="position:absolute;top:653px;left:514px;white-space:nowrap" class="ft202">Georgakilas&#160;AG, and Bonner WM. Systemic&#160;DNA damage&#160;<br/>related to cancer. Cancer Res. 2011; 71(10): p. 3437-41.</p>
<p style="position:absolute;top:692px;left:487px;white-space:nowrap" class="ft201">183.&#160;Jernberg C, Lofmark S, Edlund C, and Jansson JK. Long-</p>
<p style="position:absolute;top:710px;left:514px;white-space:nowrap" class="ft202">term&#160;impacts&#160;of&#160;antibiotic&#160;exposure&#160;on&#160;the&#160;human&#160;intestinal&#160;<br/>microbiota. Microbiology. 2010; 156(Pt 11): p. 3216-23.</p>
<p style="position:absolute;top:749px;left:487px;white-space:nowrap" class="ft201">184.&#160;Fukuda M, Kanauchi O, Araki Y, Andoh A, Mitsuyama&#160;</p>
<p style="position:absolute;top:767px;left:514px;white-space:nowrap" class="ft202">K, Takagi K, Toyonaga A, Sata M, Fujiyama Y, Fukuoka&#160;<br/>M,&#160;Matsumoto Y, and Bamba T. Prebiotic treatment of&#160;<br/>experimental colitis with germinated barley foodstuff: a&#160;<br/>comparison with probiotic or antibiotic treatment. Int J Mol&#160;<br/>Med. 2002; 9(1): p. 65-70.</p>
<p style="position:absolute;top:860px;left:487px;white-space:nowrap" class="ft201">185.&#160;Young VB and Schmidt TM. Antibiotic-associated diarrhea&#160;</p>
<p style="position:absolute;top:878px;left:514px;white-space:nowrap" class="ft202">accompanied by large-scale alterations in the composition&#160;<br/>of the fecal microbiota. J Clin Microbiol. 2004; 42(3): p.&#160;<br/>1203-6.</p>
<p style="position:absolute;top:935px;left:487px;white-space:nowrap" class="ft201">186.&#160;Dethlefsen L, Huse S, Sogin ML, and Relman DA.&#160;</p>
<p style="position:absolute;top:953px;left:514px;white-space:nowrap" class="ft202">The pervasive effects of an antibiotic on the human gut&#160;<br/>microbiota, as revealed by deep 16S rRNA sequencing.&#160;<br/>PLoS Biol. 2008; 6(11): p. e280.</p>
<p style="position:absolute;top:1010px;left:487px;white-space:nowrap" class="ft201">187.&#160;Pryde SE, Duncan SH, Hold GL, Stewart&#160;CS, and Flint&#160;HJ.&#160;</p>
<p style="position:absolute;top:1028px;left:514px;white-space:nowrap" class="ft202">The microbiology of butyrate formation in the human colon.&#160;<br/>FEMS Microbiol Lett. 2002; 217(2): p. 133-9.</p>
<p style="position:absolute;top:1067px;left:487px;white-space:nowrap" class="ft201">188.&#160;Gottenbos B, Grijpma DW, van der Mei HC, Feijen J, and&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft210{font-size:11px;font-family:Times;color:#ac2b30;}
	.ft211{font-size:11px;font-family:Times;color:#211f21;}
	.ft212{font-size:11px;line-height:18px;font-family:Times;color:#211f21;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page21-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft210">Oncotarget</p>
<p style="position:absolute;top:1111px;left:442px;white-space:nowrap" class="ft211">3306</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft210">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:114px;white-space:nowrap" class="ft212">Busscher HJ. Antimicrobial effects of positively charged&#160;<br/>surfaces on adhering Gram-positive and Gram-negative&#160;<br/>bacteria. J Antimicrob Chemother. 2001; 48(1): p. 7-13.</p>
<p style="position:absolute;top:128px;left:87px;white-space:nowrap" class="ft211">189.&#160;Terada&#160;A,&#160;Yuasa&#160;A,&#160;Kushimoto&#160;T,&#160;Tsuneda&#160;S,&#160;Katakai&#160;</p>
<p style="position:absolute;top:146px;left:114px;white-space:nowrap" class="ft212">A, and Tamada M. Bacterial adhesion to and viability on&#160;<br/>positively charged polymer surfaces. Microbiology. 2006;&#160;<br/>152(Pt 12): p. 3575-83.</p>
<p style="position:absolute;top:203px;left:87px;white-space:nowrap" class="ft211">190.&#160;Sinha G. Charged by GSK investment, battery of&#160;</p>
<p style="position:absolute;top:221px;left:114px;white-space:nowrap" class="ft212">electroceuticals advance. Nature medicine. 2013; 19(6): p.&#160;<br/>654.</p>
<p style="position:absolute;top:260px;left:87px;white-space:nowrap" class="ft211">191.&#160;Famm&#160;K,&#160;Litt&#160;B,&#160;Tracey&#160;KJ,&#160;Boyden&#160;ES,&#160;and Slaoui&#160;M.&#160;</p>
<p style="position:absolute;top:278px;left:114px;white-space:nowrap" class="ft212">Drug discovery: a jump-start for electroceuticals. Nature.&#160;<br/>2013; 496(7444): p. 159-61.</p>
<p style="position:absolute;top:317px;left:87px;white-space:nowrap" class="ft211">192.&#160;Sive HL, Grainger RM, and Harland RM. Early&#160;</p>
<p style="position:absolute;top:335px;left:114px;white-space:nowrap" class="ft212">development of Xenopus laevis : a laboratory manual. 2000,&#160;<br/>Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory&#160;<br/>Press. ix, 338 p., 7 p. of plates.</p>
<p style="position:absolute;top:392px;left:87px;white-space:nowrap" class="ft211">193.&#160;Nieuwkoop PD and Faber J. Normal Table of Xenopus&#160;</p>
<p style="position:absolute;top:410px;left:114px;white-space:nowrap" class="ft212">Laevis (Daudin). 1967, Amesterdam: North-Holland&#160;<br/>Publishing Company&#160;</p>
<p style="position:absolute;top:449px;left:87px;white-space:nowrap" class="ft211">194.&#160;Yang&#160;S,&#160;Lockwood&#160;A,&#160;Hollett&#160;P,&#160;Ford&#160;R,&#160;and&#160;Kao&#160;K.&#160;</p>
<p style="position:absolute;top:467px;left:114px;white-space:nowrap" class="ft212">Overexpression of a novel Xenopus rel mRNA gene induces&#160;<br/>tumors in early embryos. J Biol Chem. 1998; 273(22): p.&#160;<br/>13746-52.</p>
<p style="position:absolute;top:524px;left:87px;white-space:nowrap" class="ft211">195.&#160;Miyanaga Y, Shiurba R, Nagata S, Pfeiffer CJ, and&#160;</p>
<p style="position:absolute;top:542px;left:114px;white-space:nowrap" class="ft212">Asashima M. Induction of blood cells in Xenopus embryo&#160;<br/>explants. Dev Genes Evol. 1998; 207(7): p. 417-26.</p>
<p style="position:absolute;top:581px;left:87px;white-space:nowrap" class="ft211">196.&#160;James-Kracke MR. Quick and accurate method to convert&#160;</p>
<p style="position:absolute;top:599px;left:114px;white-space:nowrap" class="ft212">BCECF&#160;fluorescence&#160;to&#160;pHi:&#160;calibration&#160;in&#160;three&#160;different&#160;<br/>types of cell preparations. J Cell Physiol. 1992; 151(3): p.&#160;<br/>596-603.</p>
<p style="position:absolute;top:656px;left:87px;white-space:nowrap" class="ft211">197.&#160;Vega AV, Avila G, and Matthews G. Interaction between&#160;</p>
<p style="position:absolute;top:674px;left:114px;white-space:nowrap" class="ft212">the transcriptional corepressor Sin3B and voltage-gated&#160;<br/>sodium&#160;channels&#160;modulates&#160;functional&#160;channel&#160;expression.&#160;<br/>Sci Rep. 2013; 3: p. 2809.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>8ac7cc4f31db1c7b65d65119a7e0d42f-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft220{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft221{font-size:14px;font-family:Times;color:#000000;}
	.ft222{font-size:14px;font-family:Times;color:#000000;}
	.ft223{font-size:14px;font-family:Times;color:#000000;}
	.ft224{font-size:16px;font-family:Times;color:#ffffff;}
	.ft225{font-size:16px;line-height:26px;font-family:Times;color:#ac2b30;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page22-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:108px;left:108px;white-space:nowrap" class="ft225"><b>Transmembrane&#160;&#160;voltage&#160;&#160;potential&#160;&#160;of&#160;&#160;somatic&#160;&#160;cells&#160;&#160;controls&#160;<br/>oncogene-mediated tumorigenesis at long-range&#160;&#160;</b></p>
<p style="position:absolute;top:183px;left:108px;white-space:nowrap" class="ft221"><b>&#160;</b></p>
<p style="position:absolute;top:211px;left:108px;white-space:nowrap" class="ft221"><b>SUPPLEMENTAL MATERIAL&#160;</b></p>
<p style="position:absolute;top:240px;left:108px;white-space:nowrap" class="ft221"><b>&#160;</b></p>
<p style="position:absolute;top:798px;left:606px;white-space:nowrap" class="ft221"><b>&#160;</b></p>
<p style="position:absolute;top:823px;left:108px;white-space:nowrap" class="ft221"><b>Supplemental&#160;figure 1</b>:&#160;E. coli preferentially&#160;colonize DN-HDAC1&#160;expressing cells.&#160;</p>
<p style="position:absolute;top:852px;left:162px;white-space:nowrap" class="ft222">(A)&#160;</p>
<p style="position:absolute;top:852px;left:216px;white-space:nowrap" class="ft222">Brightfield&#160;&#160;image&#160;&#160;of&#160;&#160;DN-HDAC1/lineage&#160;&#160;tracer&#160;&#160;injected&#160;&#160;(into&#160;&#160;1&#160;&#160;cell&#160;&#160;of&#160;&#160;16&#160;&#160;cell&#160;&#160;stage)&#160;</p>
<p style="position:absolute;top:880px;left:108px;white-space:nowrap" class="ft222">embryo,&#160;which&#160;is also&#160;infected&#160;with&#160;GFP-expressing&#160;<i>E.&#160;coli</i>&#160;at&#160;stage 12.&#160;</p>
<p style="position:absolute;top:909px;left:162px;white-space:nowrap" class="ft222">(B)&#160;</p>
<p style="position:absolute;top:909px;left:216px;white-space:nowrap" class="ft223"><i>E.&#160;coli</i>&#160;colonizes region&#160;of&#160;the tail&#160;marked&#160;by&#160;GFP&#160;expression.&#160;</p>
<p style="position:absolute;top:937px;left:162px;white-space:nowrap" class="ft222">(C)&#160;</p>
<p style="position:absolute;top:937px;left:216px;white-space:nowrap" class="ft222">The&#160;same&#160;region&#160;colonized&#160;by&#160;<i>E.&#160;coli</i>&#160;is&#160;also&#160;the&#160;site&#160;of&#160;DN-HDAC1&#160;expression,&#160;which&#160;is&#160;</p>
<p style="position:absolute;top:965px;left:108px;white-space:nowrap" class="ft222">represented&#160;by&#160;the red&#160;lineage tracer.&#160;&#160;</p>
<p style="position:absolute;top:994px;left:162px;white-space:nowrap" class="ft222">(D)&#160;</p>
<p style="position:absolute;top:994px;left:216px;white-space:nowrap" class="ft222">Merged&#160;photo&#160;of&#160;B&#160;&amp;&#160;C&#160;shows&#160;that&#160;site&#160;of&#160;HDAC1&#160;expression&#160;matches&#160;the&#160;site&#160;of&#160;<i>E.&#160;coli</i>&#160;</p>
<p style="position:absolute;top:1022px;left:108px;white-space:nowrap" class="ft222">colonization.&#160;</p>
<p style="position:absolute;top:1051px;left:108px;white-space:nowrap" class="ft222">&#160;</p>
<p style="position:absolute;top:557px;left:572px;white-space:nowrap" class="ft224">DN</p>
</div>
</body>
</html>
